Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42151,0.103268197995842,0.00500490745384588,0.0934585793863039,0.11307781660538,4.28697394625908e-93
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42120,-0.0572080370639765,0.00328940075178844,-0.0636552625374819,-0.0507608115904712,5.51585795580767e-67
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42197,0.0386275110848495,0.00240902691199974,0.03390581833733,0.043349203832369,2.59803155427962e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,42255,-0.0550181437698557,0.00356354793173339,-0.0620026977160531,-0.0480335898236583,2.63808971582712e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,42172,-0.0420394090561419,0.0028074852091355,-0.0475420800660475,-0.0365367380462363,2.85118788019818e-50
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,42128,0.0476599526892892,0.0032109372928891,0.0413665155952266,0.0539533897833518,1.96913136615506e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42004,0.044468461329733,0.00303602355015472,0.0385178551714297,0.0504190674880362,3.45419420094015e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42186,0.0499099017189364,0.00349482622366827,0.0430600423205466,0.0567597611173262,6.38899306235336e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42211,0.0653058539823212,0.00466471042681442,0.0561630215457649,0.0744486864188774,3.26110189048412e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,42103,0.0649164762045718,0.00472788975023998,0.0556498122941014,0.0741831401150422,1.32710837211963e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42004,0.0464273691123713,0.00339543795152215,0.0397723107273879,0.0530824274973547,2.89563695869225e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,40092,-0.0497640284268602,0.00364071710161364,-0.0568998339460229,-0.0426282229076975,3.47405974997293e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39902,0.243009015246875,0.0180999127007032,0.207533186353497,0.278484844140253,9.09407172887444e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42126,0.125547164426459,0.00942776527463706,0.107068744488171,0.144025584364748,3.40209845618454e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42256,0.0545151602781441,0.00415533006237388,0.0463707133558913,0.0626596072003969,4.5057132766133e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41928,0.0626801837120001,0.00481064740227355,0.0532513148035439,0.0721090526204562,1.46716684490987e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,42208,0.0270872329418553,0.00208924330106648,0.022992316071765,0.0311821498119456,3.32697740683647e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,42296,0.0581220566550177,0.00463370965881625,0.0490399857237378,0.0672041275862975,6.95216095122623e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,42059,0.0287250754233121,0.00231264627848433,0.0241922887174828,0.0332578621291414,3.20510957855749e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42081,0.0374599291673271,0.00302572660403591,0.0315295050234167,0.0433903533112374,5.27063718161424e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,42168,0.0367587034730409,0.00301768070538661,0.0308440492904832,0.0426733576555987,6.0047834817874e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,42184,0.050674526741604,0.00417451604076291,0.0424924753017087,0.0588565781814993,9.98915582636262e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,42123,0.0520857791766333,0.00430629769967638,0.0436454356852676,0.060526122667999,1.69674173716031e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42094,0.0405340011858002,0.00335424507445762,0.0339596808398632,0.0471083215317371,1.93565311929498e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,42126,0.0681131155285901,0.00566421705979976,0.0570112500913826,0.0792149809657976,3.93642527732758e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42101,0.0524777343618846,0.00439732380474451,0.0438589797045854,0.0610964890191838,1.16852969788317e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,42184,0.0432855033707126,0.00363876506747947,0.0361535238384528,0.0504174829029723,1.83762895363595e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42120,0.0382963027470999,0.00323920653917037,0.031947457930326,0.0446451475638739,4.35705451004103e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42146,0.0374168297534847,0.00318856203970899,0.031167248155655,0.0436664113513143,1.22352297059866e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42120,0.0362340266053291,0.00309272730525185,0.0301722810870354,0.0422957721236227,1.52562801634708e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41876,0.0792297014589984,0.00680757859951309,0.0658868474039527,0.092572555514044,3.78248871519594e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,42186,0.0365809820575355,0.00314953205444514,0.030407899230823,0.0427540648842479,4.93661431497289e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,42185,0.0428595974978892,0.00369165898441621,0.0356239458884334,0.050095249107345,5.22417660565907e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42120,0.0446157515134363,0.00384713955463144,0.0370753579863587,0.052156145040514,6.06326998757347e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,42223,0.0398163278020974,0.00343693007402135,0.0330799448570156,0.0465527107471793,6.96774902928399e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40113,0.0290607704866683,0.00253913814437759,0.0240840597236882,0.0340374812496484,3.69460168249438e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42146,0.0399684591546525,0.00357267729904616,0.032966011648522,0.046970906660783,6.38788172069297e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42223,0.0360006058051845,0.0032573703555757,0.0296161599082561,0.0423850517021128,2.86122627581954e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,42120,0.0814820128266967,0.0073862330059911,0.0670049961349542,0.0959590295184393,3.59277878058185e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39862,0.0339598294848658,0.00307724741385116,0.0279284245537176,0.0399912344160141,3.64657169869711e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,42223,0.0698939668167953,0.00634884325511956,0.0574502340367609,0.0823376995968296,4.60091224690173e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41770,0.0440766688060452,0.00403216689659749,0.0361736216887141,0.0519797159233763,1.08840469815597e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,42099,0.0332499678953854,0.00304651049703913,0.0272788073211887,0.0392211284695821,1.30282484236116e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42144,0.0334033982941982,0.00306320833730971,0.0273995099530712,0.0394072866353253,1.44208878948249e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,42172,0.0196792370876142,0.00180474991763856,0.0161419272490426,0.0232165469261858,1.45028836545717e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,42144,0.0932406327854859,0.00857666974895317,0.0764303600775377,0.110050905493434,2.07130603162585e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39863,0.0479124943445976,0.0044151225549737,0.0392588541368491,0.056566134552346,2.71143901479935e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,42256,0.0376112315099403,0.00346869631114437,0.0308125867400973,0.0444098762797832,2.81169169985742e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42144,0.0376049842874082,0.00347832888916744,0.03078745966464,0.0444225089101764,3.97657145647716e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,42078,0.0451882937917185,0.00419620174190833,0.0369637383775782,0.0534128492058589,6.28793457471581e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42186,-0.0354598444196527,0.00330406680181786,-0.0419358153512157,-0.0289838734880897,9.30521250959275e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42126,0.0429844023351735,0.00400915915000636,0.035126450401161,0.050842354269186,1.04412280839081e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39863,0.0320667096737569,0.0029899949719291,0.0262063195287758,0.0379270998187379,1.06631594960519e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,42256,0.0542536228208263,0.00508256789484521,0.0442917897469297,0.064215455894723,1.7235802665279e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42120,0.0391181743234201,0.00368642246546727,0.0318927862911042,0.0463435623557359,3.37981485001256e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,42144,0.0371737264519777,0.0035177061470222,0.0302790224038142,0.0440684305001412,5.3730259613321e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,42146,0.0538288912467013,0.0050968802803021,0.0438390058973091,0.0638187765960934,5.75233279573176e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39942,0.0358178121682545,0.00340470412787009,0.0291445920776291,0.0424910322588799,9.3105585267601e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42120,0.0480059625997836,0.0045787543067362,0.0390316041585806,0.0569803210409865,1.28948483279124e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42256,0.0266546350691183,0.00254610127200775,0.0216642765759831,0.0316449935622535,1.51642284998751e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,42182,0.044944022176643,0.00432657407139072,0.0364639369967172,0.0534241073565688,3.53216567072001e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42094,0.0607505112250872,0.00592502817387723,0.0491374560042879,0.0723635664458866,1.42241575600124e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42197,0.0381996684038262,0.00373211991722408,0.030884713366067,0.0455146234415854,1.70479616655184e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42103,-0.0469647042526031,0.00459084098256573,-0.0559627525784319,-0.0379666559267742,1.80259742530861e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42075,0.0396796768832524,0.00388137270824244,0.0320721863750973,0.0472871673914076,1.93711355230007e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42296,0.0400222950382883,0.00392880690185252,0.0323218335106574,0.0477227565659193,2.7948354247883e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,42126,0.0286212313591102,0.00281132702683898,0.0231110303865058,0.0341314323317146,2.98534863521785e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,42098,0.0568566779173917,0.00560384441157133,0.0458731428707119,0.0678402129640715,4.25062216781004e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39755,0.0295825804864304,0.00291520202083019,0.0238687845256033,0.0352963764472576,4.37493168379549e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42213,-0.0220618262490535,0.00217917805287061,-0.0263330152326798,-0.0177906372654271,5.30955288162519e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39754,0.0392764559346213,0.00391671636823411,0.0315996918528824,0.0469532200163601,1.46485987938644e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42095,0.0542655657617593,0.00541695633815504,0.0436483313389754,0.0648828001845431,1.55303407261109e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42120,0.0302330542767085,0.0030205989782466,0.0243126802793451,0.0361534282740718,1.69511169598033e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42296,0.0510361868635227,0.005125468781727,0.0409902680513378,0.0610821056757076,2.83287930351522e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41965,0.040858852985125,0.00411815121458018,0.0327872766045478,0.0489304293657021,4.06337582112982e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42184,0.0273755671905625,0.00278475287069126,0.0219174515640076,0.0328336828171174,9.98479564629024e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,42129,-0.0439592050523738,0.00447964506630197,-0.0527393093823257,-0.0351791007224219,1.18625324467374e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42004,0.0383027891354021,0.00391653479332899,0.0306263809404772,0.0459791973303269,1.6487459734793e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,42172,0.0222798251047491,0.00228472896417083,0.0178017563349743,0.026757893874524,2.16681963388393e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39548,0.022306538325841,0.0022872256357333,0.0178235760798037,0.0267895005718782,2.24283368343454e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39575,0.0456886240372741,0.00469048774247348,0.0364952680620261,0.0548819800125221,2.51912317659893e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42056,0.0273740794571985,0.00281666272205642,0.0218534205219679,0.0328947383924291,2.99549279445149e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,42296,0.0504824169949356,0.00519478051960649,0.0403006471765069,0.0606641868133643,3.00663300356414e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,42103,0.0299311481095299,0.00309068360698505,0.0238734082398392,0.0359888879792206,4.18013357414594e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42184,-0.0262837487180615,0.0027510984699641,-0.0316759017191912,-0.0208915957169319,1.47013196805302e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42184,0.0648133514586882,0.0067898564196956,0.0515052328760848,0.0781214700412916,1.59180789851432e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41824,0.0334323254230832,0.00350829570495974,0.0265560658413622,0.0403085850048043,1.86574012365273e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,42044,0.0664796616596626,0.00698184243735206,0.0527952504824526,0.0801640728368726,2.00284517560124e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,42256,0.0253367722989753,0.00266829396699357,0.0201069161236679,0.0305666284742827,2.5676009980517e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,40113,0.0183898073412961,0.00194418222650134,0.0145792101773535,0.0222004045052387,3.74978304292753e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,42076,0.068197066523588,0.00723717351110265,0.0540122064418269,0.0823819266053492,5.1145931374846e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42144,-0.0254919179197472,0.00271107865996785,-0.0308056320932841,-0.0201782037462102,6.19107168715072e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42197,0.0550484501590252,0.00586315619221978,0.0435566640222745,0.066540236295776,7.06051172552141e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,42021,0.0494765095228566,0.00527940981739506,0.0391288662807623,0.0598241527649509,8.32574675217865e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,42122,0.0295195627333406,0.00316174646249927,0.023322539666842,0.0357165857998391,1.1567059497924e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41984,0.0318033652710155,0.00341052467886288,0.0251187369004442,0.0384879936415867,1.28930196965589e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41861,0.0442314304383151,0.00475331523893788,0.0349149325699968,0.0535479283066333,1.55221477305568e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42066,0.0304073417883542,0.00327721837958428,0.023983993764369,0.0368306898123394,1.99210776822618e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42094,0.0310188639287036,0.00334976527550648,0.0244533239887109,0.0375844038686963,2.36344880868251e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,40113,-0.0634894431456315,0.00687047809780961,-0.0769555802173383,-0.0500233060739246,2.89701705377824e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42161,-0.0328229954858182,0.00355409254258191,-0.0397890168692787,-0.0258569741023576,2.9721786408747e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41887,0.0425268400911383,0.00460931319543794,0.03349258622808,0.0515610939541967,3.2403078389066e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41476,0.0406163211933073,0.00440379647744151,0.0319848800975219,0.0492477622890926,3.35594842185789e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,42172,0.0294561566804124,0.00320415926109069,0.0231760045286746,0.0357363088321501,4.39133366942899e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,42103,0.0521229693865302,0.0056721956357839,0.0410054659403938,0.0632404728326666,4.55559719463869e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42103,0.0303566782691415,0.00330532651216172,0.0238782383053045,0.0368351182329784,4.77240962453756e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42296,0.0268693568261378,0.00292617867651515,0.0211340466201681,0.0326046670321075,4.84079678729853e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,40041,0.0313105631272832,0.00340935368511446,0.0246282299044588,0.0379928963501075,4.92101693939866e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,42296,0.0409822971738947,0.00447975168236261,0.032201983876464,0.0497626104713254,6.62535311579837e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41664,0.0229932382495341,0.00251320787843293,0.0180673508078055,0.0279191256912626,6.63322030122083e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42094,0.0322111938360996,0.00353269465010756,0.0252871123218888,0.0391352753503104,8.77026636408407e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42004,0.0533305261967833,0.00585304255964121,0.0418585627798865,0.0648024896136801,9.31167821396706e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42167,-0.059412885880444,0.00652699322099208,-0.0722057925935885,-0.0466199791672995,1.0089334716996e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42223,0.0376346077109317,0.00413990482523077,0.0295203942534794,0.045748821168384,1.12479154564674e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,40102,0.0445845136502788,0.0049056439777618,0.0349694514538657,0.0541995758466919,1.17854676188905e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42296,0.034550740688314,0.00381242254339847,0.027078392503253,0.042023088873375,1.45149905608674e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42213,0.0566935020385538,0.00626362616323391,0.0444167947586153,0.0689702093184922,1.61232723416342e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42105,0.0294441009910604,0.00325392151329067,0.0230664148250107,0.0358217871571101,1.65006534088091e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39604,0.029150681002859,0.00322232452463526,0.0228349249345739,0.0354664370711441,1.7395406975428e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42094,0.0351084079507468,0.00388337031537266,0.0274970021326164,0.0427198137688772,1.77640338511708e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40113,0.0239645377717244,0.00265656600074511,0.0187576684102639,0.0291714071331848,2.17789992089051e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,42094,0.0739693141018392,0.00821275294120875,0.05787231833707,0.0900663098666083,2.41988103281474e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40102,0.0589401027196139,0.00654356040457163,0.0461147243266535,0.0717654811125743,2.46204891458735e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42186,0.0332565973899469,0.00369651561329212,0.0260114267878943,0.0405017679919994,2.64433501848436e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39477,0.0219517897986494,0.00244248143388211,0.0171645261882405,0.0267390534090583,2.97317273174581e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41876,0.0443978810157009,0.00494701356839773,0.0347017344216414,0.0540940276097605,3.23778817440143e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39863,0.0345869727045451,0.00386026940328235,0.0270208446741117,0.0421531007349785,3.79654375812037e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42071,0.0629994937010482,0.0070492940439866,0.0491828773748344,0.0768161100272619,4.53789682379595e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42103,0.0315350737607251,0.00353341653220438,0.0246095773576045,0.0384605701638457,5.06122417937391e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40054,0.0666185808672978,0.00747408691427453,0.0519693705153197,0.0812677912192759,5.74634812150903e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,42156,0.0537103904581113,0.00603870908751346,0.0418745206465849,0.0655462602696377,6.64694547831653e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42120,0.0310346685791995,0.0034897064868759,0.0241948438649228,0.0378744932934763,6.71779504887543e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,40054,0.039899703229302,0.00448967551514155,0.0310999392196246,0.0486994672389795,7.26926520415096e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,42223,-0.0146070987638946,0.0016444068076595,-0.0178301361069072,-0.011384061420882,7.35917683900484e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,40113,0.0276489623599809,0.00313048308478558,0.0215132155138011,0.0337847092061606,1.18351229008768e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42146,0.0462901912214233,0.00529285092625005,0.0359162034059732,0.0566641790368734,2.48541268957265e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41887,0.069677854441798,0.0079701123214109,0.0540564342918326,0.0852992745917633,2.56698973662952e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42197,0.0280521666571554,0.00323534055742821,0.0217108991645961,0.0343934341497147,4.80595877166235e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42240,0.0369605545642719,0.0042663832374822,0.0285984434188068,0.045322665709737,5.12208365479159e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,42186,0.0384535046440303,0.00443919354540115,0.029752685295044,0.0471543239930165,5.1663032179719e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,40092,0.0241967689864957,0.00280055191367644,0.0187076872356899,0.0296858507373015,6.40582803138887e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39863,0.0283854499772084,0.00328645519439977,0.0219439977961848,0.0348269021582319,6.58755940009431e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42004,0.0392459734767981,0.00454708499943331,0.0303336868779088,0.0481582600756874,6.79308845653664e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,42120,0.0333313378675169,0.00386635532598492,0.0257532814285864,0.0409093943064473,7.412087816838e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,42112,0.0372638535314625,0.00432460185277131,0.0287876339000307,0.0457400731628943,7.68484071442323e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42094,0.059274968474932,0.00687987651653148,0.0457904105025303,0.0727595264473337,7.75372944938127e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42091,0.0176428592144009,0.0020486831557323,0.0136274402291656,0.0216582781996362,8.02064937698918e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41887,0.0614773704812974,0.00713958816719974,0.0474837776735859,0.0754709632890089,8.10691335674144e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,40097,0.0239367536822784,0.00278204468503759,0.0184839460996047,0.0293895612649521,8.75262255342464e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41859,0.0332286902995381,0.00386336202378919,0.0256565007329113,0.0408008798661649,8.82747072326294e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,42103,0.0506647429093852,0.00591006910567711,0.0390810074622581,0.0622484783565123,1.12588554237636e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41861,0.0697383056765375,0.00813895777394401,0.0537859484396072,0.0856906629134678,1.16941732386647e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,42003,0.0304897392025963,0.00355928497122673,0.0235135406589919,0.0374659377462007,1.19042986900376e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42180,0.0578674260590001,0.00676682228522695,0.0446044543799553,0.0711303977380449,1.34836133098295e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40054,0.0356661478953129,0.00417707616942105,0.0274790786032476,0.0438532171873781,1.54043697127451e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,42256,0.0420471995907162,0.00492703015868092,0.0323902204797016,0.0517041787017308,1.56873147018426e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42223,0.0523134534837185,0.00614799032479144,0.0402633924471273,0.0643635145203098,1.94412389707732e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40102,0.0224120878218842,0.00264141059705827,0.01723492305165,0.0275892525921184,2.43819739346858e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42094,0.0349894888137088,0.00412973962530579,0.0268951991481094,0.0430837784793081,2.65891148675413e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,42255,0.0234533621606199,0.00276919171158372,0.0180257464059158,0.028880977915324,2.72858379442751e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42184,0.0239877279232196,0.00283237912281819,0.018436264842496,0.0295391910039433,2.73661603849311e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42103,-0.0334377477003295,0.00395142212817032,-0.0411825350715434,-0.0256929603291157,2.90450591802531e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42103,0.0525948843930548,0.00623020440301137,0.0403836837631526,0.0648060850229571,3.45252298846855e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42186,0.0277507908046702,0.0032899360786293,0.0213025160905567,0.0341990655187836,3.65781114936266e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,42072,0.0308036538795149,0.00365655242581055,0.0236368111249262,0.0379704966341036,4.01364757575548e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42024,0.0350984242240116,0.00417103463687035,0.0269231963357458,0.0432736521122775,4.34988407271603e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,40054,0.0241406395423473,0.00287086178880661,0.0185137504362864,0.0297675286484083,4.6583379417653e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41887,0.0322092758522961,0.00383390928682555,0.0246948136501181,0.0397237380544742,4.8884257082132e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,42094,0.0251489930547005,0.00299692013287697,0.0192750295942616,0.0310229565151393,5.29133285065917e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,42223,0.0250283320752079,0.00298614020957328,0.0191754972644443,0.0308811668859715,5.7582141179903e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42103,0.0327085364109687,0.00390411539083286,0.0250564702449363,0.0403606025770011,5.93818117186796e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42016,0.0245161115540804,0.00292953088438373,0.0187742310206883,0.0302579920874725,6.43022729692822e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42126,0.022911694788763,0.00273912839315763,0.017543003138174,0.0282803864393519,6.64655711020677e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,42144,-0.0388445152232524,0.0046454884760276,-0.0479496726362665,-0.0297393578102383,6.80569160685541e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42213,0.0427927255299846,0.00511865226624493,0.0327601670881445,0.0528252839718246,6.89560365654639e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,42213,0.0247446590141869,0.00297196124250846,0.0189196149788703,0.0305697030495034,9.18872479798515e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41927,0.0347386755246079,0.00417433934994836,0.0265569703987091,0.0429203806505066,9.52900173003561e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40097,0.0342696961976234,0.00411776423797786,0.0261988782911868,0.04234051410406,9.64783381104346e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,42296,0.0200666287611711,0.00241544520936348,0.0153323561508187,0.0248009013715236,1.07165828749133e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42213,0.0555200362769084,0.00670047813268654,0.0423870991368428,0.068652973416974,1.28531955223514e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42256,0.0469998143157138,0.00567493774606739,0.0358769363334218,0.0581226922980059,1.32844073399691e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40102,0.0223255248493171,0.0026990639214341,0.0170353595633062,0.0276156901353279,1.47558061472301e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42004,0.0475037144686234,0.00574904380861203,0.0362355886037438,0.058771840333503,1.56091241349893e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42103,0.0427326626594149,0.00517554432748148,0.0325885957775512,0.0528767295412786,1.64303955416696e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40080,0.060816179380019,0.00736982989905604,0.0463713127778692,0.0752610459821689,1.73661724037066e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39633,-0.0355188820685653,0.00432691507021531,-0.0439996356061874,-0.0270381285309433,2.49706690215723e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42213,0.029166817426886,0.00355514331321344,0.0221987365329877,0.0361348983207843,2.539754398088e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42213,0.0654544633611123,0.00799185002827397,0.0497904373056953,0.0811184894165293,2.85084882066595e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41954,0.039339064889704,0.00483036702283053,0.0298715455249561,0.0488065842544518,4.17406908878834e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,42144,0.0478444606040437,0.0058797892899761,0.0363200735956905,0.0593688476123968,4.41588879166721e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42184,0.022497878880654,0.00277357595521088,0.0170616700084407,0.0279340877528673,5.4461313981515e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40021,0.0946442480510855,0.0116933521805972,0.071725277777115,0.117563218325056,6.39953981993334e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,42120,0.036084932619752,0.00446032385745896,0.0273426978591324,0.0448271673803716,6.4854404593455e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42256,0.026659613454188,0.00329818662513128,0.0201951676689307,0.0331240592394453,6.86605983030659e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42256,0.0323920312660001,0.00401167576774677,0.0245291467612164,0.0402549157707837,7.36950656928255e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42122,0.026240887991917,0.003253325651478,0.0198643697150201,0.0326174062688139,7.90963078754056e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,42296,0.0202868085694982,0.00252005358935401,0.0153475035343643,0.025226113604632,8.97882517010611e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40113,0.0148212116679058,0.00184526169689992,0.0112044987419819,0.0184379245938296,1.05721084320004e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,40113,0.0406073954056926,0.00507223640123863,0.0306658120592649,0.0505489787521204,1.30711633785404e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40102,0.0232451982885925,0.0029222259250039,0.0175176354755849,0.0289727611016002,1.97446514390317e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42184,0.0223566802434237,0.00281483561953358,0.0168396024291379,0.0278737580577095,2.14473100753394e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41813,0.0706223346680349,0.00889467847475663,0.0531887648575119,0.0880559044785579,2.19508651044266e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41829,0.0255359932429766,0.00322072138070793,0.019223379336789,0.0318486071491641,2.40075516087821e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42184,0.053713568811606,0.00677844584581934,0.0404278149538001,0.0669993226694119,2.48312057380018e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,42103,0.028088380428711,0.00354522456419108,0.0211397402828965,0.0350370205745255,2.51020846554429e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,42091,0.0229421457755547,0.00290083665574585,0.0172565059302928,0.0286277856208166,2.80956284380964e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41887,0.0307977991547037,0.00389656565049407,0.0231605304797354,0.0384350678296721,2.92705772793865e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40021,0.0823353946663749,0.0104242195021514,0.0619039244421581,0.102766864890592,3.0967032418445e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41887,0.0666241679671842,0.00846732890858287,0.0500282033063617,0.0832201326280066,3.88275063298442e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,42103,-0.0267159248140062,0.0034040563159099,-0.0333878751931896,-0.0200439744348228,4.54973473074239e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42094,0.0546582048540291,0.00697722641371649,0.0409828410831448,0.0683335686249135,5.10259146897102e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42248,0.031585602237477,0.00404984766546789,0.0236479008131599,0.039523303661794,6.70114555199742e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41869,0.0430015291142261,0.00551591308106339,0.0321903394753418,0.0538127187531103,6.89293749036061e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42077,0.0820330726000841,0.0105282888302804,0.0613976264927346,0.102668518707434,7.11758664862478e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39922,0.0251499439444548,0.00322924014468452,0.0188206332608731,0.0314792546280365,7.42432615185813e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41829,0.0425591143856648,0.00546578969034466,0.0318461665925892,0.0532720621787403,7.42748397979783e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,42073,0.0592934673337742,0.00763444876783418,0.0443299477488192,0.0742569869187292,8.67244633340323e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,42120,-0.0200478589273172,0.00258739556525364,-0.0251191542352143,-0.0149765636194201,1.00080813153973e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42128,0.0381856130589304,0.00494035582644698,0.0285025156390943,0.0478687104787665,1.16081670491486e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40093,0.0153727623076662,0.00198961801913697,0.0114731109901577,0.0192724136251746,1.20260308020908e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40021,0.0676394814720244,0.00877262966460718,0.0504451273293944,0.0848338356146545,1.36540291986869e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,42109,0.0234460046778811,0.00304888159428444,0.0174701967530836,0.0294218126026786,1.57722564108131e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41977,0.0275652628128973,0.00359093089822711,0.0205270382523722,0.0346034873734224,1.75543362633262e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42256,0.0367631112426808,0.00478927014903823,0.0273761417505659,0.0461500807347958,1.75574950177944e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,42091,-0.0480097428843248,0.00626024066071155,-0.0602798145793195,-0.0357396711893302,1.8575487237125e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42223,0.0449030635411316,0.0058604102915385,0.0334166593697161,0.0563894677125471,1.9581712119604e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42076,0.0332091698235627,0.00433537658867714,0.0247118317097555,0.0417065079373699,1.99123146719226e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42103,0.0459781844088905,0.00602289840517652,0.0341733035347446,0.0577830652830365,2.43742288478101e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40113,0.0129136129366118,0.00169612894909738,0.00958920019638096,0.0162380256768427,2.88606443434651e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,42184,0.03484731465017,0.00457831121545371,0.0258738246678807,0.0438208046324593,2.89839745107265e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,42074,0.0291267765141301,0.00382834527771687,0.0216232197698051,0.0366303332584552,2.97243164441705e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,42073,0.0495619641008631,0.00651577662237075,0.0367910419210165,0.0623328862807098,3.01240450367202e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,42256,0.0270859690900014,0.0035611809619519,0.0201060544045757,0.0340658837754271,3.02259480242032e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,42213,0.0175930316133993,0.00231649040579531,0.0130527104180405,0.0221333528087581,3.29538627345116e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42120,0.0287495606006062,0.00379066334224268,0.0213198604498105,0.0361792607514018,3.57073337885262e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42186,0.0304827700520562,0.00402113645988906,0.0226013425906737,0.0383641975134388,3.67161423558745e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42032,0.0437181312575989,0.00577732844731562,0.0323945675008602,0.0550416950143375,4.0735810641211e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,42274,0.0232721788545803,0.00307780762255278,0.0172396759143768,0.0293046817947837,4.25681691551815e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42103,0.028539520186958,0.00378467477607978,0.0211215576258417,0.0359574827480744,4.98231538792161e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42120,0.0326174951059864,0.00432697135567404,0.0241366312488652,0.0410983589631075,5.0829450757537e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,42094,0.0420732016404186,0.00559731468501722,0.0311024648577849,0.0530439384230524,5.9891144443018e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42184,0.0156173056628466,0.0020799271916095,0.011540648367292,0.0196939629584012,6.36668241215964e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,42162,0.0419605067125784,0.00559451470731156,0.0309952578862478,0.0529257555389091,6.7813828441338e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42223,0.0255556775110589,0.00340807501352265,0.0188758504845545,0.0322355045375633,6.86893974277408e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42109,0.0361983370691664,0.00484010232315282,0.0267117365157869,0.045684937622546,7.98214294979185e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39863,0.0232514039204548,0.0031187689768554,0.0171386167258182,0.0293641911150914,9.66089302869803e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40102,0.0165130220754888,0.00221589188559767,0.0121698739797174,0.0208561701712602,9.88280736901017e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40054,0.0679230849040104,0.00915033798269823,0.0499884224579218,0.0858577473500989,1.23052376001093e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41876,0.0684514547726349,0.00923446538071714,0.0503519026264293,0.0865510069188404,1.31695185991175e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,40020,0.0290327224608676,0.00393287893462197,0.0213242797490086,0.0367411651727267,1.67308436023652e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,42103,0.0494412322937488,0.00669972568931098,0.0363097699426993,0.0625726946447984,1.68487770742501e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42094,0.0623779386324901,0.00845300992274728,0.0458100391839054,0.0789458380810748,1.68765281143941e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39804,0.0672140875297111,0.0091240272563266,0.049330994107311,0.0850971809521113,1.87884465123107e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42120,0.0287041536881541,0.00389996275024012,0.0210602266976834,0.0363480806786247,1.94863285846747e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40080,0.0718217785525023,0.00976195451974576,0.0526883476938006,0.0909552094112039,2.01156396299618e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,42184,0.0311623081691889,0.00424741525429205,0.0228373742707765,0.0394872420676014,2.31798036972972e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42186,0.027689672858649,0.00377899940299931,0.0202828340287704,0.0350965116885277,2.48792528303673e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42083,-0.0457625499934638,0.00625399943390539,-0.0580203888839184,-0.0335047111030093,2.67935763400219e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42189,0.0199249095884213,0.0027299045924568,0.014574296587206,0.0252755225896367,3.07313645300821e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42184,0.0219819793935264,0.00302142476152213,0.016059986860943,0.0279039719261098,3.65297442901082e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,42094,0.0234278072121275,0.00322409965798276,0.0171085718824813,0.0297470425417737,3.90236096293742e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42296,0.0168082813748887,0.00231426462611919,0.0122723227076951,0.0213442400420823,4.00266395240875e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41966,0.0320164090086771,0.00442682052034538,0.0233398407888001,0.040692977228554,5.01687772757326e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40021,0.0735316656373744,0.0101944529525887,0.0535505378503007,0.0935127934244482,5.8428169019911e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41876,0.0352424628883793,0.00489799644903783,0.0256423898482651,0.0448425359284934,6.58375387278833e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42296,0.0301271940060513,0.00418914910418859,0.0219164617618417,0.0383379262502609,6.74524755035639e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42094,0.0602242894884856,0.00838041300136608,0.0437986800058081,0.0766498989711631,7.0223470543185e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42120,-0.0378563795593945,0.00526825729905754,-0.0481821638655473,-0.0275305952532417,7.05059236035016e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41967,0.0250114223879488,0.00348147795359043,0.0181877255989116,0.0318351191769861,7.13841777206404e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,42144,0.0194993858516118,0.00271926058659961,0.0141696351018765,0.024829136601347,7.85855737433283e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42120,0.0191348435373857,0.0026720661231915,0.0138975939359304,0.0243720931388411,8.438275929378e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,42164,-0.0384084637267154,0.0053701174965054,-0.048933894019866,-0.0278830334335648,8.99417381922079e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,42256,0.031756555462983,0.00444567921506629,0.0230430242014531,0.0404700867245129,9.59865385151853e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41815,0.0405815002435033,0.00569032190779014,0.0294284693042346,0.051734531182772,1.04565363744055e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42091,0.0242493151504445,0.00340395534903515,0.0175775626663356,0.0309210676345534,1.10515296771203e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42120,0.0387073823277405,0.00543718280479625,0.0280505040303399,0.0493642606251412,1.14444955761459e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,42223,0.0772351609781999,0.0109050107764444,0.0558613398563688,0.0986089821000311,1.48803371702289e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42094,0.0738993309696249,0.010448663446092,0.0534199506152845,0.0943787113239653,1.59886527643391e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,42186,0.0515905348127843,0.00729678826488885,0.0372888298136022,0.0658922398119665,1.62495395541975e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42213,0.0330867527996878,0.00468212993516956,0.0239097781267555,0.0422637274726202,1.66856386683478e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41876,0.0385745746619728,0.00545924706667583,0.0278744504112882,0.0492746989126575,1.67902940797244e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42208,0.0254914145047664,0.00361521611957371,0.0184055909104019,0.0325772380991309,1.86410252260827e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42213,0.0213287348675011,0.00303314106907656,0.015383778372111,0.0272736913628911,2.1391508580094e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42004,0.0281232115598815,0.00400264448611696,0.0202780283670923,0.0359683947526708,2.23037477029487e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39864,0.0151532547461363,0.00215768268763744,0.0109241966783669,0.0193823128139057,2.30491824111729e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42223,0.0245532425744232,0.00350275537108048,0.0176878420471055,0.031418643101741,2.50603114192849e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,42213,0.0209149776085801,0.00298758820526098,0.0150593047262685,0.0267706504908916,2.67322438647073e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42120,-0.0268769799098557,0.00384344792145313,-0.0344101378359038,-0.0193438219838075,2.82433032525123e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39863,0.0250612020309111,0.00358818390274974,0.0180283615815216,0.0320940424803006,3.03179955283902e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,42154,0.0320287557893986,0.00458864320617168,0.0230350151053021,0.0410224964734951,3.09537333435984e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,42213,0.0251917947570518,0.00360975525639501,0.0181166744545176,0.032266915059586,3.12106649933237e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39804,0.0670041619471081,0.0096262917991077,0.048136630020857,0.0858716938733591,3.59003898159063e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41861,0.0261788098426235,0.0037674857102626,0.0187945378505088,0.0335630818347382,3.8694140447146e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42162,0.0360685458312836,0.0051937696062227,0.0258887574030871,0.0462483342594801,3.97683731975634e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42256,0.0520761760520539,0.00750187512292023,0.0373725008111303,0.0667798512929776,4.05554120250312e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39881,0.0892552853043394,0.0128667924361977,0.0640363721293918,0.114474198479287,4.24066147144288e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42213,0.0319638750773252,0.00462697556583576,0.0228950029682871,0.0410327471863633,5.13814398789781e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,42175,0.0206539577564434,0.00299421869835855,0.0147852891076606,0.0265226264052261,5.52054225979617e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40097,-0.0353267650022713,0.00512829812430451,-0.0453782293259082,-0.0252753006786345,5.9451000252468e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40020,0.0389796786780751,0.00566296831179556,0.0278802607869558,0.0500790965691943,6.17350111681558e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42146,0.023993426666692,0.00349313736802424,0.0171468774253645,0.0308399759080195,6.77333151822598e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,42120,0.0382047824509658,0.00556287791613726,0.0273015417353368,0.0491080231665948,6.8177736634235e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39863,-0.0159732052509399,0.00232679933041503,-0.0205337319385533,-0.0114126785633264,7.0243099917361e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42186,0.0476026864764794,0.00694327053294555,0.0339938762319061,0.0612114967210527,7.40437754550018e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,42246,0.0165703439315213,0.0024188873884828,0.011829324650095,0.0213113632129476,7.69461129138656e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42262,0.0130950887676335,0.00192691778773531,0.00931832990367228,0.0168718476315947,1.12327745595569e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42172,0.0190364174982164,0.00280145029257062,0.013545574924778,0.0245272600716548,1.12884056281908e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42213,0.0352588549163183,0.00518921670677717,0.0250879901710351,0.0454297196616016,1.13307985382079e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39804,0.0516943088323414,0.00762076292834069,0.0367576134927936,0.0666310041718891,1.23673590800636e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41984,0.0181858232799652,0.00268655844954397,0.012920168718859,0.0234514778410714,1.35157444634376e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,42120,0.0156893144710601,0.00231800812172811,0.011146018552473,0.0202326103896472,1.35789657922524e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42197,-0.0227132806509452,0.00336200881725631,-0.0293028179327676,-0.0161237433691229,1.48029747422541e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42004,0.0726182124256985,0.0107547490328761,0.0515389043212613,0.0936975205301357,1.51901671433675e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42104,0.0197258963209477,0.00292261450542693,0.0139975718903109,0.0254542207515845,1.5479976448284e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39752,0.0301988225732874,0.00447681058792815,0.0214242738209483,0.0389733713256266,1.6036045418959e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,42120,0.0193656797992478,0.00288084275795288,0.0137192279936602,0.0250121316048355,1.86481984580538e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42186,-0.0197164814293663,0.00293334600485241,-0.025465839598877,-0.0139671232598556,1.87374666174498e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,42127,0.0225139644515271,0.00335230596351981,0.0159434447630283,0.0290844841400259,1.94638645951121e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39804,0.035407645381758,0.00527321512638537,0.0250721437340427,0.0457431470294733,1.98194681545824e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41716,0.0810063924091073,0.0120972656184483,0.0572957517969486,0.104717033021266,2.22957429081515e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,42144,0.0282189613634391,0.0042271342892389,0.0199337781565309,0.0365041445703473,2.56133784323784e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42103,0.0465200372024517,0.00697910515255559,0.0328409911034427,0.0601990833014607,2.7427026662333e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39706,0.037607805410944,0.00564779715439584,0.0265381229883282,0.0486774878335599,2.89764339709906e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42004,0.0243168678422971,0.00365279860862973,0.0171573825693829,0.0314763531152114,2.90762719225617e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39851,0.0270390547636691,0.00406358426097962,0.019074429612149,0.0350036799151891,2.99249208071302e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",42223,0.0486723853168871,0.00732652704740773,0.034312392303968,0.0630323783298063,3.18904094247751e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,40021,0.0440121427264712,0.00662655614799453,0.0310240926764019,0.0570001927765405,3.24769573836607e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40021,0.0749990238776013,0.0113095247241109,0.0528323554183439,0.0971656923368587,3.48142419837741e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42256,0.036242801297952,0.00547899479297788,0.0255039715037154,0.0469816310921887,3.86384055284257e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,42178,0.0309558527699199,0.0046830526988619,0.0217770694801506,0.0401346360596893,3.98838459576138e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42167,0.0217720561665326,0.00329918916181018,0.0153056454093846,0.0282384669236805,4.29406042301467e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40080,0.0399500199581227,0.00606052444798026,0.0280713920400814,0.051828647876164,4.54496450684432e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,42144,0.016382595592221,0.00248711298130252,0.011507854148868,0.0212573370355739,4.66168963805876e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41949,0.031660035274653,0.00481169851956365,0.0222291061763083,0.0410909643729978,4.89475169863451e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,42186,0.0214077678890914,0.00325450190663404,0.0150289441520887,0.0277865916260941,4.9543764000315e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42256,0.0475819680386165,0.00723400386863494,0.033403320456092,0.061760615621141,4.96505429125424e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42168,0.0348754471356568,0.00530811745910187,0.0244715369158171,0.0452793573554965,5.21628045789586e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41854,0.0332405336156001,0.00506306762404866,0.0233169210724647,0.0431641461587355,5.39567063322503e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39784,0.0617240906845189,0.00940110973945023,0.0432979155951964,0.0801502657738414,5.42439611040761e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41953,0.0753915708468323,0.0114961781122331,0.0528590617468554,0.0979240799468093,5.66485842356891e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,42184,-0.0277271056867336,0.00422928418543005,-0.0360165026901765,-0.0194377086832907,5.73672815611701e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40020,0.0295272936700702,0.0045064004414209,0.0206947488048852,0.0383598385352552,5.92300157446924e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42004,0.0229650622821383,0.00350898970423887,0.0160874424618301,0.0298426821024465,6.19116131642005e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,42184,0.028374063672298,0.00433600036823518,0.0198755029505571,0.036872624394039,6.22119708675085e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40054,0.0698519113950463,0.0106754390515133,0.0489280508540802,0.0907757719360123,6.29121070624347e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,40054,0.0674773850179775,0.0103377449560006,0.0472154049042164,0.0877393651317386,6.99592926248539e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42144,0.0492389811436976,0.00754828748078149,0.0344443376813659,0.0640336246060293,7.13821359414935e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40080,0.0342010640476134,0.00524346335335865,0.0239238758750305,0.0444782522201964,7.21586343883706e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41887,0.0236507574341012,0.00362693552216548,0.0165419638106569,0.0307595510575456,7.25515300433571e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39690,0.0355892967597504,0.00546305407835582,0.024881710766173,0.0462968827533278,7.62509687309495e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42223,0.0526360004436034,0.00809032540182211,0.0367789626560321,0.0684930382311748,7.9977520982442e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42256,0.0397235011908185,0.00611069458039206,0.0277465398132501,0.0517004625683869,8.28793881528186e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41861,0.0419588068636049,0.00645687178226549,0.0293033381703645,0.0546142755568453,8.42645305393396e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42223,0.0812350008277617,0.0125028715720396,0.0567293725465642,0.105740629108959,8.47440850275841e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40080,0.0182573448171122,0.00281223257787998,0.0127453689644675,0.023769320669757,8.83219273194969e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41829,0.0339067414730746,0.00523046641210614,0.0236550273053466,0.0441584556408027,9.35407307974544e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42103,0.0528227027384693,0.00815874810816355,0.0368315564464687,0.0688138490304699,9.8658886543029e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42101,0.0318054740510534,0.00491285569803948,0.022176276882896,0.0414346712192108,9.89435809182377e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39838,0.0323138753390944,0.00499598563738438,0.022521743489821,0.0421060071883678,1.03687656830955e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,42004,0.0259346875323361,0.00401179199027365,0.0180715752313997,0.0337977998332724,1.05240568491549e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,42256,0.0594430425217373,0.00919571984967914,0.0414194316163662,0.0774666534271084,1.05450633795269e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41829,0.0678726030293338,0.010500284389483,0.0472920456259472,0.0884531604327205,1.05801475979259e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42148,0.0258920162929846,0.00401075173548791,0.0180309428914283,0.033753089694541,1.11596534095247e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42219,0.0377781883117542,0.00585904629225344,0.0262944575789374,0.0492619190445709,1.1746002396263e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39863,0.0407899096238622,0.00633236089156161,0.0283784822764014,0.0532013369713229,1.23391592324985e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39995,0.0218466739652421,0.00339242477330755,0.0151975214095593,0.0284958265209249,1.24679956070628e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,42144,0.0249414015243177,0.00387709539104158,0.0173422945578762,0.0325405084907592,1.29500110087709e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41985,0.0405990842787741,0.00631222068135103,0.0282271317433261,0.0529710368142222,1.30570435613921e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41985,0.0244199267075041,0.00379896730619137,0.0169739507873691,0.0318659026276392,1.33846762544237e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40054,0.0340590607291248,0.00529850384380489,0.0236739931952673,0.0444441282629824,1.34669695431789e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41829,0.0465230377137909,0.00725149529085144,0.0323101069437221,0.0607359684838597,1.45228888168728e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41971,0.0375541472781211,0.00585783232045188,0.0260727959300354,0.0490354986262068,1.49723074400165e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,42094,0.0474035631896365,0.0073974859873081,0.0329044906545126,0.0619026357247603,1.52503884904767e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39863,0.0241626242784268,0.00377511623976079,0.0167633964484957,0.031561852108358,1.61372164931056e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,40013,0.0184559077891632,0.00288608078729858,0.0127991894460579,0.0241126261322684,1.67387845161712e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,42122,0.0199759530703105,0.00312428253829836,0.0138523592952457,0.0260995468453752,1.6740748051219e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41861,0.0354169228895097,0.00554669099648185,0.0245454085364053,0.0462884372426141,1.7711162831918e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,40080,0.0615348139228833,0.00964174279338392,0.0426369980478508,0.0804326297979158,1.81747517976979e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42186,0.0180496610795997,0.00282914501915235,0.0125045368420611,0.0235947853171383,1.83215693302928e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,40055,0.0196323841402802,0.00307965883290438,0.0135962528277877,0.0256685154527728,1.90563636378502e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41876,-0.0148904592207072,0.00234417379880273,-0.0194850398663605,-0.0102958785750538,2.1963246233783e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39784,0.053638667677112,0.0084462938390363,0.0370839317526009,0.0701934036016232,2.23332804367482e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,40080,0.0404162124333394,0.00636650380241312,0.0279378649806097,0.0528945598860691,2.2643441662546e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,42072,0.0228099271355753,0.00359599622111686,0.0157617745421863,0.0298580797289644,2.32651675856946e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42161,0.0590104322123655,0.00930774196525894,0.040767257960458,0.077253606464273,2.37490615267597e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,42120,0.076287045395045,0.0120430082201473,0.0526827492835564,0.0998913415065336,2.45924428952416e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,40113,0.0133397035800218,0.00210635195539677,0.00921125374744415,0.0174681534125995,2.49755046408492e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39804,0.0547954036521465,0.00865343953527395,0.0378346621630095,0.0717561451412834,2.51448857700412e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42215,0.0183733449359695,0.0029066078011801,0.0126763936456564,0.0240702962262825,2.67951425539751e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,42078,0.0293556414212963,0.00464757793322475,0.0202463886721758,0.0384648941704169,2.76652561796872e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42120,0.0150269987272435,0.00238252465265104,0.0103572504080474,0.0196967470464395,2.93434926200765e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42174,0.0700702036831058,0.0111286604656713,0.0482580291703902,0.0918823781958215,3.14508708250473e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40021,0.0595731806920887,0.00947125021807503,0.0410095302646617,0.0781368311195158,3.29935614745881e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41861,0.0691660096125876,0.0110010382437898,0.0476039746547597,0.0907280445704156,3.33804490646423e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,42186,0.0218413380964601,0.00347719515247875,0.0150260355976017,0.0286566405953184,3.46440859650007e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42296,0.0166611981990263,0.00265252392360065,0.0114622513087691,0.0218601450892836,3.46454335912442e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,42193,0.0194196473446755,0.00309332262099469,0.0133567350075259,0.0254825596818251,3.54035029704101e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42186,0.0140747797509041,0.00224359068865087,0.00967734200114834,0.0184722175006598,3.64626325258915e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42178,0.0455063430576864,0.00725923106581414,0.0312782501686907,0.0597344359466821,3.75468197312883e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40097,-0.0169477999032243,0.00270922939099363,-0.0222578895095719,-0.0116377102968768,4.10888831784102e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42126,-0.0238450790641841,0.00381504095585841,-0.0313225593376665,-0.0163675987907016,4.22587263883797e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40054,0.0618243973688214,0.00989962822701858,0.0424211260438649,0.0812276686937778,4.39299062499024e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42296,-0.0212829715378557,0.00341081083403003,-0.0279681607725546,-0.0145977823031569,4.51461920500867e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42094,0.0275174547249301,0.00441333399142714,0.0188673201017329,0.0361675893481273,4.65657987746868e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42178,0.0218730593466605,0.00350980193922129,0.0149938475457868,0.0287522711475342,4.74784590090274e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39804,0.020138209443449,0.00323259348482732,0.0138023262131875,0.0264740926737106,4.84929248663316e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42208,0.0413176850885848,0.00664899601104623,0.0282856529069342,0.0543497172702354,5.31864738146834e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40080,0.0455705346281135,0.00733991564038256,0.0311842999729637,0.0599567692832633,5.54098308682915e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41887,0.026820768902877,0.00432951530996628,0.0183349188953431,0.0353066189104109,6.01376074231974e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40080,0.0518367775287572,0.00836929022509513,0.0354329686875708,0.0682405863699437,6.089355863633e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42223,0.0213789040040414,0.00345609372309911,0.0146049603067672,0.0281528477013157,6.36143308811913e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42144,0.0232254449803353,0.00375587887067956,0.0158639223938033,0.0305869675668672,6.44758560069779e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41876,0.0344400519628342,0.00557149700731464,0.0235199178284976,0.0453601860971709,6.54546359532157e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,40033,0.0448538186169992,0.00726023641317829,0.0306237552471698,0.0590838819868287,6.72440275621068e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,42223,0.0348444576084719,0.00564225533600222,0.0237856371499076,0.0459032780670363,6.7861456575498e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42186,0.0590613022232417,0.00956514550850556,0.0403136170265708,0.0778089874199126,6.82919035602239e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,42103,0.0295009666883373,0.00478554877499687,0.0201212910893434,0.0388806422873311,7.27700609143535e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,42179,-0.0258832955390852,0.00420010750407193,-0.0341155062470662,-0.0176510848311042,7.37091603420744e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40021,0.0487945860603905,0.00791860132668382,0.0332741274600902,0.0643150446606908,7.43765875797024e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42144,0.0485103933469143,0.00787375643507149,0.0330778307341742,0.0639429559596544,7.44187756886094e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42120,0.0218778357245773,0.00355572230781585,0.0149086200012583,0.0288470514478964,7.83494622351969e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42256,0.0249830652269924,0.00406244679924559,0.017020669500471,0.0329454609535137,7.98648200000493e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41985,0.0586734731477635,0.00955817218626785,0.0399394556626785,0.0774074906328485,8.57328704191211e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,42085,0.0321037436208454,0.00524751126998039,0.0218186215316838,0.0423888657100069,9.75631609656657e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41876,0.0669057956100474,0.0109393763277762,0.045464618007606,0.0883469732124887,9.874295546879e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42162,0.0274559925449283,0.00448942310890973,0.0186567232514653,0.0362552618383914,9.88936908612561e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42094,0.0567591305563298,0.0092934422826003,0.0385439836824333,0.0749742774302264,1.04152836102105e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,42122,0.104642789070047,0.0171546837695934,0.0710196088816436,0.13826596925845,1.09127173388913e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40021,0.046112740205359,0.00757209297027499,0.03127143798362,0.060954042427098,1.16868665448653e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,40021,0.0459244006384069,0.0075695585528758,0.0310880658747703,0.0607607354020435,1.34691591219235e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42094,0.0405859963633881,0.00670085426691369,0.0274523220002372,0.0537196707265389,1.42683786519847e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41650,0.0205387636315,0.00339326479232103,0.0138879646385508,0.0271895626244492,1.46438450650026e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42184,0.0632464354663149,0.0104593733868681,0.0427460636280534,0.0837468073045764,1.51742864302658e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42186,0.0182283186790272,0.0030164741262491,0.012316029391579,0.0241406079664754,1.55489532058809e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39863,0.0645109928989378,0.010678410602064,0.0435813081188924,0.0854406776789832,1.58024468653145e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39863,0.0162709494727391,0.00269395697062326,0.0109907938103175,0.0215511051351607,1.59454635215348e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,42144,0.0399014731163029,0.00662061060362877,0.0269250763331906,0.0528778698994153,1.71721078468373e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42280,0.0172809805966836,0.00286767219239833,0.0116603430995829,0.0229016180937844,1.72439101620094e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42197,0.0260400162901702,0.00432396652383206,0.0175650419034594,0.0345149906768811,1.7664688117385e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,42085,0.0204991741287438,0.00340737629711444,0.0138207165863995,0.0271776316710881,1.83492784883658e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42186,0.0217010695373755,0.00361195670117114,0.01462163440308,0.0287805046716709,1.92707540184766e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40020,0.0173856748440859,0.00289489884265525,0.0117116731124816,0.0230596765756902,1.96719638052873e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42094,0.0508353793774655,0.00846623851926624,0.0342415518797036,0.0674292068752273,1.97102614390803e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,42094,0.0256465295511572,0.00427676631202739,0.0172640675795835,0.0340289915227309,2.06739175022293e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,42182,0.034739277294348,0.00579808825923956,0.0233750243062384,0.0461035302824575,2.13410292491444e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40054,0.03700212399372,0.00618099725167939,0.0248873693804284,0.0491168786070117,2.21275246526751e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41949,0.0255435865988986,0.00426787347547207,0.0171785545869734,0.0339086186108239,2.2208214401978e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,42256,-0.0238649569230425,0.00398905313062115,-0.0316835010590599,-0.016046412787025,2.25332500430506e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42057,0.0170518480684699,0.00285461510540044,0.011456802461885,0.0226468936750547,2.38450022957513e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41861,0.0752763284328135,0.0126118250161117,0.0505571514012345,0.0999955054643925,2.4553130586754e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41986,0.0276682716657792,0.00463889790893093,0.0185760317642746,0.0367605115672838,2.52007552568737e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40102,0.0162281512675175,0.00272113309378676,0.0108947304036955,0.0215615721313396,2.54161451355473e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,42197,0.0590914353214645,0.00992450884810741,0.039639397979174,0.078543472663755,2.68265421402138e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42103,0.0335191119208847,0.00563115227411701,0.0224820534636154,0.0445561703781541,2.71025650770996e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,42094,0.0461940822701129,0.00776224913029207,0.0309800739747404,0.0614080905654853,2.73223072150759e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42223,-0.0358572399238712,0.00602713408158248,-0.0476704227237729,-0.0240440571239696,2.76198234965986e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,42214,0.0325671857052086,0.00547648039899682,0.0218332841231749,0.0433010872872424,2.80552964759316e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42144,0.0347508105127901,0.00584689904470413,0.02329088838517,0.0462107326404102,2.86244747098044e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41861,0.0483807606185016,0.00815072452354031,0.0324053405523626,0.0643561806846406,3.0013650202377e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42186,0.0540978322152406,0.00911414352319355,0.0362341109097812,0.0719615535206999,3.00254107098955e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39804,0.0192842963241479,0.0032658455213175,0.0128832391023655,0.0256853535459302,3.63812874471475e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42109,-0.0104812175425287,0.00177795699661063,-0.0139660132558855,-0.00699642182917186,3.83826839551583e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,42103,0.0522310304560535,0.00886850901668009,0.0348487527833605,0.0696133081287465,3.97021494669184e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41854,0.0347540875564971,0.00590365556792723,0.0231829226433597,0.0463252524696344,4.03536803520115e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39804,0.0448675994710036,0.00763474588319209,0.0299034975399471,0.0598317014020601,4.30954107161715e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,42094,0.0478736095376627,0.00814930587011055,0.0319009700322461,0.0638462490430794,4.34415074963396e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40080,0.0568759473225994,0.00968982493583103,0.0378838904483706,0.0758680041968282,4.49441506645543e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,42063,0.0144953793232416,0.00247069111899998,0.0096528247300017,0.0193379339164816,4.54847423938297e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41829,0.0265586930634114,0.00452928541132828,0.017681293657208,0.0354360924696148,4.63782862437831e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39863,0.0320036928061478,0.00545979568134105,0.0213024932707193,0.0427048923415762,4.71719876094644e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,42116,0.0344646794026096,0.00588468329845585,0.0229307001376361,0.045998658667583,4.83710957032422e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40021,0.0806734742996471,0.0137972917258675,0.0536307825169468,0.107716166082347,5.14822951849155e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39706,0.0326322105353554,0.00558204902188141,0.0216913944524679,0.043573026618243,5.18766007062921e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,42095,0.0460897734253459,0.00788705222627001,0.0306311510618566,0.0615483957888351,5.22787579534359e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40021,0.0171573974909588,0.00294139687989319,0.0113922596063682,0.0229225353755495,5.59718697062787e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42059,0.0239673699951657,0.00411069036676644,0.0159104168763035,0.032024323114028,5.65889282625146e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41887,0.0384606267226766,0.00660235866461872,0.0255200037400239,0.0514012497053293,5.83974181258871e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,42172,0.0146178445289518,0.00251045954072748,0.00969734382912592,0.0195383452287776,5.92479510143949e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42213,0.0806295564137381,0.0138555010353955,0.053472774384363,0.107786338443113,6.0479410310175e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40102,0.0273214589240036,0.00469630590876444,0.0181166993428253,0.0365262185051819,6.13591862292834e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,40000,0.0146274807111754,0.00251718105622856,0.00969380584096745,0.0195611555813834,6.38342594757212e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42144,0.0286683073775287,0.00493505235758607,0.01899560475666,0.0383410099983974,6.42784572635223e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,42213,0.0348417397834317,0.0059999108032692,0.0230819146090241,0.0466015649578394,6.50702438567902e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42186,-0.0255088176220566,0.00439541387835658,-0.0341238288236354,-0.0168938064204777,6.64574496200681e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42223,0.0354782882322102,0.00612020119141319,0.0234826938970403,0.04747388256738,6.91106273342209e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,42186,0.0163479224224677,0.00282181239724653,0.0108171701238645,0.0218786747210709,7.05692060654255e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41829,0.0201192239470603,0.00347461978580067,0.013308969166891,0.0269294787272296,7.19159816480941e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40054,0.0653263908251492,0.0113019386805461,0.0431745910112789,0.0874781906390195,7.67094640661741e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41876,0.0545637454189902,0.00944436984404121,0.0360527805246694,0.073074710313311,7.76537839897306e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,40054,0.0440580600899403,0.00762568766431141,0.0291117122678899,0.0590044079119907,7.78631751362331e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,42120,0.0310542915090521,0.00537624346833323,0.0205168543111189,0.0415917287069852,7.81630744148714e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,42120,0.0144607793680356,0.00250366301856639,0.00955359985164547,0.0193679588844257,7.83287564352247e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42197,0.0243195814636344,0.00421961623911218,0.0160491336349745,0.0325900292922942,8.42777142550458e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42184,0.0678011292388432,0.0117705325724041,0.0447308853969311,0.0908713730807552,8.58965902934737e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42240,0.0200360023729068,0.00347873920467516,0.0132176735317435,0.0268543312140701,8.6236454256939e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,40054,0.0531171992633892,0.00922762054166802,0.0350310630017199,0.0712033355250585,8.82925699428152e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39863,0.0679085737313966,0.0118284147296845,0.044724880861215,0.0910922666015781,9.66086155954853e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41861,0.0373078016106993,0.0065050089288394,0.0245579841101741,0.0500576191112246,9.95985618147029e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42296,0.018691806412605,0.00325979313304666,0.0123026118718335,0.0250810009533764,1.00226579299898e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39804,0.0369346977646913,0.00644054903900333,0.0243112216482448,0.0495581738811378,1.00347060233382e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,42144,0.0234291528862137,0.00408773690062313,0.0154171885609923,0.031441117211435,1.01723304525468e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,42197,0.0320708133856881,0.00559845061695441,0.0210978501764574,0.0430437765949187,1.03557797109223e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42144,0.0454315071198588,0.00794097934707253,0.0298671875995966,0.0609958266401209,1.08149676736879e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39784,0.0255870033350717,0.0044835896682896,0.0167991675852241,0.0343748390849193,1.1820354517756e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42184,0.0705396820293075,0.012366506716269,0.0463013288654203,0.0947780351931947,1.19516452484302e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40021,-0.0463649338946587,0.00813941898078614,-0.0623181950969995,-0.0304116726923178,1.25595184831985e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,42120,0.0248280309598118,0.0043615337045283,0.0162794248989363,0.0333766370206873,1.27914796440572e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41843,-0.0684064968606442,0.0120189383248544,-0.0919636159773589,-0.0448493777439295,1.28680619198947e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,42296,0.033393864891518,0.00588174224369956,0.0218656500938669,0.0449220796891692,1.39541235575136e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40021,0.0608377242597313,0.0107233520270096,0.0398199542867925,0.0818554942326701,1.43594664494568e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,40021,0.0645736835335704,0.0113875848731424,0.0422540171822113,0.0868933498849296,1.45999592801688e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40028,0.0325648994414154,0.00576143717842931,0.021272482571694,0.0438573163111368,1.62393551611591e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,42094,0.0435579640201035,0.00770976116832747,0.0284468321301816,0.0586690959100253,1.64112370745918e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41876,0.0199010156674927,0.00352441202944532,0.0129931680897799,0.0268088632452056,1.67146752360263e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,42094,0.0199312038508254,0.00353686152872434,0.0129989552545257,0.0268634524471251,1.78434618730309e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42075,0.017144905538588,0.0030430606139497,0.0111805067352466,0.0231093043419294,1.79663407991904e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42213,0.0265767598705522,0.00472862058394553,0.017308663526019,0.0358448562150855,1.94423172428433e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40021,0.0263146459035238,0.00468565819958424,0.0171307558323387,0.035498535974709,2.00250443436381e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40054,0.0543487355055847,0.00968005480189857,0.0353758280938635,0.0733216429173059,2.01964440135933e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,42144,0.0147348799126882,0.00262676758026972,0.00958641545535955,0.0198833443700169,2.07057101862373e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42116,0.0125594739813144,0.00223933876529411,0.00817037000133798,0.0169485779612909,2.08199075037984e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42262,0.0282170937323183,0.00503179497996187,0.018354775571593,0.0380794118930435,2.09119296932038e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,42067,0.0466646488555916,0.00832844585197351,0.0303408949857235,0.0629884027254596,2.14941544861292e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,42223,0.0357337844297856,0.00638102945917758,0.0232269666897976,0.0482406021697737,2.18684052882949e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40102,0.040457821772653,0.0072251495833094,0.0262965285893666,0.0546191149559394,2.20067271599573e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,42004,0.0386002793539684,0.00689793498437866,0.0250803267845863,0.0521202319233506,2.23960290744094e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40054,0.0431545201693644,0.0077132529171429,0.0280365444517643,0.0582724958869645,2.26156632260365e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39804,-0.0338511126511018,0.00605334287129169,-0.0457156646788335,-0.0219865606233701,2.29845539214547e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39804,0.0526782751557198,0.00943365916675852,0.0341883031888731,0.0711682471225665,2.40727665496858e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42248,0.0212756209374578,0.0038111908737164,0.0138056868249737,0.028745555049942,2.41942197365398e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42094,0.0643420593831288,0.011545002796625,0.0417138539017439,0.0869702648645138,2.55186969264599e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40021,0.0425332315562506,0.00763994466500545,0.0275589400128399,0.0575075230996613,2.6500762928869e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41829,0.0256260971257059,0.00460514236586231,0.0166000180886157,0.034652176162796,2.67995085384296e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42094,0.0450440288577668,0.00809653676682929,0.0291748167947814,0.0609132409207522,2.69883756841474e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41796,0.0415749242696277,0.00747409273715573,0.0269257025048025,0.0562241460344529,2.71297101644259e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42121,0.0457402360334485,0.00823942073013352,0.0295909714023868,0.0618895006645102,2.88991985657462e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42223,0.0160404628719445,0.00289676001734258,0.010362813237953,0.0217181125059359,3.12972015458543e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40054,0.0208847057964336,0.0037711831429427,0.0134931868362659,0.0282762247566013,3.13115216291554e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42186,0.0157312531870435,0.00284281725326077,0.0101593313706524,0.0213031750034346,3.19644627818692e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40097,0.0330733095336827,0.00597614883501596,0.0213600578170514,0.044786561250314,3.19846860876231e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42022,-0.0187041576465683,0.0033810448091785,-0.0253310054725581,-0.0120773098205784,3.2268332367232e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,42223,0.0218953926017192,0.00395962219664488,0.0141345330962953,0.0296562521071432,3.27015824261625e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,42122,0.0215320951242489,0.00389974972827507,0.0138885856568297,0.029175604591668,3.4278821635903e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40080,0.0190905450634031,0.00346036754774919,0.0123082246698147,0.0258728654569915,3.52897443555083e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,42103,0.0277132461671937,0.00502838094129412,0.0178576195222572,0.0375688728121302,3.62889982095177e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42144,0.0699926472851027,0.0127032563371991,0.0450942648641925,0.094891029706013,3.66062837532565e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,42223,0.0208380969591866,0.00378710163887734,0.013415377746987,0.0282608161713862,3.81759565730017e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,42267,-0.0304622272618901,0.00553919683915101,-0.0413190530666261,-0.0196054014571542,3.88254776094073e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,40080,0.0250715803894939,0.00455946585817908,0.0161350273074629,0.0340081334715249,3.91022858544967e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39784,0.0245854243171282,0.00447451904092398,0.0158153669969172,0.0333554816373392,4.00796140700073e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42144,0.0401763148162578,0.00731393939939543,0.0258409935934428,0.0545116360390729,4.0235751647563e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42030,0.0238387168433959,0.00434259313424174,0.0153272343002821,0.0323501993865097,4.10701436648696e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41998,0.0564442933617562,0.0102859498310619,0.0362838316928749,0.0766047550306374,4.15380876028009e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39804,0.0483131408993081,0.00881869319940182,0.0310285022284806,0.0655977795701357,4.38761977837471e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,40080,0.0256626796412512,0.00468438084452931,0.0164812931859738,0.0348440660965287,4.38861574686342e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,42103,0.0171433054754654,0.00313111888609943,0.0110063124587105,0.0232802984922203,4.4534498007689e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0207021994693027,0.00378113877309188,0.0132911674740426,0.0281132314645628,4.45356052818258e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42093,0.0180569045627779,0.00329984916674308,0.0115892001959614,0.0245246089295943,4.53190446485543e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,42093,-0.0211584619674128,0.00386830154171429,-0.0287403329891728,-0.0135765909456528,4.59190052085173e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39804,0.0139653531609039,0.00255311633405257,0.00896124514616081,0.0189694611756469,4.60446663995991e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40020,0.0363163527584909,0.0066460527342517,0.0232900893993576,0.0493426161176243,4.7490000340592e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40021,0.0118125201191557,0.00216246087024468,0.00757409681347618,0.0160509434248353,4.79763618312515e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40080,0.0493351693247732,0.00903461491765346,0.0316273240861724,0.067043014563374,4.84726676333192e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42004,0.0166370248194788,0.00304741509562536,0.0106640912320531,0.0226099584069045,4.86675558771972e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39933,0.0145677820917007,0.00266887855524896,0.00933678012341275,0.0197987840599887,4.91153682211746e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42184,0.0710361464510034,0.0130227031857561,0.0455116482069215,0.0965606446950854,4.9927620259703e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40076,0.00829882727916041,0.00152270793939234,0.00531431971795143,0.0112833348403694,5.14553473712802e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39768,0.0446097519195191,0.0081854922230181,0.0285661871624036,0.0606533166766346,5.15423915675176e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42162,0.0482116257689868,0.00885148883578904,0.0308627076508402,0.0655605438871333,5.22411371271493e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42184,0.0215219153921339,0.00395390638499143,0.0137722588775507,0.0292715719067171,5.32810433809892e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,40080,0.0282695824901754,0.00519770579952896,0.0180820791230987,0.0384570858572522,5.47830477966987e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42144,0.0256601719735911,0.00472222134019409,0.0164046181468107,0.0349157258003715,5.61267319599973e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40021,0.0481991444123539,0.00887635963759299,0.0308014795226716,0.0655968093020361,5.75532872134369e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40054,0.0452773471458046,0.00834388710993745,0.0289233284103272,0.061631365881282,5.87345060041309e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40080,0.0153405342089653,0.00282730028767859,0.00979902564511529,0.0208820427728154,5.89121441175687e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41861,0.0163669076908791,0.00301796058477884,0.0104517049447126,0.0222821104370457,5.96266417758257e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,40113,0.0112834841384546,0.00208143517755205,0.00720387119045253,0.0153630970864566,6.05242688200937e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41861,0.0404697008623758,0.00747165212887461,0.0258252626897816,0.0551141390349701,6.19104943063992e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39863,0.0384137387062611,0.00709651916089568,0.0245045611509056,0.0523229162616166,6.33062749062565e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39784,0.0475328238555975,0.00879312867797313,0.0302982916467702,0.0647673560644248,6.59654684779531e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42103,0.020731277973988,0.00383787920512485,0.0132090347319433,0.0282535212160327,6.71627908074244e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40054,0.0283951618591749,0.00525983098321624,0.0180858931320711,0.0387044305862787,6.8618078940295e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42103,0.0642674210593599,0.0119389309097726,0.0408671164762055,0.0876677256425142,7.45306411101933e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42256,0.0526693504882702,0.00979009939778952,0.0334807556686028,0.0718579453079377,7.58301127834348e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,42192,0.0243777502188605,0.00453230154783388,0.0154944391851061,0.0332610612526149,7.63380552595815e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42094,0.0183787224508247,0.00341852787001841,0.0116784078255886,0.0250790370760608,7.73953681398796e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39767,0.0449688068693199,0.00836455985302573,0.0285742695573895,0.0613633441812504,7.77317669846713e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,40113,0.00810146441077728,0.00150793442106085,0.00514591294549801,0.0110570158760565,7.92231118814218e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42256,0.0147580233792293,0.00274812112214418,0.00937170597982672,0.0201443407786319,7.99862389551013e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41961,-0.0206791331640683,0.00385321334597787,-0.028231431322185,-0.0131268350059517,8.15812258308668e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42145,-0.0351308439767375,0.00654990056818634,-0.0479686490903828,-0.0222930388630923,8.29962152563572e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42126,0.0281991169067892,0.00525919277805356,0.0178910990618042,0.0385071347517742,8.37804033752034e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,42083,0.0238562079287248,0.00444980163089353,0.0151345967321735,0.0325778191252762,8.41038111206414e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42094,0.0661710800336163,0.0123452951279416,0.0419743015828508,0.0903678584843818,8.46434041616421e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,42099,0.0465750963926858,0.00869042196446155,0.0295418693423412,0.0636083234430304,8.49540689118224e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42184,0.0216740356970872,0.00404552672546878,0.0137448033151684,0.029603268079006,8.58065251470009e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,42179,0.0166095354658586,0.00310096108618917,0.0105316517369278,0.0226874191947893,8.64141583783736e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39863,0.0201915514935935,0.00377214710677139,0.0127981431643216,0.0275849598228654,8.83991843480326e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40020,0.0260948938182868,0.00487790474010341,0.0165342005276842,0.0356555871088895,8.9940349800469e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,42094,0.0481117582713004,0.0090017924241178,0.0304682451200296,0.0657552714225713,9.21156833664044e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41829,0.0462948325577694,0.00867840122018037,0.0292851661662159,0.0633044989493229,9.74675001353029e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41985,0.0428627000796569,0.0080433903764945,0.0270976549417277,0.0586277452175862,1.00467539428353e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39784,0.0437879983354391,0.00821627574264323,0.0276840978798584,0.0598918987910198,1.00549627275044e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40021,0.0340460842383692,0.00638947142554695,0.0215227202442971,0.0465694482324412,1.01033506042844e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42004,0.050312153713393,0.00946235390329378,0.0317659400629372,0.0688583673638488,1.07213657787412e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42120,0.0267975708443995,0.00506175279801649,0.0168765353602871,0.0367186063285118,1.21543032079607e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42172,-0.0159763209180372,0.00301845221920799,-0.0218924872676849,-0.0100601545683896,1.22363008452059e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42197,0.0226387814606767,0.00428047280228095,0.0142490547682061,0.0310285081531474,1.25082723318398e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,40080,0.0472114293672791,0.00893955955593573,0.0296898926376451,0.0647329660969131,1.30828603222806e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40002,0.0456177025237338,0.0086506029839072,0.0286625206752756,0.0625728843721919,1.36538204020748e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,41291,0.0223063095819833,0.00423119746096888,0.0140131625584843,0.0305994566054823,1.3736804802872e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39768,0.0634130677045544,0.0120379029789796,0.0398187778657543,0.0870073575433545,1.40795002724297e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39768,0.0681743964198078,0.0129468461411729,0.0427985779831088,0.0935502148565067,1.42385898961999e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40054,0.0402164369772407,0.007639665100844,0.0252426933795864,0.0551901805748949,1.43517600255898e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,42296,0.0319805553813332,0.00607821886803527,0.0200672463999841,0.0438938643626823,1.4513675249403e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40020,0.0494774654081809,0.0094038060716507,0.0310460055077455,0.0679089253086163,1.45670420314884e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42181,0.017123331641156,0.00325660003946103,0.0107403955638123,0.0235062677184996,1.47909321941235e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,42144,-0.0621758326311601,0.0118295624630832,-0.0853617750588031,-0.038989890203517,1.49585129411823e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42144,0.0451194006996006,0.00858858870568987,0.0282857668364484,0.0619530345627527,1.51674056850864e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40002,0.0362623395632438,0.00690999917144631,0.0227187411872091,0.0498059379392786,1.56836762155277e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,42094,0.024074670965114,0.00458878572912561,0.0150806509360278,0.0330686909942002,1.57544009447971e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42296,-0.0143671102750523,0.00274150728710143,-0.0197404645577711,-0.0089937559923335,1.62550480335236e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42094,0.0238452756964509,0.0045611741742404,0.0149053743149397,0.0327851770779621,1.74142047455397e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42103,0.0304676519462389,0.00583048748985215,0.0190398964661287,0.0418954074263491,1.76319618004586e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39847,0.0531924948592107,0.0101808718357116,0.0332379860612159,0.0731470036572054,1.7768721371982e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42146,-0.0135315235892327,0.00259041006398973,-0.0186087273146526,-0.00845431986381285,1.78103262788697e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,42004,0.0498245444532803,0.00954855066991964,0.0311093851402378,0.0685397037663228,1.83668175884036e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42103,0.0425250662890175,0.00815573291446044,0.026539829776675,0.0585103028013599,1.87533361494251e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42004,0.0415565082391602,0.00800067457930863,0.0258751860637153,0.0572378304146051,2.08839184571083e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42296,0.034131627013371,0.00657493238796302,0.0212447595329634,0.0470184944937785,2.12097186255316e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41829,0.0349850108355612,0.00674236003357268,0.0217699851697588,0.0482000365013637,2.14888911394466e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39899,0.00700942651649818,0.00135210692623479,0.00435929694107799,0.00965955609191837,2.21046592781079e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42120,0.0395395402292366,0.00764068029535552,0.0245638068503398,0.0545152736081334,2.31484527506665e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42076,0.0132376416909902,0.00255884755420628,0.00822230048474593,0.0182529828972346,2.33470432457296e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41953,0.0177271031643893,0.00343008578991642,0.0110041350161531,0.0244500713126255,2.40028507606981e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41635,-0.0194947491444566,0.00377746566280644,-0.0268985818435572,-0.012090916445356,2.49683408737576e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,42094,0.0419844524084244,0.00813914713963113,0.0260317240147474,0.0579371808021014,2.52848841542633e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39863,0.0434713732729771,0.00844016566434284,0.0269286485708652,0.0600140979750891,2.64378559980376e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,40092,0.00758143866469038,0.00147234281340169,0.00469564675042305,0.0104672305789577,2.66115341910855e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,42154,0.0286208973325952,0.00556093803798936,0.0177214587781361,0.0395203358870544,2.68879541166336e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42094,0.0143103621362263,0.00278326000627076,0.00885517252393558,0.0197655517485169,2.76421816366247e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42103,0.0251661801800828,0.00489568694592956,0.0155706337660609,0.0347617265941048,2.78043481611379e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42186,0.0311880554167569,0.00607773635920298,0.0192756921527191,0.0431004186807947,2.91550191920894e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,42162,0.043970700046275,0.00858618542190696,0.0271417766193374,0.0607996234732126,3.08116680304861e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,42223,-0.0127818997016651,0.00249663859216887,-0.0176753113423161,-0.0078884880610141,3.10477435983016e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,42184,0.0182425186299113,0.00356849764774766,0.0112482632403259,0.0252367740194967,3.23125637305577e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42213,0.0340243926504828,0.00665903449697484,0.0209726850364121,0.0470761002645535,3.27570819966364e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,40054,0.0161469613110025,0.00316023218875141,0.00995290622104971,0.0223410164009552,3.28635198701587e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,42127,0.0207037213124457,0.00405283201878021,0.0127601705556365,0.0286472720692549,3.29424161479198e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,42094,0.0142873216983649,0.0028000825528396,0.00879915989479931,0.0197754835019305,3.40023404346827e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40054,0.0456711708849842,0.00895066950600535,0.0281278586532137,0.0632144831167547,3.40784397440823e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40054,0.0495247986527799,0.00971140399749537,0.030490446817689,0.0685591504878708,3.46013487900252e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41887,0.0151988954257542,0.0029810454647932,0.00935604631475955,0.0210417445367489,3.47264398509717e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39863,0.0126456984319233,0.00248117844859132,0.00778258867268436,0.0175088081911623,3.51637970500004e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42171,0.0605647228932825,0.0118875737188788,0.03726507840428,0.083864367382285,3.54026558905001e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39863,-0.0158611984385843,0.00311352358205439,-0.0219637046594109,-0.00975869221775769,3.56031731679905e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,42106,0.0208639417605374,0.00409749564207107,0.0128328503020781,0.0288950332189967,3.59530508041436e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39847,0.0189899546886932,0.00373132442246487,0.011676558820662,0.0263033505567243,3.65453608318324e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42186,0.0365135238103384,0.00717668086424159,0.0224472293164249,0.0505798183042519,3.67293876761756e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41984,0.0258997850872116,0.00509265180278758,0.015918187553748,0.0358813826206753,3.71423479142267e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42144,0.0421202188132385,0.0082873015743332,0.0258771077275454,0.0583633298989315,3.77690938233802e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41984,0.0451071473383992,0.00888170683822512,0.0276990019354779,0.0625152927413204,3.85461924968392e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39804,-0.0188250035443093,0.00370886274302,-0.0260943745206285,-0.01155563256799,3.92655602264766e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,42163,0.0161611566020732,0.00318503802121711,0.0099184820804877,0.0224038311236588,3.94749131444362e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42103,0.0604471020661,0.0119236723386789,0.0370767042822894,0.0838174998499107,4.04377907515379e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40054,0.0198066791821179,0.00390965864501503,0.0121437482378885,0.0274696101263474,4.12746066377487e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39706,0.0311460232108964,0.00614901569103655,0.0190939524564648,0.0431980939653281,4.14885812020026e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,40021,0.0515555835177725,0.0101931367214817,0.0315770355436684,0.0715341314918765,4.30905915596191e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40021,0.0319851586603733,0.00632829777857075,0.0195816950143747,0.044388622306372,4.39014008195929e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42186,0.0142340748538461,0.00281965925657598,0.0087075427109572,0.0197606069967351,4.52137473278912e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,42144,0.060730217289799,0.0120356978165934,0.0371402495692759,0.0843201850103221,4.57651952944878e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42184,0.0167536266205115,0.00332271865460307,0.0102410980574894,0.0232661551835335,4.66547745213078e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42097,-0.0126206919400108,0.00250676661864851,-0.0175339545125619,-0.00770742936745969,4.8518093461055e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41991,0.0350617082304018,0.00696581535618527,0.0214087101322786,0.0487147063285249,4.88413715445397e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,42094,0.0276834072518929,0.00550394562043408,0.0168956738358421,0.0384711406679437,4.97750934333155e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42184,0.0550824109931989,0.0109649492772012,0.0335911104098846,0.0765737115765133,5.14124998668334e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40054,0.0286533982035068,0.00570929191827735,0.0174631860436832,0.0398436103633304,5.2838294526786e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40093,0.012809040335071,0.00255226593827095,0.00780659909605998,0.0178114815740821,5.28455279454384e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39863,0.0313972393986541,0.00625954650956343,0.0191285282399098,0.0436659505573984,5.36363757025473e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41887,0.0242968930266753,0.00485025130463179,0.014790400469597,0.0338033855837536,5.53316766931762e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,42150,0.0341153040693125,0.0068226446951628,0.0207429204667934,0.0474876876718316,5.79885029910563e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,42211,0.013845590754002,0.00277302258692887,0.00841046648362138,0.0192807150243826,6.02306751715277e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,42256,0.0153735054668563,0.00307928946102792,0.00933809812324159,0.021408912810471,6.03559036728747e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41876,0.0460982135856819,0.009233315135675,0.0280009159197589,0.0641955112516049,6.03645372800426e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,42213,0.0143068048737867,0.0028676292374674,0.00868625156835055,0.0199273581792228,6.14534127233239e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40054,0.0409289225341927,0.00820732211616889,0.0248425711865017,0.0570152738818838,6.23111325098313e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39719,0.0492322336255109,0.00988182855442969,0.0298638496588287,0.068600617592193,6.38985588027497e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,42166,0.0215586004246249,0.00433067334203095,0.0130704806742443,0.0300467201750056,6.50302427128205e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42099,0.0250367647386579,0.00504207077909722,0.0151543060116273,0.0349192234656884,6.93745846724248e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42162,0.0422605556030892,0.0085109238499918,0.0255791448571052,0.0589419663490731,6.94142700060742e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,42150,0.046753649096912,0.00941946994223513,0.0282914880101312,0.0652158101836929,7.01099605963791e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,40080,0.0352743343622739,0.00711373832674734,0.0213314072418491,0.0492172614826987,7.20662855552063e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42128,0.0462094024135643,0.00932268582730142,0.0279369381920535,0.0644818666350751,7.26229378737946e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41887,0.0233208219396095,0.00470851422084764,0.0140921340667481,0.0325495098124709,7.40547933148737e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42004,0.0490788984540729,0.0099139081109061,0.029647638556697,0.0685101583514489,7.49614867632876e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39911,-0.0309780757417593,0.00626552971020206,-0.0432585139737553,-0.0186976375097632,7.76130230332617e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39753,0.0242335919698085,0.00490703133802866,0.0146158105472723,0.0338513733923447,7.99131911850517e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42193,0.014713202548101,0.00298048555803961,0.00887145085434332,0.0205549542418586,8.05187895477833e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39992,0.0224248035194961,0.00454261465970319,0.0135212787864778,0.0313283282525143,8.07090995760616e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39601,0.0399861605214985,0.0081008901347977,0.024108415857295,0.055863905185702,8.09691944598084e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41887,-0.0195953884890818,0.00397104376172505,-0.0273786342620629,-0.0118121427161007,8.13471256748099e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41876,0.0372270331502094,0.00754835965952191,0.0224322482175464,0.0520218180828724,8.25057643091774e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42103,-0.0296652758693996,0.00601672519413217,-0.0414580572498986,-0.0178724944889005,8.3052433212437e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42144,0.0136299677848005,0.00276771491880971,0.00820524654393349,0.0190546890256676,8.55634827123736e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39863,-0.0157581835690392,0.0032018319108389,-0.0220337741142835,-0.00948259302379498,8.71165861101698e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41829,0.0417239209485646,0.0084849070762866,0.0250935030790429,0.0583543388180863,8.87912563317226e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42094,0.0218435442303146,0.0044483583523272,0.0131247618597533,0.0305623266008759,9.19696716754011e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,40085,0.0273619227043819,0.00557405716063228,0.0164367706695426,0.0382870747392212,9.29649119423744e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39793,0.027261046012051,0.00555371753903237,0.0163757596355475,0.0381463323885544,9.30898193925752e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,42112,0.0449664970368729,0.00916189108819867,0.0270091905040036,0.0629238035697423,9.31363099471537e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41861,0.0198805402368297,0.00405138615637264,0.0119398233703393,0.02782125710332,9.35848203496756e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,42120,0.020081986539859,0.00409395275032338,0.0120578391492252,0.0281061339304928,9.44295744251345e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39881,0.0362343104165059,0.00738998965497013,0.0217499306927644,0.0507186901402473,9.56941058423585e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42094,0.04302391733008,0.00877690182066816,0.0258211897615704,0.0602266448985896,9.60452898086143e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,40097,0.0405152658042563,0.00827035377309267,0.0243053724089947,0.0567251591995179,9.77819716323126e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39948,0.0482302560221492,0.00985310016542815,0.02891817969791,0.0675423323463883,9.97682020995273e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,40054,0.0269279343215368,0.00550378867244384,0.0161405085235469,0.0377153601195267,1.00932141962726e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40080,0.0440673929069945,0.00900702697806013,0.0264136200299966,0.0617211657839924,1.00959825632155e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41959,-0.0138452855712076,0.00283133740527469,-0.019394706885546,-0.00829586425686923,1.02055724640606e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41821,0.0527417905887449,0.0107905361980128,0.0315923396406398,0.07389124153685,1.03231707869319e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,42144,-0.0175480781870859,0.00359136952395238,-0.0245871624540326,-0.0105089939201392,1.04041623888482e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,42161,0.0187294416072155,0.00383404756301155,0.0112147083837128,0.0262441748307181,1.04647417472518e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41861,0.0288480353683116,0.0059154031692396,0.0172538451566019,0.0404422255800212,1.09149179113998e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,42004,0.021430527234883,0.00439502751050314,0.0128162733142968,0.0300447811554692,1.09510926294673e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39863,0.0458601098129908,0.00940446446150985,0.0274273594684315,0.0642928601575501,1.09587765955958e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,42094,0.0139430938652679,0.00285989668813509,0.00833769635652309,0.0195484913740126,1.09890765806445e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42103,0.0504817802117574,0.0103577154277445,0.0301806579733781,0.0707829024501367,1.10754579250774e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40026,0.0527231622019299,0.0108174635301283,0.0315209336828785,0.0739253907209814,1.10971994502182e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42184,0.0415606097808279,0.00853091088547088,0.0248400244453049,0.0582811951163508,1.11909211593351e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41887,0.0295602971177662,0.00607567245075851,0.0176519791142796,0.0414686151212529,1.15624462966542e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41887,0.0447383054145451,0.00919882926934965,0.0267086000466198,0.0627680107824704,1.16724081531335e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40020,0.0251942719108654,0.00519161172073136,0.015018712938232,0.0353698308834989,1.23378995715466e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42095,0.00922802219606515,0.00190252894394194,0.00549906546593895,0.0129569789261913,1.24652872125617e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39804,0.0291659094969395,0.00602025976810255,0.0173662003514585,0.0409656186424205,1.28644693413778e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,42103,0.026842995415311,0.00554179660389816,0.0159810740716706,0.0377049167589514,1.28899781492839e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39804,0.0335480891517818,0.00693035485671286,0.0199645936326246,0.047131584670939,1.3117676471772e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,40054,0.0112763301438827,0.00232980810380082,0.00670990626043311,0.0158427540273323,1.3161012398375e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42004,0.0450196083939596,0.00931640302652507,0.0267594584619705,0.0632797583259488,1.36532489164985e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41959,0.0276022114970501,0.0057159737214217,0.0163989030030636,0.0388055199910366,1.388398822916e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41887,0.0267665286939004,0.00554833794554207,0.0158917863206379,0.0376412710671628,1.42169760583722e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42094,0.0370786612696254,0.00769090115537775,0.022004495005085,0.0521528275341657,1.44391968187994e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39881,-0.0262903990426603,0.00545279772267866,-0.0369778825791104,-0.0156029155062101,1.44482266716415e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39863,0.0319101645580852,0.00661912333458307,0.0189366828223024,0.044883646293868,1.44881095303735e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39804,0.0233804605222037,0.00485000970788424,0.0138744414947505,0.0328864795496568,1.45037960376848e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39959,0.0204576641557551,0.00425131493151933,0.0121250868899772,0.028790241421533,1.51397047738792e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40057,0.00959733260468028,0.00199535031693923,0.00568644598347939,0.0135082192258812,1.53074218364025e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39863,0.0425168104074172,0.00884237915443196,0.0251857472647305,0.0598478735501038,1.54299339683713e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40021,0.0697223290266826,0.0145231472560406,0.0412569604048431,0.0981876976485222,1.60169788160167e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39863,0.0201557291885226,0.00420322172828863,0.0119174146010769,0.0283940437759683,1.64624093200812e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,42193,0.0562727217157793,0.0117403902806343,0.033261556765736,0.0792838866658226,1.66051447687059e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39784,0.0239226866074506,0.00499406754607303,0.0141343142171474,0.0337110589977537,1.68858216991926e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40020,0.0163422030816547,0.0034130383808264,0.00965264785523495,0.0230317583080745,1.70540138694339e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41887,0.0140904559071057,0.00294431572096661,0.00831959709401109,0.0198613147202002,1.72357872048474e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40020,0.0392938549525274,0.00821407455985365,0.0231942688152142,0.0553934410898405,1.74349671205875e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,40054,0.0179475431356746,0.00375347098695924,0.0105907400012345,0.0253043462701147,1.76202588543241e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42256,0.0314902529708394,0.00659017361858145,0.0185735126784198,0.0444069932632591,1.7865019225577e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39784,0.0380516520785372,0.00796321450392932,0.0224437516508357,0.0536595525062387,1.79044781691912e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42004,0.0372682911530119,0.00780167127782849,0.021977015448468,0.0525595668575557,1.79936003750657e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40054,0.0502019405018381,0.0105097874279856,0.0296027571429864,0.0708011238606898,1.8054074712876e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40020,0.0376615189735999,0.00788527238654225,0.022206385095977,0.0531166528512227,1.80996213914457e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41782,0.0222182909573758,0.00465408016174601,0.0130962938403536,0.031340288074398,1.82691300981931e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39922,0.0133063832401838,0.00278767359319997,0.00784254299751185,0.0187702234828557,1.83631926788826e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40021,0.0429354069956688,0.00900782802981704,0.0252800640572274,0.0605907499341102,1.89936156735444e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,42094,0.0485845071292885,0.0102013940308986,0.0285897748287273,0.0685792394298497,1.93255256460803e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42296,-0.01189876359103,0.002505794520877,-0.0168101208519489,-0.0069874063301111,2.07102120278695e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,42213,0.0623335161637845,0.0131331170220412,0.0365926068005838,0.0880744255269852,2.09391253007904e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42111,0.0272710443521991,0.00574607019273641,0.0160087467744357,0.0385333419299624,2.09668179344244e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,40001,0.0203188643493717,0.00428211165504519,0.0119259255054831,0.0287118031932603,2.11119020422591e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39863,0.0590135382307062,0.01244305143928,0.0346251574097174,0.0834019190516951,2.13631436823433e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42144,0.0308201128600303,0.0065182110097171,0.0180444192809848,0.0435958064390758,2.28784565230025e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42111,0.0142506653108443,0.0030174403049711,0.00833648231310095,0.0201648483085877,2.35105965998158e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42103,0.052412988856879,0.0111080870813112,0.0306411381775091,0.074184839536249,2.40137648213405e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42094,0.0535091144986831,0.0113486268068243,0.0312658059573075,0.0757524230400587,2.44205254833275e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,42145,0.0492601427495912,0.0104588279690162,0.0287608399303194,0.0697594455688631,2.50398998489952e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,40102,0.0427796274693848,0.00908390637399558,0.0249751709763534,0.0605840839624161,2.51527464445501e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,42144,0.0356048405294446,0.00756194858945006,0.0207834212941225,0.0504262597647667,2.52231803255555e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42103,0.0198590851904542,0.00421799768961023,0.0115918097188181,0.0281263606620902,2.52540478041832e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42094,0.0150884661516633,0.00320495352091342,0.00880675725067301,0.0213701750526536,2.52938622596752e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40020,0.0243296695156381,0.00517566733789208,0.0141853615333696,0.0344739774979065,2.62368438448786e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41953,-0.0280749907643715,0.00597564456872665,-0.0397872541190757,-0.0163627274096673,2.6515724426914e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42144,0.0406001053654235,0.00864636458748645,0.0236532307739501,0.057546979956897,2.68517718783202e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40054,0.0277767374936006,0.00592361616107408,0.0161664498178954,0.0393870251693058,2.77681610934645e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41829,0.0212945716777575,0.00454868544364224,0.0123791482082187,0.0302099951472963,2.8777537972918e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42120,0.0212515564363479,0.00454117235706286,0.0123508586165047,0.0301522542561911,2.9013843438883e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41987,0.0701716640111499,0.0150023029899463,0.0407671501508552,0.0995761778714447,2.93519159193438e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,42256,0.0361828917432371,0.00775739154695651,0.0209784043112023,0.0513873791752718,3.12722305744146e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42133,0.035212016546392,0.00755462003357405,0.0204049612805868,0.0500190718121971,3.17831983431608e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,42162,0.0229331345742059,0.00492322674493722,0.0132836101541289,0.0325826589942828,3.22232488548109e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,40102,0.0248491189535029,0.0053382274210739,0.014386193208198,0.0353120446988077,3.27899135241832e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42094,0.0246816890981918,0.00530559529210312,0.0142827223256697,0.035080655870714,3.31980306613528e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40080,0.015248052405542,0.00327747129747361,0.00882420866249375,0.0216718961485903,3.31989223414365e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40054,0.111538572901844,0.0239943001858669,0.0645097445375446,0.158567401266143,3.38223696648421e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40054,0.0393294016844672,0.00846267007572344,0.0227425683360492,0.0559162350328851,3.40103526800435e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40080,0.0127275809785881,0.00274060049622986,0.00735600400597754,0.0180991579511986,3.45587106740594e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,42256,0.0192081117309712,0.00413800195571508,0.0110976278977696,0.0273185955641728,3.48612592893483e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,40038,0.0301672899324858,0.00650012216236703,0.0174270504942465,0.0429075293707252,3.50734339447476e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42213,0.0441917396679982,0.00953153019070024,0.0255099404942257,0.0628735388417707,3.58020914568149e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,42213,0.0271548575733439,0.00586624525337723,0.0156570168767245,0.0386526982699633,3.70983359589889e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40021,0.0448935486130925,0.00970940209754538,0.0258631205019035,0.0639239767242814,3.81283219669834e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39804,0.0280654717552286,0.00607471802880652,0.0161590244187678,0.0399719190916894,3.88174986930453e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,42144,0.017291236881077,0.00374454277849644,0.00995193303522399,0.02463054072693,3.91719332060933e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42256,0.0217861944194673,0.00472014297761029,0.0125347141833511,0.0310376746555834,3.95733226415621e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,42223,0.0102027693082533,0.0022110641944578,0.005869083487116,0.0145364551293906,3.97962605113839e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40054,0.0217219061788427,0.00470733765875598,0.012495524367681,0.0309482879900044,3.98597450438602e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42094,0.0181673618845137,0.0039376317374027,0.0104496036792044,0.025885120089823,3.99220449212e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41876,0.0386825013109591,0.00838551355024798,0.0222468947524731,0.0551181078694452,4.00754009573604e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41887,0.0522353774082576,0.0113287238770539,0.030031078609232,0.0744396762072832,4.0488392406259e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42103,0.0328158392370773,0.00712221616182093,0.0188562955599083,0.0467753829142463,4.11376651918697e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,42208,0.0278887862711634,0.00605544771827725,0.01602010874334,0.0397574637989868,4.15237188639359e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40054,0.0132662797527461,0.00288380604935713,0.00761401989600613,0.0189185396094861,4.26723393559511e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41861,0.0240353449567119,0.00522749855447732,0.0137894477899363,0.0342812421234874,4.30967982624964e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,42144,0.0216358382489759,0.00470923738148882,0.0124057329812579,0.030865943516694,4.38217431449373e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,40054,0.0213981312226138,0.00465798551858529,0.0122684796061866,0.030527782839041,4.40020043937396e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40080,0.0241373460060831,0.0052564713610122,0.0138346621384992,0.034440029873667,4.44090122244557e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39804,0.046827939005142,0.0102043521196597,0.0268274088506089,0.066828469159675,4.50450066067743e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40021,0.0139749812145747,0.00304632794298127,0.00800417844633146,0.019945783982818,4.53657536685632e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39804,0.0348884244172005,0.00760843399078142,0.019975893795269,0.0498009550391321,4.58097588163635e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42186,0.0382905934502443,0.00835836653787305,0.0219081950360131,0.0546729918644755,4.66817696949903e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40097,-0.0214815686286953,0.00469024515803907,-0.0306744491384519,-0.0122886881189388,4.70011114525596e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39863,0.0394635272950015,0.00862146715765226,0.0225654516660031,0.056361602924,4.76210349790835e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42103,0.0166288602031616,0.00364121048636905,0.00949208764987829,0.023765632756445,4.99689347075985e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40097,0.0128030739899774,0.0028064607756307,0.00730241086974119,0.0183037371102135,5.12217049012212e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,40054,0.0340125589336266,0.00745672294577088,0.0193973819599157,0.0486277359073376,5.1387827870519e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42184,0.0394831112125109,0.00868269373480062,0.0224650314923017,0.0565011909327201,5.48209426461178e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40054,0.0448644772575505,0.00987612431164691,0.0255072736067226,0.0642216809083785,5.61314489178869e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41779,0.0314233383251577,0.00692089471234088,0.0178583846889695,0.0449882919613458,5.66799831866414e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42120,0.0166480541313355,0.00366710124174986,0.00946053569750578,0.0238355725651652,5.68052109704824e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42094,0.0391617945159324,0.0086330212747002,0.02224107281752,0.0560825162143447,5.77718926006715e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,42186,0.0281312211497902,0.00620156376532468,0.0159761561697538,0.0402862861298266,5.78036406558273e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42094,0.0255651507760329,0.00563956208889557,0.0145116090817976,0.0366186924702683,5.86250019460839e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40054,-0.0191717054730987,0.00423001655501006,-0.0274625379209184,-0.010880873025279,5.89683199777102e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,42213,0.026082752884447,0.00575997175793925,0.0147932082388861,0.0373722975300079,5.99942794546046e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40054,0.0214225174495515,0.00473303754978778,0.0121457638519674,0.0306992710471355,6.07017133335715e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40080,0.0352324040622679,0.00778419174493988,0.0199753882421858,0.0504894198823501,6.07055649247711e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42262,0.015172811543659,0.00335260000395748,0.00860171553590238,0.0217439075514157,6.07314683476597e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42004,0.0274123644622392,0.00605835082143216,0.0155379968522321,0.0392867320722462,6.10184525807213e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39804,0.0326535618295497,0.00721714065449785,0.0185079661467339,0.0467991575123655,6.12119856958122e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39863,0.0468268579739266,0.0103499704825442,0.0265409158281401,0.0671128001197132,6.12368764705549e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,42094,0.0323554186902415,0.00715288378453451,0.0183357664725539,0.0463750709079291,6.13944875974676e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40544,-0.0144115126155156,0.00318765566508484,-0.0206593177190819,-0.00816370751194931,6.21602498605705e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41861,0.017217169146328,0.00380946026762563,0.00975062702178173,0.0246837112708742,6.25230371576574e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39804,0.0181209735585747,0.00400983754290072,0.0102616919744893,0.0259802551426601,6.27662415006645e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42213,0.0577652532870643,0.0127842984545075,0.0327080283162297,0.0828224782578989,6.28415025640114e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41852,0.0180057748630544,0.0039873624320405,0.0101905444962551,0.0258210052298538,6.36749486823755e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39904,0.0252117020196214,0.00558583171224571,0.0142634718636198,0.036159932175623,6.44437738284932e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39706,0.0305458495957877,0.00676932338135093,0.0172779757683399,0.0438137234232355,6.47960830031414e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,42237,0.0156151971480692,0.00346206197241242,0.00882955568214084,0.0224008386139975,6.52779817824756e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39984,0.0421097427018073,0.00935056007613343,0.0237826449525858,0.0604368404510288,6.75620715574361e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39432,-0.051136512100032,0.0113597100237262,-0.0734015437465354,-0.0288714804535286,6.81989228729803e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39980,0.0489285979636174,0.0108728389521572,0.0276178336173892,0.0702393623098455,6.86404341520988e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42120,0.0536504783608253,0.0119308399512703,0.0302660320563356,0.0770349246653151,6.95877321507436e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,42079,0.0298252811078234,0.0066411785742467,0.0168085711022998,0.0428419911133469,7.15183181712016e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42004,-0.0213666004080601,0.00475937104010069,-0.0306949676466574,-0.0120382331694627,7.20560667965152e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39768,0.0248079750377713,0.00552917996295684,0.0139707823103759,0.0356451677651667,7.3085965874922e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41716,0.0179726662373961,0.00400619088928698,0.0101205320943936,0.0258248003803986,7.31425201624738e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41829,0.0496155677119264,0.0110838188019884,0.0278912828600292,0.0713398525638236,7.65778911691083e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,42004,0.0391894546560262,0.00875819308814178,0.0220233962032683,0.0563555131087841,7.72125429573646e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42280,0.0107129409219767,0.00239497575556227,0.00601878844107461,0.0154070934028787,7.77471213182082e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42186,-0.0107686346632485,0.00240873090023156,-0.0154897472277024,-0.00604752209879465,7.86363218511911e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,42120,0.0123136188756278,0.00275448900812026,0.00691482041971205,0.0177124173315435,7.87444457673478e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,40054,0.0305678679038883,0.00683895027172764,0.0171635253713022,0.0439722104364745,7.91330517938135e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,42132,0.0246226528104263,0.00551370161101477,0.0138157976528374,0.0354295079680153,8.04753972312614e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,42103,0.0372478787231666,0.00835348986495679,0.0208750385878513,0.0536207188584819,8.3053236390957e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,42101,0.029633827308873,0.00664849710574794,0.016602772981607,0.0426648816361389,8.3728361119993e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41810,0.020891457255935,0.00468820123933766,0.0117025828268332,0.0300803316850368,8.41527085214396e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39774,0.0157276373072455,0.00353174506871354,0.00880541697256692,0.022649857641924,8.54593837975999e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,42103,0.0247163602463768,0.00555521102250139,0.013828146642274,0.0356045738504795,8.69036132270455e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42167,0.0310436802413512,0.00700164917950804,0.0173204478495154,0.0447669126331869,9.33616267307652e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40054,0.0333405569743171,0.0075290015238571,0.0185837139875571,0.048097399961077,9.59142490015481e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40080,0.0309946130903825,0.00700250455401024,0.0172697041645224,0.0447195220162426,9.68330039774081e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,42186,0.0306794197018667,0.00694447360654862,0.0170682514330315,0.044290587970702,1.00509172526525e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,42256,0.0414000364229262,0.00938058923053643,0.0230140815310748,0.0597859913147776,1.02588542691117e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40021,0.0131771466923812,0.00298765732470222,0.00732133833596485,0.0190329550487976,1.04114396943621e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40054,0.0319579481005696,0.00724887350115534,0.0177501560383051,0.0461657401628341,1.05003051663504e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41861,0.0333250350331178,0.00756080435435964,0.0185058584985729,0.0481442115676627,1.0538008671902e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39804,0.0297906048839237,0.00676176749595601,0.0165375405918499,0.0430436691759974,1.06456658835199e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42004,0.0346922466443993,0.00787635870459593,0.0192545835833913,0.0501299097054074,1.06836812512576e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39768,-0.0146813803237825,0.00333934227205124,-0.0212264911770029,-0.00813626947056204,1.11090597513811e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39804,-0.0228567495768283,0.00520758052025651,-0.033063607396531,-0.0126498917571255,1.14905459757535e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39863,0.0222745428970072,0.00507793136776928,0.0123217974161794,0.032227288377835,1.16273741776545e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,42103,0.0243200168768694,0.00554524048670551,0.0134513455229266,0.0351886882308122,1.16504355225221e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40097,-0.0241254607973839,0.0055009234637813,-0.0349072707863953,-0.0133436508083726,1.16692145950641e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39804,0.0273660005052556,0.00625125679499124,0.0151135371870728,0.0396184638234385,1.21097875979714e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,42296,0.00860468541013428,0.00196601772345628,0.00475129067215996,0.0124580801481086,1.2141799100498e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41829,0.0266409472837948,0.00609906387784151,0.0146867820832255,0.0385951124843642,1.26366177250281e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,42162,0.0141788520461821,0.00324771378480554,0.00781333302796326,0.020544371064401,1.27642633768495e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41829,0.0223748813285991,0.00512528138963505,0.0123293298049143,0.0324204328522838,1.27787622338427e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41887,0.0371096844843171,0.00850608675256721,0.0204377544492854,0.0537816145193488,1.294687208415e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,40113,-0.0119947579297839,0.00275377553048543,-0.0173921579695354,-0.0065973578900325,1.33822173495965e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42177,-0.0106056225948068,0.00243596230848041,-0.0153801087194284,-0.00583113647018522,1.34840011210234e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41861,0.0273672977954941,0.00629294084106095,0.0150331337470147,0.0397014618439736,1.37898623364349e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40054,0.0371811259212749,0.00854935337724843,0.0204243933018679,0.0539378585406818,1.38007955383229e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,40097,-0.017717832963684,0.00408089477778673,-0.025716386728146,-0.00971927919922204,1.42690560360206e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40036,0.0346739092889319,0.00799132980584088,0.0190109028694838,0.05033691570838,1.44467360813812e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,42223,-0.0187800288005822,0.00433157202204424,-0.027269909963789,-0.0102901476373755,1.46444599722157e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,42213,0.0280561976066567,0.00647317081827755,0.0153687828028327,0.0407436124104807,1.47370451691033e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41829,0.0301461160028761,0.00695644908146941,0.016511475803196,0.0437807562025561,1.47858462660891e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40080,0.0123621112369155,0.00285343505269111,0.00676937853364091,0.01795484394019,1.48841399752746e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42103,0.0413098087223654,0.00954490969643725,0.0226017857173483,0.0600178317273824,1.51642597887913e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41963,0.0292414251253088,0.00675957362807937,0.0159926608142732,0.0424901894363443,1.53045348345014e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,42256,0.0267648969971212,0.00619508326876368,0.0146225337903444,0.038907260203898,1.5693665243613e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41829,0.0214788247001189,0.00497548673094585,0.0117268707074651,0.0312307786927728,1.59419895250918e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,42223,0.0172207614606154,0.00399633293798614,0.00938794890216254,0.0250535740190682,1.65092150135245e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42079,0.0382170997813845,0.00887042014117917,0.0208310763046733,0.0556031232580957,1.65677120195675e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39863,0.0193881773012397,0.00450028318089139,0.0105676222666926,0.0282087323357869,1.66052990841603e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,42144,0.0289515675509406,0.0067220907946224,0.0157762695934807,0.0421268655084005,1.66756020589093e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,42140,0.0147996056263074,0.00344104994150247,0.0080551477409625,0.0215440635116522,1.71353806736525e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41829,0.0288635581538768,0.00671320116231671,0.015705683875736,0.0420214324320176,1.72450439022537e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,42120,0.0318204544632083,0.00740729987102393,0.0173021467160014,0.0463387622104152,1.75317580688572e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,40097,0.0226709469383536,0.0052808939766733,0.0123203947440739,0.0330214991326333,1.77788476252717e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39863,0.0195221673561084,0.00455094279686516,0.0106023194742527,0.0284420152379641,1.80492910903152e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,42162,0.0133622229550264,0.00311813022834256,0.00725068770747503,0.0194737582025779,1.83783134903251e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,42162,0.0250243474216021,0.00584093937644399,0.0135761062437718,0.0364725885994323,1.84635358077289e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40054,0.0172473246998387,0.00403255808570563,0.00934351085185567,0.0251511385478217,1.91033986356833e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,42296,0.0227949185269974,0.00533123648306459,0.0123456950201908,0.033244142033804,1.9186240300555e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,42144,0.02599919281324,0.00608071065459142,0.0140809999302409,0.0379173856962392,1.91916985525792e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,40054,-0.0302004059528183,0.00706741266347615,-0.0440525347732315,-0.016348277132405,1.94338233575328e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41876,0.0309519218267575,0.00724599945163125,0.0167497629015602,0.0451540807519547,1.95500810600522e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40054,0.0134090144049915,0.00313919294954644,0.00725619622388047,0.0195618325861025,1.95829214103729e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42121,0.0260818548519188,0.00610835726911815,0.0141094746044472,0.0380542350993904,1.96988525365783e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,42184,0.0390894524622617,0.0091589511217822,0.0211379082635686,0.0570409966609549,1.98724514753743e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41876,0.0236091013913473,0.00553314285867205,0.0127641413883501,0.0344540613943445,1.99689475854835e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42186,-0.0191605643731728,0.00449828327228647,-0.0279771995868543,-0.0103439291594913,2.06300616624837e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40054,0.0205331372839773,0.00483582651994567,0.0110549173048838,0.0300113572630708,2.19387630650133e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40054,0.0494092910238869,0.0116438077322999,0.0265874278685791,0.0722311541791948,2.2198998849868e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,42103,0.0286065570805879,0.00674485421248306,0.0153866428241211,0.0418264713370547,2.23835415770554e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42094,0.0379980720560895,0.00896810251226219,0.0204205911320556,0.0555755529801234,2.28074521989615e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,42296,0.012811334867623,0.0030255684450632,0.0068812207152991,0.0187414490199469,2.3077101453061e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42103,0.0424769087985464,0.0100341244927779,0.0228100247927018,0.062143792804391,2.3193663127727e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39784,0.0322695833036509,0.007624400204141,0.0173257589035345,0.0472134077037673,2.3315026351646e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40020,0.0293566338083177,0.00694138404060874,0.0157515210887245,0.0429617465279108,2.36432191148058e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42256,0.0323318022571531,0.00764667823853705,0.0173443129096205,0.0473192916046858,2.37155347906904e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,42103,0.0215563417828157,0.00509847178669441,0.0115633370808946,0.0315493464847367,2.37400503052706e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40054,0.0201244293581987,0.0047600769117551,0.0107946786111587,0.0294541801052387,2.3796895622707e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,42090,0.0179763230927686,0.00425620074562221,0.00963416963134902,0.0263184765541881,2.42123051840037e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,42176,-0.016335789572068,0.00388251711251387,-0.0239455231125952,-0.00872605603154085,2.59917478139873e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39863,0.0356146403189326,0.00846561294266002,0.019022038951319,0.0522072416865463,2.60925809316821e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39847,-0.00888809317592888,0.00211374638578736,-0.0130310360920721,-0.00474515025978565,2.6333231375728e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,42213,0.0120537437759311,0.00286728984461755,0.00643385568048066,0.0176736318713815,2.64130048850266e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,42144,0.0230151433136808,0.00548092608301023,0.0122725281909808,0.0337577584363808,2.69729158103766e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,42161,-0.0192450979344662,0.00458879960049734,-0.028239145151441,-0.0102510507174914,2.75986360653411e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41783,0.0304280848976539,0.00726069388737639,0.0161971248783961,0.0446590449169116,2.79875449486626e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42248,0.0220436354833191,0.00526401327489621,0.0117261694645225,0.0323611015021156,2.8375753615248e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41887,0.0204815503582245,0.00489221524584621,0.0108928084763659,0.0300702922400831,2.85124770663578e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,42256,-0.0036899908464265,0.000881543096851997,-0.00541781531625642,-0.00196216637659659,2.85984821904474e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41936,0.0346349811592299,0.0082770328266836,0.01841199681893,0.0508579654995298,2.87751052387365e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42296,0.00953645246606434,0.00228121645045034,0.00506526822318167,0.014007636708947,2.92856153095201e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40054,0.0264774796627354,0.00633488084459322,0.0140611132073327,0.0388938461181382,2.94267421846812e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,42144,0.0280951066061349,0.00673059288924877,0.0149031445432073,0.0412870686690624,3.00937371089596e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40020,0.0230710787930575,0.00553344600431396,0.0122255246246022,0.0339166329615129,3.07798300785409e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39991,0.0301861735706706,0.00724478882999223,0.0159863874638858,0.0443859596774553,3.11577569763921e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40028,0.0240831649471421,0.00578777930508186,0.0127391175091817,0.0354272123851026,3.19252089284216e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40021,0.0360622638480481,0.00868247649030591,0.0190446099270486,0.0530799177690477,3.30007804672231e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39881,0.0204662568220853,0.00492951360966685,0.0108044101471382,0.0301281034970323,3.32460120166663e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,42126,0.0101846951962408,0.002453892825363,0.00537506525852931,0.0149943251339523,3.33985565288678e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41985,0.0139694364651574,0.00337094833609915,0.00736237772640307,0.0205764952039117,3.43396105170855e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,40113,0.010750188212159,0.00259403023339776,0.0056658889546994,0.0158344874696186,3.43570209804047e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39858,0.0192723703542324,0.00465490799732388,0.0101487506794776,0.0283959900289872,3.49634895137213e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,42120,0.0128904735768886,0.00311810222548113,0.00677899321494553,0.0190019539388316,3.58633938782379e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,40080,0.0343124944430401,0.00829951201259296,0.0180454508983579,0.0505795379877223,3.58741631027843e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40054,0.026478144697396,0.00640754792022971,0.0139193507737458,0.0390369386210463,3.61788583045853e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39965,0.0130074303113987,0.00315158792005686,0.00683031798808723,0.0191845426347101,3.69871937397432e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39863,0.0238741579229571,0.00578495873251375,0.0125356388072301,0.035212677038684,3.70421824502794e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40080,0.0165828020587606,0.00402676187889144,0.00869034877613341,0.0244752553413879,3.84750921539511e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41969,0.0234410625651425,0.00569288076641182,0.0122830162629754,0.0345991088673097,3.85229907930349e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,40069,0.0180463390265348,0.00438601911418284,0.00944974156273643,0.0266429364903332,3.90855159545144e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39863,0.0302692616735372,0.00736094994737315,0.0158417997766859,0.0446967235703886,3.94946264678493e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,40113,-0.0295739179993946,0.00722524865893085,-0.043735405370899,-0.0154124306278901,4.28642744934456e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41829,0.025095491050462,0.00613266304517703,0.013075471481915,0.037115510619009,4.30133292668821e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41829,0.0207798204776648,0.00508414994216217,0.010814886591027,0.0307447543643027,4.39353936177958e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,40080,-0.0109539364663258,0.00268098090251594,-0.016208659035257,-0.0056992138973945,4.4241227436055e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41861,0.0302437211225706,0.00740420550776567,0.0157314783273499,0.0447559639177913,4.44114807785843e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39944,0.0269094918961335,0.00658949508610256,0.0139940815273725,0.0398249022648945,4.46462971624798e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,42144,0.0123974563453846,0.00303653395572616,0.00644584979216135,0.0183490628986079,4.47702639656133e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,40055,0.0195415876651626,0.00479380920257795,0.0101457216281098,0.0289374537022154,4.60598568954628e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41876,-0.0217328723303725,0.00534536165434559,-0.0322097811728899,-0.0112559634878551,4.81685672320134e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,40054,0.0338875667612602,0.00833700401408679,0.0175470388936501,0.0502280946288703,4.84295556958468e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41876,0.0193788479337932,0.00477701478180412,0.0100158989614571,0.0287417969061292,5.00719826662708e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,42099,0.0373168140180037,0.00919957084815003,0.0192856551556296,0.0553479728803777,5.01355863746207e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41861,0.027551264543558,0.00679212055652646,0.0142387082527662,0.0408638208343499,5.01427851044468e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39706,0.0279732662450782,0.00689747176697916,0.014454221581799,0.0414923109083573,5.03705178296061e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,40021,0.0282458843489949,0.00698458577354624,0.0145560962328443,0.0419356724651455,5.29041218443388e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40102,0.0110680494301908,0.00274073148155058,0.00569621572635169,0.01643988313403,5.41955441024319e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,42144,-0.0154320195580658,0.00383316963220801,-0.0229450320371935,-0.00791900707893814,5.7077178466376e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39835,-0.0195388504711505,0.00485418401837741,-0.0290530511471703,-0.0100246497951308,5.73320087716077e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41974,-0.0272614832786001,0.00677609209212173,-0.0405426237791587,-0.0139803427780415,5.77465034250698e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39863,0.0199530035456801,0.00496407377155108,0.0102234189534399,0.0296825881379202,5.87273038325196e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39881,0.0364601023438644,0.00909195956726992,0.0186398615920154,0.0542803430957135,6.10935395131674e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40054,0.0318032021102433,0.00793849932680918,0.0162437434296973,0.0473626607907893,6.21153871181395e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,40092,0.00891714673509124,0.00222682697850959,0.00455256585721243,0.01328172761297,6.2582755702201e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,42256,0.0116818789066738,0.00291866348015199,0.00596129848557591,0.0174024593277717,6.30293915034445e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,40054,0.0176517039870218,0.00441631641299141,0.00899572381755863,0.0263076841564849,6.45937053724286e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,42099,0.0292546914479527,0.00732076736743829,0.0149059874077737,0.0436033954881318,6.47459238460203e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,40080,-0.0154513815312078,0.00386964039171936,-0.0230358766989778,-0.00786688636343786,6.56778644260751e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39881,0.0269991717892953,0.00676850060510328,0.0137329106032929,0.0402654329752977,6.6810509693476e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41989,0.0188172553244315,0.00471922768192348,0.00956756906786148,0.0280669415810015,6.71842389664493e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40080,0.010697277619957,0.00268412164170159,0.00543639920222186,0.0159581560376921,6.78081973835409e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42223,-0.0145234842766512,0.00365050842359374,-0.021678480786895,-0.00736848776640751,6.97318714698349e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,42094,0.0237217444197833,0.00596533259803109,0.0120296925276424,0.0354137963119242,7.02889466877221e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39804,0.0181940673122418,0.00457649386443358,0.00922413933795201,0.0271639952865316,7.06832139844423e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,42256,0.0230273781741923,0.00579604181527842,0.0116671362162466,0.034387620132138,7.13695018410332e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39768,0.0320002871345006,0.00805707349883767,0.0162084230767787,0.0477921511922224,7.18342966460339e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39804,0.0203927136906602,0.00513683689852296,0.0103245133695552,0.0304609140117652,7.23779010631923e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40054,0.0265755798705173,0.00669577884995783,0.0134518533245999,0.0396993064164346,7.2637972000676e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39863,0.0211246717200875,0.00532527962238225,0.0106871236602183,0.0315622197799567,7.3300084195153e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41985,0.0440202316259624,0.011097784161611,0.0222685746692048,0.06577188858272,7.33092278550696e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,42223,0.0106878808175081,0.00269472032831935,0.00540622897400223,0.0159695326610141,7.3408994786791e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41861,0.0309170765327394,0.00779742332716322,0.0156341268114995,0.0462000262539793,7.37877370052692e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40054,0.0245735630155936,0.00620194734145357,0.0124177462263446,0.0367293798048426,7.47267995245162e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42193,0.022554990344133,0.00569368799323967,0.0113953618773832,0.0337146188108827,7.49084597000392e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,42223,0.0187299162603192,0.00473526402664589,0.00944879876809322,0.0280110337525451,7.68076431567292e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,42184,-0.0255186897273278,0.00645771022604081,-0.0381758017703678,-0.0128615776842878,7.80208860126186e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,42144,0.0140719260599326,0.00356602630569433,0.00708251450077173,0.0210613376190935,7.98510506376757e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39784,0.0351480260146648,0.0089082848432456,0.0176877877219034,0.0526082643074262,8.01331087242412e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40076,-0.0194153470773609,0.00493337988205629,-0.0290847716461912,-0.00974592250853059,8.3538022812613e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42094,0.0313015924237362,0.00795762477791318,0.0157046478590264,0.046898536988446,8.41440923504993e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41880,0.0157081965662652,0.00399509776356109,0.00787780494968547,0.0235385881828449,8.47364891058419e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42223,-0.0135719927127785,0.00345197325686719,-0.0203378602962382,-0.00680612512931883,8.47971240457477e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41999,-0.0203999873013717,0.00519216658712963,-0.0305766338121458,-0.0102233407905976,8.57502711662599e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,42296,0.0282656296447989,0.00719458761030482,0.0141642379286014,0.0423670213609963,8.58320161017835e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,42296,0.0245609570027053,0.00625784560982183,0.0122955796074545,0.0368263343979561,8.72360571828219e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41813,0.022317894031817,0.00568741070212699,0.0111705690556482,0.0334652190079859,8.75211119215816e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,42213,0.0147883906918947,0.00377104281337125,0.00739714677768706,0.0221796346061024,8.8426808358805e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,42256,0.0188381166853546,0.00480943364143706,0.00941162674813792,0.0282646066225712,9.01478114648228e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40054,0.0144437126735569,0.00368743991582775,0.00721633043853454,0.0216710949085793,9.0205711410793e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,42107,0.0183621801864887,0.00468935501498891,0.00917104435711049,0.027553316015867,9.05999569962845e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40054,0.0491203311928055,0.0125478375853124,0.0245265695255932,0.0737140928600178,9.10904240390059e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42120,0.00914432844169576,0.00233981432058275,0.00455829237335357,0.0137303645100379,9.34826083290755e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42095,0.0164902052174915,0.00422244743290784,0.00821420824899213,0.0247662021859909,9.45620325014459e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42096,0.0264084277779439,0.00676345103104252,0.0131520637571006,0.0396647917987872,9.48701670556394e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42120,0.0130997756211101,0.00335829306431215,0.00651752121505825,0.0196820300271619,9.63908306233988e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42053,0.0175944646618053,0.00451112610432604,0.0087526574973263,0.0264362718262844,9.6587066541122e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39804,0.0355053955117253,0.00911618367907489,0.0176376755007385,0.0533731155227121,9.88968642929676e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42094,0.0533043535675395,0.0136958202640499,0.0264605458500017,0.0801481612850774,9.99147047706619e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,40080,-0.0116440372839107,0.00299540305434265,-0.0175150272704223,-0.00577304729739915,0.000101966119505238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41829,0.0152228285417274,0.00391837762768926,0.00754280839145645,0.0229028486919983,0.000102859267214719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,40020,0.0321585245573956,0.00828280359769501,0.0159242295059134,0.0483928196088778,0.000103974375382954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41876,0.031585338514906,0.00813651008108728,0.015637778755975,0.0475328982738371,0.000104157059558082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41887,0.0206857148083823,0.00533363441441362,0.0102317913561316,0.031139638260633,0.000105696771450146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,40080,0.0262242808440588,0.00676607191295031,0.0129627798946762,0.0394857817934414,0.000106876727680353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,42197,0.0216860394780048,0.00559979884163164,0.0107104337484068,0.0326616452076029,0.000108187289240583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41651,0.0355636588990608,0.00919091782979576,0.0175494599526611,0.0535778578454605,0.000109643788004429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39784,0.0180647067820745,0.00466986216211538,0.0089117769443284,0.0272176366198207,0.000110226262182024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42126,-0.0289670034703974,0.00748984046444774,-0.043647090780715,-0.0142869161600798,0.000110492791495999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39706,0.0156005696995117,0.00403514554361263,0.00769168443403092,0.0235094549649924,0.000111222384741373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41876,0.0208729708670429,0.00539947800233978,0.010289993982457,0.0314559477516289,0.000111305860197692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41876,0.0137804238026812,0.0035658764408428,0.00679130597862928,0.0207695416267331,0.000111859400356587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39863,0.0318503958713813,0.00824155298164602,0.0156969520273551,0.0480038397154075,0.000111925531840122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,42103,-0.0148767592408036,0.00385026837156807,-0.022423285249077,-0.00733023323253017,0.000112171571854928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40102,0.0202837114391786,0.00525463981756601,0.00998461739674917,0.0305828054816079,0.00011396991930126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39804,0.0281180560416324,0.00728798854465836,0.013833598494102,0.0424025135891628,0.000114931043069009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42256,0.0257804294717035,0.00668667771660418,0.0126745411471593,0.0388863177962477,0.000116050986390437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39881,0.0147986876797303,0.00383891006508578,0.00727442395216213,0.0223229514072984,0.000116446077703616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40080,0.0242621588404304,0.00629527943013337,0.011923411157369,0.0366009065234918,0.000116859733357971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41967,0.0106433974173038,0.00276224012395371,0.0052294067743545,0.016057388060253,0.000117165811178968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,40021,0.0231559660166743,0.00601010631951277,0.0113761576304292,0.0349357744029193,0.000117430361686894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40054,0.0276628713779159,0.00718314465566031,0.0135839078528217,0.0417418349030101,0.000118272969210373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40021,0.0202805888173272,0.00526703845716825,0.00995719344127744,0.030603984193377,0.000118568660014904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39863,0.0221118717088409,0.00575695417742629,0.0108282415210854,0.0333955018965965,0.000123294705586556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39881,0.0143686456190585,0.00374499118559978,0.00702846289528289,0.021708828342834,0.000125383786920302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39768,0.0177491789711766,0.00464013990465935,0.00865450475804431,0.026843853184309,0.000131449937738859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,42093,0.0334490456378611,0.00874696941632644,0.0163049855818613,0.0505931056938609,0.000131883094558402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39784,0.0215384142500674,0.00563567701206026,0.0104924873064293,0.0325843411937055,0.000133240741451239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42223,0.0152427132717533,0.00398969487566608,0.00742291131544775,0.0230625152280588,0.000133788397709065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42211,0.007730792869608,0.00202681226422582,0.00375824083172539,0.0117033449074906,0.000137221449548216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,42248,0.00830965707536127,0.00218754737426407,0.0040220642218037,0.0125972499289188,0.000146164958240548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,42137,0.070728912603005,0.0186281149811332,0.034217807239984,0.107240017966026,0.000147191523128353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42094,0.0202314276120963,0.00533515099815536,0.00977453165571181,0.0306883235684808,0.000150059678242874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39804,0.0110660885575755,0.00292123590409053,0.00534046618555802,0.0167917109295929,0.000152609746341318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40020,0.0265306248105816,0.00700474432073222,0.0128013259419465,0.0402599236792168,0.000152980257371648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,42262,0.0107779544927813,0.00284817373893457,0.00519553396446957,0.0163603750210931,0.000154915250688202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40020,0.020833044204703,0.00550972572112066,0.0100339817913065,0.0316321066180996,0.000156951081537767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,40080,0.0344464327911179,0.00911062936467725,0.0165895992363505,0.0523032663458853,0.000157093877001844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,40097,0.0165711984719885,0.0043871463705401,0.00797239158572992,0.0251700053582471,0.000159434538597625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41861,0.0292595588144837,0.00775211072857556,0.0140654217864756,0.0444536958424918,0.000161125677060184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42144,0.0437809484076011,0.0116016646503743,0.0210416856928674,0.0665202111223348,0.000161575585952439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42223,0.0129545954180896,0.00343709272972338,0.00621789366783173,0.0196912971683474,0.000164588996935933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39784,0.0154873845105055,0.00410963759272805,0.00743249482875848,0.0235422741922525,0.00016508815394234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40054,0.0303226630793545,0.00804921470469053,0.0145462022581611,0.046099123900548,0.000165989120043324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39863,0.00876032957644645,0.00232575796238438,0.00420184397017307,0.0133188151827198,0.000166338453856402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,40097,0.00965862614341909,0.00256478867103215,0.00463164034819607,0.0146856119386421,0.000166851619491769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40054,-0.0266423655427719,0.00707609438367022,-0.0405115105347656,-0.0127732205507783,0.000167345051521522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40020,0.0154647449097265,0.00411432554713793,0.00740066683733621,0.0235288229821169,0.000171658067888443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40054,0.0259250513165697,0.00689814968393104,0.0124046779360648,0.0394454246970745,0.000171994084275829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40020,0.0328814335380237,0.00876986737388746,0.0156924934852043,0.0500703735908431,0.00017820611609745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42094,-0.020507440932614,0.00547028381376975,-0.0312291972076027,-0.00978568465762529,0.000178401281580812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,40054,0.012467001692687,0.00332738331493824,0.00594533039540802,0.0189886729899659,0.000180040343406457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,40080,0.0120841300184254,0.0032280180235743,0.00575721469221977,0.018411045344631,0.000182398873049894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",40113,0.00627858972070286,0.00167827729538131,0.00298916622175549,0.00956801321965022,0.000184160595846491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40054,-0.0225229309807138,0.00602518504518827,-0.0343322936692828,-0.0107135682921448,0.000186344934067845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39847,0.0317415332086032,0.00849180337167222,0.0150975986001257,0.0483854678170808,0.000186532629952578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40031,0.0141439224148818,0.00378556060438271,0.00672422363029166,0.0215636211994719,0.000187719980189804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39863,-0.0293382044707458,0.00785794423432927,-0.0447397751700312,-0.0139366337714604,0.000189764661531559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42186,0.0206518810129868,0.00554137306001786,0.00979078981535179,0.0315129722106218,0.000194707936839204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41887,-0.0116734563875232,0.00313382957380822,-0.0178157623521873,-0.00553115042285908,0.000196176034214561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42120,-0.0154431414738544,0.004145934590941,-0.0235691732720987,-0.00731710967561002,0.000196233299628454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42103,0.0368002516607005,0.0098997657261026,0.0173967108375394,0.0562037924838616,0.000202226363592418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41829,0.022877130464388,0.00616292771476293,0.0107977921434526,0.0349564687853233,0.000206465975987917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,42057,0.0122229654449328,0.00329586613395514,0.00576306782238068,0.0186828630674848,0.000209305670645881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,42107,0.0380831521016107,0.0102703102217022,0.0179533440670745,0.058212960136147,0.000209709348859677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40054,0.0241872823291931,0.00652549852131737,0.011397305227411,0.0369772594309751,0.000211121319926284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42120,-0.010087153371401,0.00272924438679406,-0.0154364723695174,-0.00473783437328467,0.00021997023934477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42186,0.0114023229133352,0.00308590868454616,0.00535394189162471,0.0174507039350457,0.000220820507689982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40054,0.0119034928524349,0.00322537495371086,0.00558175794316159,0.0182252277617082,0.000224840856137211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40097,0.0126265326660067,0.00342214745940207,0.00591912364557868,0.0193339416864348,0.000225654211657187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40021,0.0189392069474651,0.00513577925483533,0.00887307960798781,0.0290053342869423,0.000227398297697633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42103,0.0320765087756194,0.0087020599927451,0.015020471189839,0.0491325463613998,0.000228665382141107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,42186,0.0208886394736765,0.00567048249346747,0.0097744937864803,0.0320027851608728,0.000230760654738162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,40113,0.00822669247483676,0.00223479011311935,0.00384650385312284,0.0126068810965507,0.000233264309805997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,42120,-0.0165091491961126,0.00449128286700382,-0.0253120636154401,-0.00770623477678515,0.000238045791972906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42296,0.00586896385020174,0.00159754490919739,0.00273777582817486,0.00900015187222862,0.000239978743208472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40092,0.00673686977280364,0.00183462614096653,0.00314100253650924,0.010332737009098,0.000241747538324394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39532,0.0391461188890152,0.010661813446001,0.0182489645348532,0.0600432732431772,0.000242233420906935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42162,-0.0321013058242486,0.00874854825206344,-0.0492484603982929,-0.0149541512502042,0.000244162031176803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42116,0.0350841850664935,0.00957900599488887,0.0163093333165113,0.0538590368164756,0.000250653385521449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39706,0.0148118031873524,0.00404424296287128,0.00688508698012472,0.0227385193945801,0.000251049538570304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,42144,0.0313166496775453,0.00855379988846184,0.0145512018961601,0.0480820974589305,0.000252095754431136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40080,0.029971299982415,0.00819269842932796,0.0139136110609322,0.0460289889038978,0.000255098351179229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42094,-0.00977396495731863,0.00267216537347721,-0.015011409089334,-0.00453652082530329,0.000255507049525322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42103,0.0303731824848671,0.00830843135889982,0.0140886570214235,0.0466577079483108,0.000257493297325837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40080,0.0265050621327669,0.00726716630888436,0.0122614161673536,0.0407487080981803,0.000266314973455505
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40054,0.016637468685488,0.00456195633361893,0.00769603427159494,0.0255789030993811,0.000266557897478349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40054,0.014050699666047,0.00385567483872541,0.00649357698214518,0.0216078223499488,0.000269516771439014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41829,0.0284675230100052,0.00781246190838355,0.0131550976695734,0.0437799483504369,0.000269654969189242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42128,0.0206932210651233,0.00568363549627885,0.00955329549241678,0.0318331466378299,0.000272807809823544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39768,0.0227359194722941,0.00625034954835878,0.0104852343575109,0.0349866045870773,0.000276560173957046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41861,0.0145100334007116,0.00399115287816037,0.00668737375951726,0.0223326930419059,0.000278488036839779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39804,0.0202945254737204,0.00558544032370719,0.00934706243925428,0.0312419885081865,0.000280956247573303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41829,0.0260202280213999,0.00716173709515243,0.0119832233149011,0.0400572327278986,0.000281006119355689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,42158,0.0399615338006569,0.0110219959005064,0.0183584218356643,0.0615646457656494,0.000289377257134538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39784,0.0109033967634519,0.00300809252958103,0.00500753540547304,0.0167992581214307,0.000290666872936169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,42186,0.00797332803188115,0.00220018680043054,0.0036609619030373,0.012285694160725,0.000291265189926001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40097,-0.0106498455553496,0.0029416614477375,-0.0164155019929152,-0.00488418911778414,0.000295537784033991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39793,0.0288197974957209,0.00796112896520897,0.0132159847239114,0.0444236102675305,0.000295903019894069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39784,0.0162488911720129,0.00449038992609838,0.00744772691686007,0.0250500554271657,0.000297589586298945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41985,0.0269868773630244,0.00746733661923622,0.0123508975893214,0.0416228571367274,0.000302678206602003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39916,0.0393460268300435,0.0108987232616438,0.0179845292372215,0.0607075244228654,0.000307415636827597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39906,0.00295129463399856,0.000817672152334667,0.00134865721542262,0.00455393205257451,0.000308322389030229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40054,0.0144111296805684,0.00399763694715955,0.00657576126413572,0.0222464980970012,0.000313657098351207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40054,0.0295254231313206,0.00821365791870904,0.0134266536106509,0.0456241926519903,0.000326237127918815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40021,0.0165740065560697,0.00461096903026286,0.00753650725675448,0.0256115058553849,0.000326492472414198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39706,0.0215540944534777,0.0059980468378461,0.00979792265129938,0.0333102662556561,0.000327733745138184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39863,0.0398761799528178,0.0110971223973478,0.0181258200540162,0.0616265398516195,0.0003278860674488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42226,0.0102328818374272,0.00285478676492839,0.00463749977816753,0.0158282638966868,0.000339004208409996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,42155,-0.0126593046966655,0.00353354600255939,-0.0195850548616819,-0.0057335545316491,0.000341429841664298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39863,0.0411477063888648,0.0115111646427915,0.0185858236889935,0.0637095890887362,0.00035232500858388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42004,0.0193988138052746,0.00543291117565621,0.00875030790098847,0.0300473197095608,0.00035745350516173
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42296,0.025560882564094,0.00716420552608556,0.0115190397329663,0.0396027253952217,0.000361193673686008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,40113,0.0110702651704228,0.00310350132430955,0.0049874025747761,0.0171531277660695,0.000362603619814845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42103,0.0230161466905946,0.00645457938972813,0.0103651710867274,0.0356671222944617,0.000363972082014282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,40102,0.00960075606763488,0.00269401252733473,0.00432049151405881,0.014881020621211,0.000367171763551769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,40020,0.0188789060134363,0.00531420229412944,0.00846306951694256,0.02929474250993,0.000383156449809108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39804,0.02432296021868,0.00685125942956854,0.0108944917367257,0.0377514287006343,0.000386686575678622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,42103,0.0263185992377914,0.00741950904291493,0.0117763615136782,0.0408608369619047,0.000390706186066675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41829,0.0100560665448268,0.00283853572473941,0.00449253652433755,0.015619596565316,0.000397488455118954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,42004,0.0212696315851935,0.00600450684918862,0.00950079816078381,0.0330384650096032,0.000398097569305436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,42120,0.0183637075163459,0.00518786806518218,0.00819548610858881,0.0285319289241029,0.000401927636668716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40054,0.0265953778618521,0.00751442731502533,0.0118671003244025,0.0413236553993018,0.000402955160460002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42273,0.0426638117876447,0.0120562995216193,0.0190334647252708,0.0662941588500186,0.000403473865650962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42186,0.0186205903984279,0.00526869380708383,0.00829395053654361,0.0289472302603122,0.00041044088395168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39804,0.017271851622384,0.00489387054159591,0.00767986536085605,0.026863837883912,0.000418452489171695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41879,-0.0212195985957698,0.00601665206957553,-0.0330122366521379,-0.0094269605394018,0.000422081263232453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,42284,0.0161004588950212,0.00456650126743226,0.00715011641085401,0.0250508013791885,0.000423687986677541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40020,0.0148434793596959,0.00421402038394774,0.00658399940715834,0.0231029593122335,0.000429414771424971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41861,-0.0108371544361377,0.00307946705581656,-0.0168729098655381,-0.00480139900673721,0.000434425140057869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42213,0.0184121248994979,0.00523504859053381,0.00815142966205162,0.0286728201369441,0.000437795551125862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42213,0.0220891538122617,0.00629489960663462,0.00975115058325787,0.0344271570412656,0.000451219089364685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39881,0.0392631135362171,0.0111906199457061,0.0173294984426333,0.061196728629801,0.000452369276937008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40054,0.023478245948416,0.0066940951197244,0.0103578195137562,0.0365986723830758,0.000454496137400586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41957,-0.0102238756179372,0.00291644811605269,-0.0159401139254004,-0.00450763731047392,0.000457157447495809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,42213,0.0159310692779763,0.00454577359735327,0.00702135302716387,0.0248407855287887,0.000458849128581857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39768,0.0147219401826668,0.00420289993913185,0.00648425630196832,0.0229596240633652,0.000462287657738393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,42223,-0.0161674473656962,0.00461642174878411,-0.0252156339933131,-0.00711926073807939,0.000463048226781493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,42296,0.0303673887931754,0.00867481156110659,0.0133647581334065,0.0473700194529443,0.00046568651170022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39863,0.0292111337771918,0.00834535005760296,0.01285424766429,0.0455680198900936,0.000466652314497183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42120,0.00846650049628721,0.00243274125291847,0.003698327640567,0.0132346733520074,0.000502634598336085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42144,-0.00887140469901015,0.00255481275606789,-0.0138788377009032,-0.00386397169711708,0.000517455967661383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39768,0.0241643491697128,0.00696329249673268,0.0105162958761168,0.0378124024633089,0.00052205315417996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40054,0.02020007883556,0.00582155964394104,0.0087898219334356,0.0316103357376845,0.000522724134947543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42103,0.0144585395418525,0.00416776623804021,0.00628971771529373,0.0226273613684114,0.000523842767543188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,42296,-0.00567148555746997,0.00163485956737742,-0.00887581030952972,-0.00246716080541023,0.000523890744629375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,40080,0.0184884685311016,0.00534888432158851,0.00800465526078817,0.0289722818014151,0.00054930955750654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41876,0.0170178215240397,0.00492798799855466,0.0073589650468726,0.0266766780012069,0.000555580828976904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39706,0.0201199596459516,0.00582839739810226,0.00869630074567118,0.031543618546232,0.000558519508320036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,40021,0.0241684816051095,0.00700560123439832,0.0104375031856888,0.0378994600245302,0.000562973975451007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42186,0.0239673592600537,0.00695051612034413,0.0103443476641792,0.0375903708559282,0.000565947275822747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,42213,-0.0110755826810751,0.00321726438896771,-0.0173814208834518,-0.00476974447869841,0.000578076308855522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,42120,-0.0226703458354535,0.00659338409534129,-0.0355933786623224,-0.00974731300858455,0.000587121036220364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40021,0.0290323271916278,0.00844983476104566,0.0124706510599783,0.0455940033232773,0.000592925120303397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41887,0.027007782918645,0.00787097287935152,0.011580676075116,0.0424348897621739,0.000602577535577388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,42094,0.0102011533544645,0.00297383364319541,0.00437243941380145,0.0160298672951275,0.000604793277088633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,42120,0.0159500817785953,0.00466799913528513,0.00680080347343643,0.0250993600837542,0.000635338287359525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42004,0.0125053866616686,0.00366292147083829,0.00532606057882557,0.0196847127445117,0.000642037830627328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39686,-0.021495511028722,0.0063119178559817,-0.0338668700264461,-0.00912415203099785,0.000662799930863023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,42282,0.0121573250694861,0.00357249573229101,0.00515523343419574,0.0191594167047765,0.000668415961077558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39959,0.0107812200639282,0.00317144096038055,0.00456519578158234,0.0169972443462741,0.000677614693499991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42296,0.0140058722753783,0.00412213144818379,0.00592649463693804,0.0220852499138185,0.000681506646150813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39804,-0.0199395334337465,0.00587014962922235,-0.0314450267070223,-0.00843404016047067,0.000684371998447927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39768,0.0273567763698718,0.00805480354978656,0.0115693614122902,0.0431441913274535,0.000685472549112518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39784,-0.0152283138242172,0.00448733067268212,-0.0240234819426742,-0.00643314570576027,0.000692271012163134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40113,0.0104063679064656,0.0030674560027006,0.0043941541411724,0.0164185816717588,0.000695018962764477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,40080,0.0251077048402348,0.00741233019690867,0.0105795376542938,0.0396358720261758,0.000708369244693701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42186,-0.00801726833861359,0.00236776278188213,-0.0126580833911026,-0.00337645328612462,0.000711268877830041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41887,0.0253570609340922,0.0074940035730335,0.0106688139309465,0.0400453079372378,0.000717462919013306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,42193,0.0168751868479255,0.00499366761125516,0.00708759832986537,0.0266627753659856,0.000728796791450174
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40080,0.0164119477164788,0.00487439840578576,0.00685812684113868,0.0259657685918188,0.000762624233497002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41984,-0.0157364916709875,0.0046820021043769,-0.0249132157955663,-0.00655976754640882,0.000778711616810277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,42094,0.011208781116607,0.00333614229247845,0.00466994222334921,0.0177476200098648,0.000782241282067192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,42144,0.013712438148689,0.00408370446795167,0.00570837739150371,0.0217164989058742,0.000787795558720431
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39784,0.0101219333185387,0.00301688597793313,0.00420883680178973,0.0160350298352876,0.000796170036139336
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41887,0.0124866095058621,0.00372636454924286,0.00518293498934608,0.0197902840223781,0.000807894636487725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40054,0.0160238652249377,0.00478524997904721,0.00664477526600519,0.0254029551838702,0.000814986099253912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41876,0.0310258132406453,0.00928016432347159,0.012836691166641,0.0492149353146496,0.000830460643556344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,42178,0.0205484318219606,0.00614775380195938,0.00849883437012023,0.032598029273801,0.000832831390035552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41861,0.0170518419902569,0.00510984482870407,0.0070365461259969,0.0270671378545168,0.000849143835708865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39784,-0.0420083063778637,0.0125993567123077,-0.0667030455339868,-0.0173135672217405,0.000858502356337272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39804,0.0101731086491534,0.00305119303760009,0.00419277029545727,0.0161534470028496,0.000858563162492909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41829,-0.0173946456590894,0.0052209867734181,-0.0276277797349889,-0.00716151158318996,0.00086571758451081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39804,0.0173636355290562,0.00521347654085411,0.00714522150898217,0.0275820495491303,0.00086976857944132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,40113,0.0137792486268061,0.00414071290958718,0.00566345132401526,0.021895045929597,0.000878404344527261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42184,0.00946007703893816,0.00284460430455089,0.00388465260201841,0.0150355014758579,0.000884661454909761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,40054,0.014077681337946,0.00423306152014766,0.00578088075845662,0.0223744819174354,0.000885050610233865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,42103,0.0228759133373308,0.00688267208806933,0.0093858760447149,0.0363659506299467,0.000890799972066801
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42127,-0.0103020672257537,0.00309999323691257,-0.0163780539701024,-0.00422608048140511,0.000892206247703873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39881,0.0116195818293764,0.00349899274640796,0.00476155604641682,0.018477607612336,0.000900489426831865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42186,0.00817935136643428,0.00246412999591257,0.00334965657444565,0.0130090461584229,0.000904700755115426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40054,0.0160519834245062,0.00483599769394674,0.00657342794437057,0.0255305389046418,0.00090550131302425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,42213,-0.00781032999232175,0.00235456789555682,-0.0124252830676131,-0.00319537691703039,0.000912071693477689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39863,-0.00955305591907441,0.00288073475511711,-0.015199296039104,-0.00390681579904487,0.000915593892016846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40097,-0.0109589142536315,0.00330830052208977,-0.0174431832769274,-0.00447464523033553,0.000927501262688849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40020,0.02007916091531,0.00606503869662993,0.00819168506991539,0.0319666367607047,0.000933872395271808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40080,0.0244198737646533,0.00738625862083292,0.00994280686782078,0.0388969406614858,0.000949029357396484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40054,0.0219582856342986,0.00664806933327682,0.00892806974107605,0.0349885015275212,0.000959803736916491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42004,0.0143785059624699,0.00435663016376047,0.00583951084149938,0.0229175010834404,0.000968200797237087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39804,0.016412463011518,0.00497430587579277,0.00666282349496412,0.0261621025280718,0.000971944693441127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,40054,0.0445764791988297,0.0135240223097602,0.0180693954716996,0.0710835629259597,0.000983528806414025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39719,0.017950321506432,0.00544658971062908,0.00727500567359902,0.028625637339265,0.000985018553030244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,40102,0.0228430118816188,0.0069319718196909,0.00925634711502467,0.036429676648213,0.000986260343266828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39784,0.0161754076858886,0.00491387496456386,0.00654421275534342,0.0258066026164337,0.000998804549827399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41829,0.0173202905995248,0.00526548125436978,0.00699994734096005,0.0276406338580896,0.00100674785760712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41861,-0.0126541503714032,0.00384786448927872,-0.0201959647703895,-0.00511233597241688,0.00100955643315802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39863,-0.0170909348204193,0.0052060330949674,-0.0272947596865554,-0.00688710995428317,0.00103072198185691
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,40021,0.0365234218697454,0.0111348572961709,0.0146991015692505,0.0583477421702403,0.00104098976476506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41829,0.0236868135037352,0.00722784959803903,0.00952022829157867,0.0378533987158917,0.0010514018689933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,42094,0.0231536691014555,0.00706745764280881,0.00930145212155022,0.0370058860813608,0.00105530646850057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39804,0.0173205093382208,0.00528917000768935,0.00695373612314966,0.0276872825532919,0.00106108673261313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40069,0.0155111328699516,0.00473753080384493,0.0062255724944155,0.0247966932454876,0.00106331629698474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40054,0.0133966884880986,0.0040927839791235,0.00537483188901659,0.0214185450871807,0.00106652278115564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,40020,0.0129877538967288,0.0039683701893413,0.00520974832561988,0.0207657594678378,0.00106814707641102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41861,0.0162417066639576,0.00496395677301438,0.00651235138884943,0.0259710619390658,0.00107102771420191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39768,0.0198932205822226,0.00608352665676189,0.00796950833496927,0.0318169328294759,0.00107885970570544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,42296,-0.00912358415295766,0.00279158550753789,-0.0145950917477319,-0.00365207655818339,0.00108495579746969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,42121,0.0215669135611377,0.00660248139050263,0.00862605003575249,0.0345077770865228,0.00109174900472479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,42103,0.0217465823305198,0.00666508259753691,0.00868302043934747,0.0348101442216922,0.00110618578304945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,42094,0.0106505958074145,0.00326648161837545,0.00424829183539863,0.0170528997794304,0.0011147644945108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42256,-0.00830094411756577,0.00255205237031629,-0.0133029667633857,-0.00329892147174583,0.0011462274797283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41829,0.0158638907141679,0.00488326099513301,0.00629269916370721,0.0254350822646286,0.00116266616647528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40113,0.00848469439171318,0.0026129641969092,0.00336328456577115,0.0136061042176552,0.00116917566313032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42213,0.0232968606584305,0.00717877135385116,0.00922646880488222,0.0373672525119788,0.00117646637418766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40080,0.00988864950964814,0.00304861349806585,0.00391336705343908,0.0158639319658572,0.00118362553459072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39998,0.0098018384596379,0.00302270981196512,0.00387732722818626,0.0157263496910895,0.00118748763964471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,40048,0.0271631776498293,0.00839487292325526,0.010709226720249,0.0436171285794096,0.0012171423657373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,42146,0.0111251457602334,0.00343960131615279,0.00438352718057397,0.0178667643398929,0.00122191921324992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39804,0.0180590833961441,0.00559383224764868,0.00709517219075267,0.0290229946015355,0.00124866756573529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39804,0.00912121048066328,0.00282632535571712,0.00358161278345773,0.0146608081778688,0.00125373172396367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,40040,0.0315505079283699,0.00977945180991768,0.0123827823809312,0.0507182334758085,0.00125816025565783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40080,0.0343529505127274,0.0106509936361819,0.013477002985811,0.0552288980396438,0.00126199885868647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39784,0.0176719055097374,0.00548053278714344,0.00693006124693627,0.0284137497725385,0.00126581405321436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,42103,0.0304937204314992,0.00946692093108507,0.0119385554065724,0.0490488854564259,0.00128024423942497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39784,0.00867516935478509,0.00269432240250896,0.00339429744586753,0.0139560412637026,0.00128668658959665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40021,0.0180892528854729,0.00562332495860596,0.00706753596660522,0.0291109698043406,0.00129998703826854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40020,-0.0122637647922281,0.00381493178368308,-0.0197410310882469,-0.00478649849620924,0.00130975480265645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39706,0.0114644220574222,0.00357011067164865,0.00446700514099089,0.0184618389738536,0.00132568966076327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,42158,0.0108503049748815,0.00338192808095437,0.00422172593621096,0.0174788840135521,0.00133837825827055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39863,0.0192296033192039,0.00599879087524727,0.00747197320371926,0.0309872334346886,0.00135187664909766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,42103,0.0203384960014662,0.00635527772916062,0.00788215165231143,0.0327948403506211,0.00137639221199837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39863,0.0138735165175452,0.00434075271231436,0.00536564120140901,0.0223813918336813,0.00139700581755464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42184,0.0332780999080366,0.010428023643159,0.012839173567445,0.0537170262486281,0.00142011257614565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40021,0.0127463985999377,0.00399474626553037,0.0049166959194982,0.0205761012803772,0.00142288962874135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,42043,0.014594078564845,0.00457660551455288,0.00562393175632131,0.0235642253733686,0.00143185846530921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42186,-0.00804408699870355,0.00252275888472344,-0.0129886944127615,-0.00309947958464561,0.00143299069708796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,42120,0.0185165621285353,0.00581291117170972,0.00712325623198429,0.0299098680250864,0.00144887470600964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42099,0.00755788409345337,0.00237327926543321,0.00290625673320428,0.0122095114537025,0.00145311622120345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42240,0.00994832294501948,0.00312990104235673,0.00381371690200029,0.0160829289880387,0.00148395825962524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42213,0.00987958560542976,0.00311152050037779,0.00378100542468929,0.0159781657861702,0.00150101161497105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42115,0.0359167301425857,0.0113195263404795,0.013730458515246,0.0581030017699255,0.00151231697193544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41829,0.0236937085395732,0.00748137696311511,0.0090302096918676,0.0383572073872788,0.00154373326219383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,40005,0.0278532409597775,0.00879647097170539,0.010612157855235,0.0450943240643201,0.00154761397824695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39804,0.0234966442504985,0.00742416303087758,0.00894528470997843,0.0380480037910185,0.00155581062187366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,42004,0.0113570548793217,0.00358909175878122,0.00432243503211049,0.0183916747265329,0.00155806310928324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39863,0.0241974782235254,0.00765622196237741,0.00919128317726564,0.0392036732697851,0.00157939729880833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42157,0.00676939745424274,0.00214451278044085,0.00256615240457868,0.0109726425039068,0.00159978450794975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42004,0.0185615588148247,0.00588345299307556,0.00702999094839662,0.0300931266812528,0.00160938261702678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,42146,0.0107475999865474,0.00340722127069572,0.00406944629598382,0.017425753677111,0.00161218675133507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,40020,0.0310144330200027,0.00984771939829517,0.0117129029993442,0.0503159630406613,0.00164049598008199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39706,0.0215837305834169,0.00685349551552586,0.00815087937298624,0.0350165817938476,0.00164119053317731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39804,0.0264130271107451,0.00839257788492625,0.00996357445628961,0.0428624797652005,0.00165304776877674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,40054,0.0218917982117298,0.00699189371306475,0.00818768653412293,0.0355959098893367,0.00174659200208517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,40113,0.00624798339659223,0.0019965125754768,0.0023348187486577,0.0101611480445268,0.00175596081526815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40097,0.019788318005934,0.00634005866841574,0.00736180301583912,0.0322148329960288,0.00180612633866611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39640,0.0225676808169167,0.00723449025578785,0.00838807991557252,0.0367472817182609,0.00181677823636198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,42146,-0.00667242561714384,0.00214186850249772,-0.0108704878820394,-0.00247436335224832,0.00184199217348428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39804,-0.0124254494213479,0.00398996557671576,-0.0202457819517108,-0.00460511689098503,0.00184951464792894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41861,0.0262901107682951,0.00845225483444547,0.00972369129278196,0.0428565302438082,0.00187232651171908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39784,0.0177261180688314,0.00570186459238936,0.00655046346774827,0.0289017726699146,0.00188328761072266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42168,0.0154003041332882,0.0049549424611924,0.00568861690935109,0.0251119913572253,0.00188721016770897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39758,0.00857897232302155,0.00276038727714661,0.0031686132598142,0.0139893313862289,0.00188930154931259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42091,0.021151468255926,0.00680774787807817,0.00780828241489274,0.0344946540969592,0.00189426077428792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40054,0.0148463289402939,0.00478574132807422,0.00546627593726844,0.0242263819433194,0.00192580505054428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41783,0.00956418879322653,0.00308612665968314,0.00351538054024758,0.0156129970462055,0.00194542952616468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41861,0.0178718746528332,0.00576887732868173,0.00656487508861705,0.0291788742170494,0.00195269927046409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39577,0.0152091596964978,0.00491112206868804,0.0055833604418692,0.0248349589511263,0.00196089850188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41876,0.0120533167935265,0.00389542538651314,0.00441828303596078,0.0196883505510923,0.0019775804696343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,40021,0.0207914825369946,0.00672267371930784,0.00761504204715122,0.033967923026838,0.00198822250854123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42144,0.00984789011015145,0.00319120361568852,0.00359313102340194,0.016102649196901,0.00203331981246362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42197,0.0111641209017467,0.00361973745948142,0.00406943548116308,0.0182588063223302,0.00204504223169321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41887,0.0209977138886766,0.00681103833333832,0.00764807875533346,0.0343473490220197,0.00205437306618853
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42094,0.00777860175315803,0.00252341392681626,0.00283271045659817,0.0127244930497179,0.0020565386242604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39863,0.00869757464802764,0.00282289514430927,0.00316470016518147,0.0142304491308738,0.00206774183930963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41861,0.0179664233542887,0.00583211252232979,0.00653548281052228,0.0293973638980551,0.00207024604224259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,40080,0.0197063864660396,0.00640271491726008,0.00715706522820987,0.0322557077038694,0.00209041059852741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39784,0.0124302164849437,0.00403970536938359,0.00451239396095185,0.0203480390089355,0.00209621566859232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40020,0.016209525848933,0.00526810203547694,0.00588404585939818,0.0265350058384678,0.00209673983173807
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40054,0.0116939647803607,0.00380109424017252,0.00424382006962257,0.0191441094910989,0.00209986160928132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39959,0.00931729649836065,0.00303019348963504,0.00337811725867597,0.0152564757380453,0.00211157895892958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42111,0.0334463545488504,0.0108950619634693,0.0120920331004506,0.0548006759972502,0.00214600861988671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41829,0.0224351342674266,0.0073173663003981,0.00809309631864634,0.0367771722162069,0.00217392511219898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42186,0.00817726574917759,0.00267022172401969,0.00294363117009899,0.0134109003282562,0.00220024589158566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41813,0.0176375015847258,0.00575988818018727,0.00634812075155876,0.0289268824178928,0.00220233610707136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41829,0.0176391438748106,0.00576092199412402,0.00634773676632754,0.0289305509832937,0.00220427520956784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39706,0.0382545805684784,0.0124995332943879,0.013755495311478,0.0627536658254788,0.00221539176744548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39784,0.0243690259211662,0.00798758957213605,0.00871335035977957,0.0400247014825529,0.00228750706358479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39784,0.0128860812657089,0.00424200148900312,0.00457175834726275,0.021200404184155,0.00238943062043009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42162,0.0150029868355937,0.00494212631253092,0.00531641926303315,0.0246895544081543,0.00240425994584318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,42094,0.0167319401114725,0.00551540776824783,0.00592174088570672,0.0275421393372382,0.00242077257201609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41861,0.0146775804178639,0.00485864749611142,0.00515463132548554,0.0242005295102423,0.00252511520192047
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42184,0.00662312407615068,0.00220193252785368,0.00230733632155748,0.0109389118307439,0.00263590463014956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40080,0.0201476243948092,0.00670122959127752,0.00701321439590523,0.0332820343937131,0.00264827877718083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41861,0.0188703927476021,0.00627770401580115,0.00656609287663189,0.0311746926185724,0.00265281131892763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,42094,0.0274126019322879,0.00912037416166106,0.00953666857543223,0.0452885352891436,0.0026552829459424
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39706,0.0197292583416058,0.00656632407675356,0.00685926315116883,0.0325992535320428,0.00266546321715478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42080,-0.0551181275093292,0.0183655479307197,-0.0911146014535399,-0.0191216535651186,0.0026945947011297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39706,0.0108377446703257,0.003615669128108,0.00375103317923406,0.0179244561614174,0.00272895223933067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42120,0.0170196857524495,0.00568379586024039,0.00587944586637838,0.0281599256385207,0.00275485479915609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40020,0.0213679617217807,0.00714164013085059,0.00737034706531352,0.0353655763782478,0.0027775869603162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41887,0.0120550476144392,0.00403463068415949,0.0041471714734866,0.0199629237553918,0.00281444460890393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42004,0.0217323942365486,0.00729116553571124,0.0074417097865546,0.0360230786865427,0.00288179957096156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41876,0.0126139508157133,0.00424074829453309,0.00430208415842849,0.0209258174729982,0.00294054056875014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,42004,0.0101150499768966,0.00340185183838625,0.00344742037365951,0.0167826795801336,0.00295073256422657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42099,-0.0248653029033014,0.00836717163362109,-0.0412649593051988,-0.00846564650140411,0.00296635246981774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39867,0.019312800030181,0.00649948882053072,0.00657380194194081,0.0320517981184212,0.00297073659469991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42239,0.00932730150189739,0.00313976530170676,0.00317336151055215,0.0154812414932426,0.00297663024840726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,42061,0.0178176283272265,0.00599973338057965,0.00605815090129041,0.0295771057531626,0.00298605050899127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40080,0.0264455315165935,0.00890839557741315,0.00898507618486376,0.0439059868483233,0.00299803835523426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39784,0.00952934161744719,0.0032103697317511,0.00323701694321504,0.0158216662916793,0.00300121766631945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42084,-0.0101974795184399,0.00343651447306412,-0.0169330478856456,-0.00346191115123425,0.00300891069213472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39881,-0.010970875877479,0.00370901945356182,-0.0182405540064601,-0.00370119774849779,0.00310429688338697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,42103,0.0250888471985236,0.00848389400093842,0.00846041495668435,0.041717279440363,0.0031097611391346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,40102,0.00711944199677636,0.00240752896763377,0.00240068522021418,0.0118381987733385,0.00311155076715336
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40102,-0.00807324539999242,0.00273352251576488,-0.0134309495308916,-0.00271554126909326,0.00314942536259288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42162,0.022318990814269,0.0075704717268482,0.00748086622964655,0.0371571153988915,0.00320237502960036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40035,0.0251317335448275,0.00852665154890899,0.0084194965089659,0.0418439705806891,0.00321107007398212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42207,0.00652428898616198,0.00221421488588209,0.00218442780983309,0.0108641501624909,0.00321912974550178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40102,0.0120259178099815,0.00408683882979813,0.00401571370357717,0.0200361219163858,0.00326157422772446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39881,0.0201479008488144,0.00685297852991992,0.00671606293017139,0.0335797387674575,0.00328892902493672
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41876,0.0229566004669417,0.00782238667166354,0.00762472259048116,0.0382884783434022,0.00334435525971614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42126,0.00865650014205816,0.00295065548078382,0.00287321539972187,0.0144397848843945,0.00335476583326485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,42146,0.00723494158552383,0.00246705190698009,0.00239951984784286,0.0120703633232048,0.00336696564579373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,42256,0.0102073776080399,0.00348291279361967,0.00338086853254529,0.0170338866835344,0.00338783396781564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40021,0.0104562889847646,0.003569375154476,0.00346031368199164,0.0174522642875376,0.00340276175141414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41861,0.0234687204676304,0.00801432488526845,0.00776064369250421,0.0391767972427565,0.00341376880375206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39719,0.0221067506601542,0.00755026008863168,0.00730824088643613,0.0369052604338723,0.00341940777489918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41861,0.0195247602657344,0.00667197423331229,0.00644769076844232,0.0326018297630265,0.00343536317156573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,40054,0.0111619656412086,0.00381471426329213,0.00368512568515604,0.0186388055972612,0.00344029758188792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42217,0.00923339366989135,0.00315985425177492,0.0030400793364125,0.0154267080033702,0.00348283283252444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39784,0.00870159340404595,0.0029777903826702,0.00286512425401237,0.0145380625540795,0.00348342722331335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41829,0.0151604673090318,0.00519106374603037,0.0049859823668123,0.0253349522512514,0.00350095506046784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40054,0.0125942482641041,0.00431333931414125,0.00414010320838721,0.0210483933198209,0.00350934223951585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41829,0.0156346920273832,0.00535661020048225,0.005135736034438,0.0261336480203284,0.00352039831101746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39804,0.00971621871209625,0.00334551976034201,0.00315899998182591,0.0162734374423666,0.00368896161365775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39768,0.0124275808713572,0.00429587058927881,0.00400767451637069,0.0208474872263436,0.00382465829898932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40021,0.0128333306750153,0.00444024538118157,0.00413044972789941,0.0215362116221312,0.00385724822776838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40021,0.0239291954622849,0.00828198488613618,0.00769650508545802,0.0401618858391118,0.00386858341734422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40020,0.0125981431883573,0.00436417696238651,0.00404435634207975,0.0211519300346349,0.00390054474387225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40080,0.0096048845217847,0.00333794351724777,0.00306251522797907,0.0161472538155903,0.00401637663591241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41876,0.0146973370286186,0.00511998167513132,0.00466217294536118,0.024732501111876,0.00410392354731188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40080,0.0159865425899445,0.00558758397391298,0.00503487800107504,0.0269382071788139,0.00423000406547206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42004,0.0163979821102884,0.00573321804042141,0.0051608747510624,0.0276350894695143,0.00424097571275938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42296,0.00784843966501328,0.00274962787501857,0.00245916902997689,0.0132377103000497,0.00431907092430122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39863,-0.00765967885564519,0.00268575538025527,-0.0129237594009455,-0.00239559831034485,0.00435334323858413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39863,0.00792650004441816,0.00278064818426391,0.00247642960326089,0.0133765704855754,0.00437212866154401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,42204,0.0439192966511843,0.0154334573937225,0.0136697201594882,0.0741688731428803,0.00443804057829306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41853,0.0144753086678687,0.00509057876125125,0.00449777429581628,0.0244528430399212,0.00446856507728552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40054,0.0190940539011158,0.00671587290234951,0.00593094301251079,0.0322571647897209,0.00447571721292204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41861,0.0171632525399632,0.00605010090778601,0.00530505476070264,0.0290214503192238,0.00456327619179051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40020,0.0304971845421908,0.0107584615573229,0.00941059988983795,0.0515837691945436,0.00459513708578538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40097,0.0115839728850935,0.00408815064071217,0.00357119762929761,0.0195967481408893,0.00461188625537058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42075,0.00744829456614197,0.00263054751187984,0.00229242144285748,0.0126041676894265,0.00464076042618909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41829,0.0104755990356639,0.00370473112672494,0.00321432602728298,0.0177368720440448,0.00469681033163792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,40054,0.0299570448271416,0.0106603694384917,0.00906272072769794,0.0508513689265853,0.00496097893392134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,40097,0.00783746889608689,0.00278988738328112,0.0023692896248559,0.0133056481673179,0.00497466900076318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,40020,0.0230822794068271,0.00821763344846621,0.00697571784783333,0.0391888409658209,0.00498045093866925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40021,0.00872492679653273,0.00310785438090374,0.0026335322099614,0.0148163213831041,0.00500356705061999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42186,0.0230766582541474,0.00824403872190396,0.00691834235921569,0.0392349741490792,0.0051305991297268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,40113,0.00745152371179816,0.00266427761368495,0.00222953958897566,0.0126735078346207,0.00516974198487012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41739,0.0284751478275143,0.010186687658846,0.0085092400161761,0.0484410556388525,0.00519256311830098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40054,0.00665558063405283,0.00238123445848933,0.00198836109541374,0.0113228001726919,0.00519887292890476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41861,0.0121562208884677,0.00435891776958941,0.00361274206007242,0.0206996997168629,0.00529800018328915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42193,0.0114944103070388,0.00412347880971427,0.00341239183999879,0.0195764287740787,0.00531850781188564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42079,0.024163091571716,0.00867124280943682,0.00716745566521984,0.0411587274782122,0.0053345765875004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41861,0.0144156730643269,0.00517331030126515,0.00427598487384724,0.0245553612548066,0.00533521281291818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39804,0.0283012011148698,0.0101589006890918,0.00838975576424984,0.0482126464654897,0.00534818731905501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,40054,0.0134473416290374,0.00482857198439203,0.00398334053962904,0.0229113427184458,0.00536283511812677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39706,0.0285681567442059,0.0102623530282046,0.0084539448089249,0.0486823686794869,0.00538250725043902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,40097,-0.0107189902491991,0.00385188497483528,-0.0182686847998763,-0.00316929569852198,0.00539862461870032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,42180,0.0105547306680971,0.00380428046427331,0.00309834095812143,0.0180111203780728,0.00553766033501127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39863,-0.00929268841951269,0.00334994693104497,-0.0158585844043608,-0.00272679243466456,0.00554711905865739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,42074,0.0201351672526779,0.00727034193789471,0.00588529705440429,0.0343850374509516,0.00562238164820696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40021,0.0161552899382346,0.00585567449747909,0.00467816792317557,0.0276324119532936,0.00580915636296527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41829,0.0176311413337801,0.00640010475228308,0.00508693601930528,0.0301753466482549,0.00588083514866076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39768,0.0150585555501342,0.00547344508492726,0.00433060318367675,0.0257865079165916,0.00594780125015367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39706,0.0109940038116529,0.0040015178484008,0.00315102882878733,0.0188369787945184,0.0060161468219832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42197,0.00763277622556146,0.00278299938285586,0.00217809743516398,0.0130874550159589,0.0061030166237338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40021,0.0141745604825981,0.00518643746568354,0.00400914304985839,0.0243399779153379,0.00628612225162183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40054,0.00894552976288433,0.00327384597597006,0.00252879164998302,0.0153622678757856,0.00629721685224273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42096,0.0177004072113966,0.00648042942358191,0.00499876554117603,0.0304020488816171,0.00631586272542634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39768,0.0133831036111113,0.00490500624450377,0.00376929137188394,0.0229969158503387,0.00637363240598566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41887,0.0180363788539906,0.00661514092232992,0.00507070264622398,0.0310020550617573,0.00640920405676446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39804,0.0318489372045947,0.0116965868996382,0.00892362688130385,0.0547742475278856,0.00648123809526024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,40080,0.00998415274733279,0.00367118915492871,0.00278862200367252,0.0171796834909931,0.00654653222551408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41662,0.00882863579998741,0.00324725994920554,0.00246400629954455,0.0151932653004303,0.00656107414999924
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39863,0.0182511645195285,0.00671347173853767,0.0050927599119947,0.0314095691270624,0.0065667159800083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42223,0.0145900792898376,0.00536934966454331,0.00406615394733276,0.0251140046323425,0.00659059022068204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39804,0.0118660337506964,0.00437077765296812,0.00329930955087889,0.0204327579505139,0.00664117484628153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42111,0.00947438136560658,0.00349195118446321,0.00263015704405869,0.0163186056871545,0.00667240829629422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39916,0.00929211206532041,0.0034271838995385,0.00257483162222494,0.0160093925084159,0.00671274045554451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41861,-0.0159869608601262,0.00589663358490816,-0.0275443626865462,-0.00442955903370619,0.00671302814285179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39706,0.0198838044498691,0.00735521030086438,0.0054675922601749,0.0343000166395633,0.00687520680450293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41829,-0.00983956254945483,0.00364222437941932,-0.0169783223331167,-0.00270080276579296,0.00691142534188498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39863,0.00880069340658405,0.00325879588322588,0.00241345347546133,0.0151879333377068,0.00693244549529363
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42094,0.019722969989097,0.0073037324219352,0.005407654442104,0.03403828553609,0.00693473555069275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42177,-0.00826274752805945,0.00306424200094591,-0.0142686618499134,-0.00225683320620546,0.00701614782306786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41865,0.0116580066784974,0.00432539581097956,0.00318023088897743,0.0201357824680173,0.00704294409496029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42144,-0.00473124990280662,0.00175642917717235,-0.00817385109006443,-0.00128864871554881,0.00707600142860803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,40021,0.00956441615278056,0.00357429283944089,0.00255880218747642,0.0165700301180847,0.00746431571819024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39784,0.0145634551425489,0.00544381523305464,0.00389357728576184,0.025233332999336,0.00747929033567947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40097,0.00624891736413619,0.00233699007555795,0.00166841681604261,0.0108294179122298,0.00750827558106575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,42186,0.0140814918992067,0.00526838844272814,0.00375545055145951,0.0244075332469538,0.00753089207241615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41876,0.00935343615578736,0.00350428622585413,0.00248503515311327,0.0162218371584615,0.00761421982010667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,40021,0.0229394190522448,0.00859677541901028,0.00608973923098466,0.039789098873505,0.00763327264687257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42256,-0.00975680978101387,0.00366236862831904,-0.0169350522925192,-0.00257856726950855,0.00772960639262077
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,40021,0.0277271903865023,0.0104160449839026,0.00731174221805326,0.0481426385549514,0.00777997427061861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42296,0.0175636857908028,0.00660173998254359,0.00462427542501741,0.0305030961565883,0.00781283185841843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42094,-0.0091690919464873,0.00344690466898735,-0.0159250250977025,-0.0024131587952721,0.00782153378280516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,40054,0.0174151729296599,0.00654816006240326,0.00458077920734955,0.0302495666519703,0.00783594700987824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,42004,0.0240665864459273,0.00905393276947435,0.00632087821775762,0.0418122946740971,0.00786717141379663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41861,0.0150822816500235,0.00568065876152248,0.00394819047743949,0.0262163728226076,0.00794021026610978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39706,0.0174489404150553,0.0065756864666406,0.00456059494043971,0.0303372858896709,0.00797687862588846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39706,0.0163513802236095,0.00617658633563817,0.00424527100575869,0.0284574894414603,0.0081254346219832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,40054,0.0144870086899076,0.00547325482771261,0.00375942922759084,0.0252145881522243,0.00813571553230567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42103,0.023932585524751,0.00904819913405315,0.00619811522200684,0.0416670558274952,0.00817871871843918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42144,0.0176876971160467,0.00668951935264274,0.00457623918486696,0.0307991550472265,0.00820093993925344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41968,0.0177340399841069,0.00671202784863638,0.00457846540077957,0.0308896145674342,0.00824872100054899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41984,-0.0140698849630319,0.00533347366676199,-0.0245234933498854,-0.00361627657617844,0.00834891644229898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41828,0.0206127573475592,0.00782714567869514,0.00527155181731668,0.0359539628778016,0.00846137507791831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39804,0.0104742819273547,0.00397786068877011,0.00267767497736525,0.0182708888773441,0.00847209977045128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40080,0.00963997579186642,0.00366114072633924,0.00246413996824151,0.0168158116154913,0.00847408163984897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41861,0.00747343161804856,0.00283972524362996,0.00190757014053383,0.0130392930955633,0.00850506443881418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40054,0.00817205756307431,0.0031053850849732,0.00208550279652684,0.0142586123296218,0.00851099206913144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,42082,-0.0183156315664702,0.00696267639215929,-0.0319624772951024,-0.00466878583783802,0.00853495355612186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39784,0.00456411240394408,0.00173832358949531,0.00115699816853328,0.00797122663935488,0.00866251432838594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39784,-0.015006586611921,0.00571832898321649,-0.0262145114190253,-0.00379866180481664,0.0086952957685892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41887,-0.0122755279978498,0.00468596063733755,-0.0214600108470314,-0.00309104514866824,0.00881274656347343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39706,-0.0165470477052889,0.0063269804810707,-0.0289479294481874,-0.00414616596239031,0.00892724887943858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42181,0.0150787249245422,0.00576713582861392,0.00377513870045887,0.0263823111486254,0.00894364610032106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40054,0.00992949032757849,0.00380022702833171,0.00248104535204833,0.0173779353031086,0.00899097722285327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,40080,-0.00738181061236402,0.00282599428017063,-0.0129207594014985,-0.0018428618232296,0.0090108607357201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39921,0.00631373070881929,0.00241712842863296,0.00157615898869869,0.0110513024289399,0.0090118823930811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41876,0.0115148626729804,0.00440993861619685,0.00287138298523454,0.0201583423607262,0.00903534170251718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42243,0.0137525330824319,0.0052676030185978,0.00342803116598021,0.0240770349988836,0.0090440256707582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41741,0.0216747892783044,0.00830272790534044,0.00540144258383713,0.0379481359727717,0.00905009395859916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41829,0.0075213817251525,0.00288212370329648,0.0018724192666914,0.0131703441836136,0.00907373860608175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41861,0.00866629262758126,0.0033257124595138,0.0021478962069342,0.0151846890482283,0.00917550343938042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,40097,0.0125053497666556,0.00480001853364534,0.0030973134407107,0.0219133860926004,0.0091926269589529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41829,0.0141871970413115,0.00545259338783714,0.00350011400115072,0.0248742800814723,0.00928123594773108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,40021,0.0114298788526558,0.0043938457223117,0.00281794123692484,0.0200418164683867,0.00929871824637258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39706,0.0100592646596449,0.00387058268731337,0.00247292259251067,0.0176456067267791,0.00936531089055117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39784,-0.0107255655059174,0.00413085291154221,-0.0188220372125401,-0.00262909379929464,0.009432192467827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,40063,0.0121684271830694,0.00468794990694239,0.00298004536546237,0.0213568090006765,0.0094530339199343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39706,0.0104004861880267,0.00400990801229918,0.0025410664839203,0.0182599058921331,0.00950817996946174
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40020,0.0130517655250628,0.00503508103902133,0.00318300668858095,0.0229205243615446,0.00955019012337415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39940,-0.0140457684552819,0.00542428801044445,-0.024677372955753,-0.00341416395481079,0.00962669561418796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40054,0.0202457734325707,0.00783086113025691,0.00489728561726712,0.0355942612478742,0.00974000179894357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39881,0.019719630607271,0.00763331307145812,0.00475833698721304,0.0346809242273289,0.00979734367788447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42149,-0.0127842748641717,0.00495160913133457,-0.0224894287615875,-0.00307912096675598,0.00983832055092837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,42103,0.0159900235376855,0.00620239142753073,0.00383333633972524,0.0281467107356457,0.00994718155681198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,40021,0.0150780067851487,0.00585049442290435,0.00361103771625614,0.0265449758540412,0.00997298393886484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39863,0.0176427349044487,0.00686167906433371,0.00419384393835467,0.0310916258705428,0.0101481629517676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39784,0.00865594667050963,0.00337462312076653,0.00204168535380724,0.015270207987212,0.0103308928159294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41757,0.00511486354279042,0.00199425885460031,0.00120611618777381,0.00902361089780703,0.0103352116166958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,42162,0.0171729651821342,0.00670259747158521,0.00403587413782718,0.0303100562264412,0.01041425690347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42156,0.0149393378238995,0.00583708318776177,0.00349865477588646,0.0263800208719126,0.0104970278017919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39665,0.0132449171832787,0.00518592453127758,0.00308050510197462,0.0234093292645827,0.0106629705261563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,40113,0.00586571138016482,0.00229699859451582,0.00136359413491382,0.0103678286254158,0.0106737546087359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39958,0.00683479432205993,0.00267831043151682,0.00158530587628697,0.0120842827678329,0.0107272607566335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39784,0.0136353976862007,0.00534856217285465,0.00315221582740562,0.0241185795449958,0.0108061290144968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42103,0.0122757647666178,0.00482068606772768,0.00282722007387158,0.0217243094593641,0.0108931576616667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39784,0.00553121030327641,0.00217551486099902,0.00126720117571833,0.00979521943083448,0.0110208986116582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41797,0.0124224413416275,0.00488649348086428,0.00284491411913349,0.0219999685641215,0.0110275915354262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41876,0.00808957293435295,0.00318591505026124,0.00184517943584091,0.014333966432865,0.0111234938942539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,40058,-0.00496943257076169,0.001958223484799,-0.00880755060096772,-0.00113131454055566,0.0111714181372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39881,0.0190285295837919,0.00750297127717765,0.00432270588052374,0.0337343532870601,0.0112225468563037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42296,-0.00879426115508188,0.00347014667498481,-0.0155957486380521,-0.00199277367211165,0.0112799869903182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42121,-0.0246758770534135,0.00975034346508797,-0.0437865502449859,-0.00556520386184108,0.0113930053252781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39872,0.011161117681082,0.00441196628690948,0.00251366375873945,0.0198085716034246,0.0114290411681382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39706,0.0174971975891081,0.00691707536353654,0.00393972987657651,0.0310546653016397,0.0114348634824589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40080,-0.00813167621096679,0.00321788170344764,-0.0144387243497242,-0.00182462807220942,0.0115172856230956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40021,0.0259713934863371,0.0102799983575072,0.00582259670562292,0.0461201902670513,0.0115379331907901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39804,0.0150624869252728,0.00598433812572484,0.00333318419885216,0.0267917896516935,0.0118510181446643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,42049,0.0148242888133694,0.00589524792586803,0.00326960287866811,0.0263789747480708,0.0119282917744623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,40020,0.008589974831859,0.00341594166875617,0.00189472916109691,0.0152852205026211,0.0119286713960922
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41876,0.00781425237469907,0.0031100691646875,0.00171851681191157,0.0139099879374866,0.0119979932634186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,42256,0.0154015901045765,0.00613370839636489,0.00337952164770132,0.0274236585614517,0.0120517888321398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,42256,0.0109629748920731,0.00437181391964223,0.00239421960957428,0.0195317301745718,0.0121657647295254
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,42003,-0.00699342350609393,0.00278967826590693,-0.0124611929072715,-0.00152565410491635,0.012192058451805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42296,-0.00752044485385515,0.00300177612945713,-0.0134039260675911,-0.00163696364011918,0.0122456962140693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40020,0.00943369890201436,0.00378454302382871,0.00201599457531009,0.0168514032287186,0.0126927159054158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39784,-0.00909297041093907,0.00364974011134387,-0.0162464610291731,-0.00193947979270508,0.0127391861574559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41829,0.0211598321640193,0.00849773179681227,0.00450427784226728,0.0378153864857714,0.0127850308303356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41861,0.0190727701014311,0.00766376482421637,0.00405179104596701,0.0340937491568952,0.0128340483523899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39768,0.015238094210315,0.00613744767762547,0.00320869676216906,0.0272674916584609,0.0130505838055901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,42120,0.0224779860176941,0.00906405355186215,0.0047124410560443,0.0402435309793439,0.013154403595787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41887,0.0119401586179572,0.00481728600112105,0.0024982780557599,0.0213820391801544,0.0132025522550747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39768,0.0160310359838401,0.00647000966148062,0.00334981704733803,0.0287122549203421,0.0132370491235576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,40021,0.00903366467662978,0.0036546465803765,0.00187055737909185,0.0161967719741677,0.0134576074016162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39784,0.00508778293694106,0.00206896364445299,0.0010326141938132,0.00914295168006893,0.0139445617367686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39665,0.0131202504425404,0.0053416303360333,0.00265065498391514,0.0235898459011657,0.0140566079917105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39784,0.0221718737559902,0.00903747941015142,0.00445841411209345,0.039885333399887,0.0141702411795831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,42094,0.0131605590665349,0.00537296290800131,0.00262955176685237,0.0236915663662175,0.0143224723167761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,40102,0.00700143300976861,0.00286020482296937,0.00139543155674864,0.0126074344627886,0.0143856703637989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41887,0.00834066084275756,0.00340841229234252,0.00166017274976622,0.0150211489357489,0.0144153093787259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39706,-0.00904163647471324,0.00369622819018715,-0.0162862437274801,-0.00179702922194642,0.0144541965838774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41810,0.0115514657142066,0.00472576102153256,0.00228897411200282,0.0208139573164104,0.0145244930182588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42094,0.00534053572329513,0.00218497291274294,0.00105798881431897,0.00962308263227129,0.01453021300039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,42103,0.00879370660603462,0.00359791167787862,0.00174179971739253,0.0158456134946767,0.0145341223638822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41829,0.0125120655527787,0.00512404295024186,0.00246894137030468,0.0225551897352528,0.0146264562800288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41861,0.0237274506556697,0.00974532677722103,0.00462661017231651,0.0428282911390229,0.0149157244578382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39784,0.022180920977093,0.00912157387141472,0.0043026361891201,0.0400592057650658,0.0150446628607426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,42197,0.0117836783239268,0.00484766047398991,0.00228226379490659,0.021285092852947,0.0150790817544219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,42223,-0.0108351604984628,0.00446539779919814,-0.0195873401848912,-0.0020829808120345,0.0152599243015135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40097,0.00563225955417009,0.00232252683105551,0.00108010696530128,0.0101844121430389,0.0153221252417459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39706,0.0105457568653306,0.00435593652344149,0.00200812127938529,0.0190833924512759,0.0154943632262582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39768,0.0133407089487376,0.00551134355074822,0.00253847558927107,0.0241429423082041,0.015512031682197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42144,0.00850988105123121,0.00351975502704179,0.0016111611982293,0.0154086009042331,0.0156305972460387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,40097,0.00785316722966683,0.0032617741685485,0.00146008985931177,0.0142462446000219,0.0160726523818067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42184,0.00606589216582623,0.00252132263742074,0.00112409979648158,0.0110076845351709,0.0161493300232973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,42186,0.0167699235076564,0.00699016615053716,0.00306919785260354,0.0304706491627092,0.0164506091222265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41829,0.00922622437907261,0.00385276438737427,0.00167480617981904,0.0167776425783262,0.0166483341170349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41947,0.0180221252571932,0.00754204456880561,0.00323971790233421,0.0328045326120522,0.0168832652404386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40021,-0.0105278363185767,0.00441096989975566,-0.0191733373220978,-0.00188233531505563,0.0170155943169177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42094,0.0231154329159627,0.00971735278973509,0.00406942144808189,0.0421614443838434,0.0173845610873104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42146,-0.0081617046259147,0.00343270500287488,-0.0148898064315495,-0.00143360282027994,0.0174386973660457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42120,-0.00958823089141154,0.00403309602788608,-0.0174930991060682,-0.00168336267675483,0.0174502362678467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41829,-0.0156346186124432,0.00658340965803245,-0.0285381015421868,-0.00273113568269963,0.0175708652146571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40054,0.0116116155144168,0.00489340435597516,0.00202054297670551,0.0212026880521281,0.0176658005014039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42004,-0.0123909038650508,0.00522410684203979,-0.0226301532754488,-0.0021516544546528,0.0177129947215175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39706,0.0146592189211257,0.00620361296089181,0.00250013751777778,0.0268183003244737,0.0181451278214111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,40041,0.00768675040738635,0.00325802173409955,0.00130102780855122,0.0140724730062215,0.0183255575301311
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,40113,0.00453820884043714,0.00192533756843124,0.00076454720631192,0.00831187047456237,0.0184359500044086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42103,0.0201499506426392,0.00854900271567742,0.00339390531991142,0.0369059959653669,0.0184383775221651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,42103,0.0213989911047189,0.00910361415736475,0.00355590735628396,0.0392420748531538,0.0187579360534087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,42004,0.0076897163779304,0.00327290262249014,0.00127482723784973,0.0141046055180111,0.0188132539214099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40041,0.00966915052365039,0.0041176141786186,0.00159862673355794,0.0177396743137428,0.0188801696400395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39784,0.00732572022325461,0.00313077905011909,0.00118939328502119,0.013462047161488,0.0193072085336934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41887,0.0101061663771612,0.00432071619995457,0.00163756262525024,0.0185747701290722,0.0193507296815006
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42223,-0.00625204891017172,0.0026752338473418,-0.0114955072509616,-0.00100859056938179,0.0194537191444802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41829,-0.0083367990237932,0.00356971727675047,-0.0153334448862241,-0.00134015316136228,0.0195369128183858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,42173,0.0154853577331898,0.00663267989550674,0.00248530513799663,0.0284854103283831,0.019573950311285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42120,-0.0067615732073159,0.00290048458623682,-0.0124465229963401,-0.00107662341829173,0.0197587713873645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39625,0.00766589459371656,0.00329096566762377,0.00121560188517397,0.0141161873022591,0.0198581766535414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,42144,0.0185653907872008,0.00798681646322607,0.00291123051927767,0.0342195510551239,0.0201138552581042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39881,0.00701452735911772,0.00301768698339188,0.00109986087166964,0.0129291938465658,0.0201188811897693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40021,0.0230051209178463,0.00990216794719794,0.00359687174133833,0.0424133700943542,0.0201846469594572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41810,0.0113005352169298,0.00487150692018853,0.00175238165336024,0.0208486887804993,0.0203718738245962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39706,-0.00812965898701297,0.00351009196303505,-0.0150094392345617,-0.00124987873946427,0.0205729597431797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41861,0.0101374007250744,0.00438356045566718,0.00154562223196674,0.0187291792181821,0.0207608544020979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41813,0.014059827006708,0.00608962387259143,0.00212416421642883,0.0259954897969872,0.0209698165001466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42094,-0.0126670286609425,0.00550774467709188,-0.0234622082280426,-0.00187184909384247,0.0214721751302068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41861,0.0173228568543945,0.0075349753714315,0.00255430512638878,0.0320914085824003,0.0215215240997913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41876,0.0327224149579615,0.014240014326886,0.00481198687726491,0.0606328430386581,0.021582534802215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42120,-0.0123450322752367,0.00537289070174897,-0.0228758980506646,-0.00181416649980867,0.0215975079417359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,42223,-0.0083077614803433,0.00361748039351141,-0.0153980230516257,-0.00121749990906093,0.0216596613271472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39881,0.0150895254113663,0.00657639525676006,0.00219979070811654,0.027979260114616,0.0217812082075774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42094,0.0128813201614616,0.0056188432414955,0.0018683874081304,0.0238942529147927,0.0218915761851273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41887,0.0112282091645482,0.0049138591737055,0.0015970451840854,0.020859373145011,0.0223287580852107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,42059,0.00848891903171079,0.00371679592252814,0.00120399902355563,0.0157738390398659,0.0223915900871294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39863,0.0190570491080987,0.00837078607115481,0.0026503084086353,0.0354637898075622,0.0228290001461561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39719,0.0104902850288082,0.00460902214357655,0.00145660162739812,0.0195239684302182,0.0228640527181318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40054,0.0149770695152485,0.00658250093274123,0.00207536768707568,0.0278787713434213,0.022908201356802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,42194,-0.0143366304234078,0.0063075705779255,-0.0266994687561417,-0.00197379209067377,0.0230469888302455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,42103,-0.00758511049708184,0.00333885736062203,-0.014129270923901,-0.00104095007026267,0.023116886835366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41963,0.00565462321306949,0.00249150232123576,0.0007712786634474,0.0105379677626916,0.0232506698431358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42094,0.0134838876475243,0.00594133573038455,0.00183886961597058,0.025128905679078,0.0232541030685101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41861,0.0206008503826276,0.00908542609529292,0.00279341523585345,0.0384082855294017,0.0233788451296648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39784,0.0123031581663654,0.00542724169051189,0.00166576445296208,0.0229405518797687,0.0234147895174041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,40007,0.0135750380645866,0.00600134493404204,0.00181240199386421,0.025337674135309,0.0237172126578807
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40054,0.0242498785385288,0.0107325668929927,0.00321404742826312,0.0452857096487945,0.0238740980581896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42184,-0.00963656123471689,0.00426757442185115,-0.0180010071015452,-0.00127211536788863,0.0239566578563984
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40054,0.00668292625639176,0.00296638089134678,0.000868819709352065,0.0124970328034315,0.0242860361020067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40010,0.00618115499077055,0.00274612633975664,0.00079874736484753,0.0115635626166936,0.0244141951367667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,42103,0.0181508270432153,0.00806680386108427,0.0023398914754901,0.0339617626109404,0.0244616362911959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40020,0.00900547504165704,0.00400260974150106,0.00116035994831496,0.0168505901349991,0.0244752404642727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40097,0.00878398735525472,0.00390702251879391,0.00112622321841867,0.0164417514920908,0.0245797555586166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41999,0.0227697116967952,0.010146541999896,0.00288248937699909,0.0426569340165913,0.0248438891739443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,42067,0.0188070721284888,0.00838680819567008,0.00236892806497547,0.0352452161920022,0.0249486854642304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39768,0.00908947853644248,0.00405688337341597,0.00113798712454717,0.0170409699483378,0.025078660893724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39881,0.0145514060426541,0.00649903911310151,0.00181328938097518,0.0272895227043331,0.0251758353347818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42186,-0.0218812796687804,0.00980564497597202,-0.0411003438216856,-0.00266221551587529,0.0256651334405444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,42213,0.00852391044403265,0.00382372210140802,0.00102941512527293,0.0160184057627924,0.0258163934841407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39719,0.0245524060561172,0.0110282390220465,0.00293705757290608,0.0461677545393284,0.026013737811982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42094,0.00844767194097134,0.00380071830976894,0.000998264053824209,0.0158970798281185,0.0262565826359033
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41829,0.019116755976159,0.00860185824307004,0.00225711381974168,0.0359763981325762,0.0262740287725368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42144,0.00761605768303568,0.00342704621269849,0.000899047106146649,0.0143330682599247,0.0262776268421829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39706,-0.0106639862315337,0.00480883971892368,-0.0200893120806242,-0.00123866038244331,0.0266047923416183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41897,-0.0102742106176865,0.0046360547333904,-0.0193608778951317,-0.00118754334024128,0.0266986190714604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39783,0.0154679450543915,0.00699449096888467,0.0017587427553775,0.0291771473534054,0.0270261867461858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39863,0.009153612645475,0.00414085454192202,0.00103753774330785,0.0172696875476421,0.0270873715198613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,42176,0.00616491852021375,0.00278979207307538,0.000696926056985997,0.0116329109834415,0.0271355342782518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,40020,0.0104183804227069,0.00472975307990189,0.00114806438609915,0.0196886964593146,0.027634609308545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41887,0.00990005962887312,0.00449916346642433,0.00108169923468143,0.0187184200230648,0.0277948948827976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,40086,-0.00782989343185782,0.00356250586600561,-0.0148124049292288,-0.000847381934486829,0.027979967301659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,40102,-0.00552861125427635,0.00251927380831064,-0.0104663879185652,-0.000590834589987497,0.0282186417603541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40054,0.00792495480444251,0.00361605233008307,0.0008374922374797,0.0150124173714053,0.0284292724889151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41829,0.0112104812802576,0.0051204007771403,0.00117449575706266,0.0212464668034526,0.0285877683015765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41861,-0.0126920733398436,0.00580259996617285,-0.0240651692735423,-0.00131897740614479,0.0287382650130059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39665,-0.00676450132416722,0.00309455802105724,-0.0128298350454394,-0.000699167602895017,0.0288424620068205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42088,0.00536432792077133,0.00245493401032324,0.000552657260537781,0.0101759985810049,0.028897909444763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39706,0.00851132677262671,0.00389851280265795,0.000870241679417134,0.0161524118658363,0.0290413574706201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39784,0.0121618872499003,0.0055846019092463,0.00121606750777756,0.023107706992023,0.0294463752210766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39804,0.0112618179861801,0.00517917781486775,0.0011106294690393,0.0214130065033209,0.0296940334646038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42004,0.0134370827453129,0.00619652439599244,0.00129189492916768,0.025582270561458,0.0301399939992662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42094,0.0178159733103478,0.00821760250640781,0.00170947239778846,0.0339224742229071,0.0301749553860988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42103,0.0152706966980362,0.00704720848726347,0.00145816806299975,0.0290832253330726,0.030259620506495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39768,0.00846028366284726,0.00390481478279386,0.00080684668857129,0.0161137206371232,0.0302854408496944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42296,0.00539452549882156,0.00249302764026337,0.000508191323905341,0.0102808596737378,0.0304942569762635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42296,-0.00597243062214615,0.00276066999601591,-0.0113833438143373,-0.000561517429954961,0.0305285273840193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41887,0.0143618731590589,0.00663943840028663,0.00134857389449708,0.0273751724236206,0.0305508913446543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,42296,-0.00377397240287943,0.00174508800073928,-0.00719434488432842,-0.000353599921430431,0.0305880028139321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39784,0.00945776624634174,0.00437531793495079,0.00088214309383818,0.0180333893988453,0.0306699613363793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41985,-0.0107898775811621,0.00501166890408665,-0.0206127486331719,-0.00096700652915226,0.0313411689488309
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39768,0.00681562774763039,0.0031681167160065,0.000606118984257649,0.0130251365110031,0.0314736594619064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40054,0.0199976413120155,0.00931218582114374,0.0017457571025738,0.0382495255214573,0.0317779339262289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40021,0.0127486949856132,0.00594135856316254,0.00110363220181462,0.0243937577694118,0.0319147626508018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41829,0.0118948210063836,0.00554392562833084,0.00102872677485511,0.022760915237912,0.0319271561972886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,42144,0.0232457645116707,0.0108553152130317,0.00196934669412865,0.0445221823292127,0.0322589719302474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42178,-0.015388544312591,0.00718875908543985,-0.0294785121200531,-0.00129857650512889,0.0323216612508408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,42120,-0.00516395535983982,0.0024153346027171,-0.00989801118116534,-0.000429899538514298,0.0325364504152187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40080,-0.0060779978444119,0.00284525347429865,-0.0116546946540372,-0.000501301034786548,0.0326862884681501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42256,0.00602275028127124,0.00282068067155276,0.000494216165027834,0.0115512843975146,0.0327622742667914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39881,-0.015158161194142,0.00710606887835036,-0.0290860561957087,-0.00123026619257531,0.0329368652465348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41989,0.00790852011614377,0.0037120435481847,0.00063291476170176,0.0151841254705858,0.0331491210393083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41887,0.0119026545593254,0.00559153832374377,0.000943239444787643,0.0228620696738632,0.0332990754986775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42296,-0.00678173628231205,0.00318640921118167,-0.0130270983362281,-0.000536374228395971,0.0333281847081585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40054,0.008752563553109,0.00411241187101965,0.00069223628591049,0.0168128908203075,0.0333323025768509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39784,0.00559163865033982,0.00263383389027799,0.000429324225394962,0.0107539530752847,0.0337766861940123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42103,0.0219676747561376,0.0103561154312627,0.00166968851086271,0.0422656610014124,0.0339216835739377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42193,0.0145895157579088,0.00688273495651528,0.00109935524313886,0.0280796762726787,0.0340480136528232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39706,-0.0113530588897506,0.00535891020542987,-0.0218565228923931,-0.000849594887108033,0.0341528607438411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41887,0.0119935501050399,0.00567691517311771,0.000866796365729176,0.0231203038443506,0.0346469603421831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40054,0.0121257666053927,0.00573956827910977,0.000876212778337599,0.0233753204324479,0.0346524855294947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41876,0.00752511223970431,0.00357102145072499,0.00052591019628332,0.0145243142831253,0.0351136203542289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0117983008000836,0.00560960389817758,-0.0227931244405116,-0.000803477159655515,0.0354648290128861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40020,0.0116318237113691,0.00554747483394932,0.000758773036828397,0.0225048743859097,0.0360363666771529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39784,0.00841408510046931,0.00401486602384939,0.000544947693724512,0.0162832225072141,0.0361296092264288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,42197,0.0100291400143681,0.00479451221455715,0.000631896073836053,0.0194263839549001,0.0364761444417815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39849,-0.0122905385023645,0.00587698314206196,-0.0238094254608059,-0.000771651543923059,0.0365247468451954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39784,0.0120960199204677,0.00580002485711587,0.000727971200520568,0.0234640686404148,0.0370467560763525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,42103,0.0194282287245196,0.00932446889791245,0.00115226968461116,0.037704187764428,0.0372184813395029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39804,-0.00470406853746693,0.00225816614021447,-0.00913007417228729,-0.000278062902646576,0.0372626579757172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40097,0.0296746153306649,0.014250712348311,0.00174321912797525,0.0576060115333545,0.0373360467339452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40080,0.00618207195506555,0.0029696193436328,0.00036161804154526,0.0120025258685858,0.0373865571018604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39957,-0.0227557329419472,0.0109354738324685,-0.0441892616535855,-0.00132220423030888,0.0374657649195815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39975,0.0100741746857426,0.00484216095971578,0.000583539204699675,0.0195648101667855,0.0375021386191004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39955,0.0123991219210523,0.00596125373541432,0.000715064599640191,0.0240831792424643,0.0375535416643805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41965,0.00640340715191904,0.00308059280601841,0.000365445252122964,0.0124413690517151,0.0376714505296348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41876,-0.00694000834928415,0.00333975585425112,-0.0134859298236163,-0.000394086874951958,0.0377295439783368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41861,0.0167083770646161,0.00808588015209951,0.00086005196650106,0.0325567021627311,0.0388143383280248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,40097,0.0191637602804065,0.00928338895126583,0.000968317935925448,0.0373592026248875,0.0390122625809049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40061,0.00465895789089887,0.00225891772317331,0.000231479153479194,0.00908643662831855,0.0391863915611834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41861,0.00958704164209599,0.00465246004207098,0.000468219959636876,0.0187058633245551,0.0393578432821089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40054,0.0113239951017973,0.00550372590750926,0.000536692323079169,0.0221112978805155,0.0396605944668583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41810,0.00889598456551889,0.00433160415630926,0.00040604041915274,0.017385928711885,0.0400215204669903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41866,0.0182982506798808,0.00892740323708421,0.000800540335195755,0.0357959610245659,0.0404169632969252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39719,0.0153061345216456,0.00747065832393295,0.000663644206737002,0.0299486248365541,0.0405031501005738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42296,0.00648315256856421,0.0031645448182859,0.000280644724723853,0.0126856604124046,0.0405128972269366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42004,0.0109152822565328,0.00534324487846251,0.000442522294746247,0.0213880422183193,0.0410907817645952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39804,0.00820110608733959,0.00401883148947853,0.000324196367961679,0.0160780158067175,0.0413084080019441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39784,0.0090760982134833,0.00445811067186502,0.000338201296627864,0.0178139951303387,0.0417890492869188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39706,-0.00805849560302522,0.00395855345561271,-0.0158172603760261,-0.000299730830024301,0.04180377881244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42200,0.0133407777689047,0.00657364557398433,0.000456432443895385,0.0262251230939139,0.04243445760181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39804,0.00647268097513809,0.00319021875282439,0.000219852219602283,0.0127255097306739,0.0424919225659382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39784,0.00714145793481266,0.00352527156196651,0.000231925673358294,0.014050990196267,0.0428113899390113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,42006,0.0142094383421967,0.00701515206917468,0.000459740286614368,0.0279591363977791,0.0428331127578608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42197,-0.00935039559895297,0.0046211732943128,-0.0184078952558061,-0.000292895942099894,0.0430542677587089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39881,-0.00711798764125306,0.0035194582789622,-0.014016125868019,-0.000219849414487144,0.0431530044926469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40054,0.0115771217495183,0.00573086540926927,0.000344625547350536,0.0228096179516861,0.0433938906862851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39768,0.0145154647155353,0.00719214699819749,0.000418856599068188,0.0286120728320023,0.043591676571086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41841,0.0121247708083699,0.00601471779808563,0.000335923924122105,0.0239136176926178,0.0438367364363951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41861,0.00785148314014032,0.00389599971460318,0.000215323699518075,0.0154876425807626,0.0438976693333857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39784,0.0249664612615577,0.0124020762386333,0.000658391833836404,0.049274530689279,0.0441307107655461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,42103,0.0164569224755013,0.00818699519542442,0.000410411892469462,0.0325034330585332,0.0444382233877301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,40054,0.0140683098117003,0.00702613412026265,0.00029708693598555,0.0278395326874151,0.0452791084620409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40021,0.00819719219264622,0.00410041230027132,0.00016038408411442,0.016234000301178,0.0456209560121177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,40113,0.00608113959793868,0.00304266655336653,0.00011751315334029,0.0120447660425371,0.0456740419059368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42296,0.00823339392753922,0.00412957217235304,0.000139432469727268,0.0163273553853512,0.0461985036315494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41876,0.0115485654280913,0.00579275902242231,0.000194757744143575,0.022902373112039,0.0462148819445936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41861,0.0113623876510516,0.00570145573260886,0.000187534415138279,0.022537240886965,0.0462946514806551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39784,0.0099560995603595,0.00500692513640497,0.000142526293005771,0.0197696728277132,0.0467858908552826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41887,0.0138010335366746,0.00694267367520835,0.000193393133266231,0.027408673940083,0.0468490978022908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42103,0.0114860707127008,0.00579530274828573,0.000127277326060783,0.0228448640993408,0.0475046501426413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40054,0.0124753786237239,0.00630372665377978,0.000120074382315495,0.0248306828651322,0.0478358021514731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42274,0.012257065394285,0.00622475582453209,5.65439782021174e-05,0.0244575868103679,0.0489645531611209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,42103,0.0184080829879987,0.00936040421226113,6.16907319668722e-05,0.0367544752440305,0.0492518171861156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39706,0.0101110172948781,0.00514427692282582,2.82345261395194e-05,0.0201938000636167,0.0493840079284648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42094,-0.0117289466803443,0.00597469348421811,-0.0234393459094118,-1.85474512768413e-05,0.0496555050013223
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39719,0.0125873407656333,0.00642404910597924,-3.79548208599353e-06,0.0251784770133526,0.0500912435496464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41861,0.0129225350568071,0.00660289045368502,-1.91302324155703e-05,0.0258642003460297,0.0503573211204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39706,0.0130202114478118,0.00665561867627731,-2.48011576917378e-05,0.0260652240533153,0.0504593683595133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42213,0.0112869173778991,0.0057790257507182,-3.99730935085503e-05,0.0226138078493068,0.050831145374219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42144,0.00736279695928859,0.00377472860887052,-3.56711140976247e-05,0.0147612650326748,0.0511321391004079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,40021,-0.0219979318262914,0.0112795346171452,-0.044105819675896,0.000109956023313113,0.0511718938366398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,42186,0.011089575037094,0.0056889827595949,-6.08311717119718e-05,0.0222399812459,0.0512802379952875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42296,0.00460028796898256,0.00236061397175993,-2.65154156669075e-05,0.00922709135363202,0.0513445026115192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42103,0.00771880237172351,0.00397586756211229,-7.38980500165761e-05,0.0155115027934636,0.0522298923275274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,40020,0.00631511418822441,0.00325519963392223,-6.50770942631652e-05,0.012695305470712,0.0524046217882186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39804,0.0071714119187493,0.00370601948541066,-9.23862726555872e-05,0.0144352101101542,0.0530080911087846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39706,0.00633948537593647,0.00327673826907022,-8.29216314411673e-05,0.0127618923833141,0.0530546725851539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41887,0.0120768723479155,0.00625957063786054,-0.000191886102291124,0.0243456307981222,0.0537102897428911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,42094,0.00814626042246602,0.00422358972407652,-0.000131975436723952,0.016424496281656,0.0537834744121137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39768,0.0147238137262285,0.00764388074428532,-0.00025819253257075,0.0297058199850277,0.0541033941979396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,40020,0.0222381199755846,0.0115774429029178,-0.00045366811413431,0.0449299080653035,0.0547813344384078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,40097,0.0219152090357704,0.0114284103020538,-0.000484475156255014,0.0443148932277958,0.0551868543240516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42120,0.0114011130426089,0.00594642367867136,-0.000253877367587018,0.0230561034528047,0.0552211008804848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40102,-0.0113044250511255,0.00589687741520642,-0.0228623047849301,0.000253454682679073,0.0552616334771416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40020,0.0216826025190528,0.0113380789775812,-0.000540032277006445,0.043905237315112,0.0558551100581927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40054,-0.00523856055356916,0.0027396744360808,-0.0106083224482875,0.000131201341149198,0.05588829152315
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,42223,-0.0115724274488739,0.00609365273952238,-0.0235159868183378,0.000371131920589962,0.0575740104188624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39881,0.0134337256536521,0.0070805471341819,-0.000444146729344421,0.0273115980366486,0.0578189443299113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41829,-0.00859279029940363,0.00453071088981249,-0.0174729836434361,0.000287403044628851,0.0579080845176901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,42184,-0.0147131251070263,0.00776316437284074,-0.0299289272777941,0.000502677063741576,0.0580816763092662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41829,0.00662729576301417,0.00350558100620047,-0.000243643009138751,0.0134982345351671,0.0587141775059939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39804,-0.00667858237536613,0.0035343635071652,-0.0136059348494099,0.000248770098677659,0.0588368557920279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41861,-0.00601926222511366,0.00318600910651266,-0.0122638400738785,0.000225315623651151,0.0588771830466349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40054,-0.00848808677810093,0.00449302023498953,-0.0172944064386804,0.000318232882478542,0.0588954393237046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39665,-0.00901437434006721,0.00477239458784794,-0.0183682677322492,0.000339519052114762,0.058938507031245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39768,0.0128034169441263,0.00677956709678718,-0.00048453456557653,0.0260913684538292,0.058982158902052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41829,0.0119249681680589,0.00631515087467968,-0.000452727546313305,0.024302663882431,0.0590071143198626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42094,0.00748729666950813,0.00398708261577062,-0.000327385257402288,0.0153019785964185,0.0604189578298868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39863,0.0146813371273379,0.00782163046187014,-0.000649058577927608,0.0300117328326033,0.0605429639831063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39881,0.0136942215394349,0.0073128499608784,-0.000638964383886793,0.0280274074627565,0.0611475459959918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39706,-0.012486034437612,0.0066852707215612,-0.025589165051872,0.000617096176647933,0.0618326565112317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,42213,0.0141116173634845,0.00756069262796008,-0.000707340187317235,0.0289305749142863,0.0620015890256079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39719,0.00885836713021569,0.0047465843369189,-0.000444938170145352,0.0181616724305767,0.0620325926268196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,40020,0.00394515275477399,0.00211396215556959,-0.000198213070142409,0.0080885185796904,0.0620353407337975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40054,0.0164422923337342,0.00883041087409303,-0.000865312979488147,0.0337498976469565,0.0626290058298724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39804,0.0143472643633526,0.0077081136811608,-0.000760638451722515,0.0294551671784278,0.0627266682183819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41887,0.0150592580628314,0.00810096848444095,-0.00081864016667286,0.0309371562923357,0.0630580052429233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39863,0.00400857731149929,0.00216253581344886,-0.000229992882860477,0.00824714750585906,0.0638173103068268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41861,0.013374761540536,0.00723764044712936,-0.000811013735837569,0.0275605368169095,0.0646335946909102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,42153,-0.00514249317172832,0.00278487241321928,-0.0106008431016381,0.000315856758181465,0.064830640106927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39784,0.00575065699167639,0.00311512521051846,-0.000354988420939802,0.0118563024042926,0.0649137636110652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39999,0.00729855806844894,0.00395405560700597,-0.000451390921282767,0.0150485070581807,0.0649426291176302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39768,0.00764367476180165,0.00414333828115201,-0.000477268269256285,0.0157646177928596,0.0650930299565561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,42223,0.0119362014314917,0.00647942489809393,-0.000763471368772386,0.0246358742317558,0.0654730135987283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39706,-0.00823728786237486,0.00447234367406002,-0.0170030814635325,0.000528505738782787,0.06552846315974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39804,0.0133667373301448,0.00725854573989989,-0.000860012320058993,0.0275934869803486,0.0655736882566442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39706,-0.00949830267663081,0.0051619952444452,-0.0196158133557434,0.000619208002481777,0.0657898306109981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42067,0.00397597250723426,0.00216142545416434,-0.000260421382927854,0.00821236639739637,0.0658626252935873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,40097,0.0180631197278871,0.00982379466565433,-0.00119151781679538,0.0373177572725696,0.0659848796259427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42120,-0.00828782077528039,0.00450960575066388,-0.0171266480465816,0.000551006496020814,0.0661126173907016
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39784,0.00814457270757083,0.00443635318278657,-0.000550679530690849,0.0168398249458325,0.0664047397877406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39784,0.00634124246710304,0.00345774144201717,-0.000435930759250624,0.0131184156934567,0.0666930016533412
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40020,0.00894651161837569,0.00487851460532896,-0.000615377008069061,0.0185084002448204,0.0667022488756961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41861,-0.0100312336934923,0.00548035994308274,-0.0207727391819345,0.000710271794949873,0.0672140986147787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39784,0.0177090706782512,0.00969782353702864,-0.00129866345432489,0.0367168048108274,0.0678652820414769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,40020,0.0128107553938627,0.00702816100923935,-0.00096444018424645,0.0265859509719718,0.0683650611123813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39650,0.00970172422944886,0.00532456230837333,-0.000734417894962874,0.0201378663538606,0.0684729466410483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42237,-0.00655894752511795,0.00362841873629435,-0.0136706482482549,0.000552753198018974,0.0706824566867858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40097,0.0150368350447883,0.00834564629690741,-0.0013206316971502,0.0313943017867268,0.0716111003055411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.00555712267862217,0.00308915174545721,-0.0116118600997183,0.000497614742473958,0.072055450868037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41829,0.0068941642744907,0.00383446089574232,-0.000621379081164243,0.0144097076301456,0.0722089893910391
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40043,0.0124000507892744,0.00689723146728,-0.00111852288659443,0.0259186244651432,0.0722317191775844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41876,0.0122934712407175,0.00686566768493717,-0.00116323742175938,0.0257501799031943,0.0733858720485271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,42273,-0.0106370894115875,0.00596938303893886,-0.0223370801679076,0.00106290134473271,0.0747820196550745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41876,0.00596690453371675,0.00335550102570914,-0.00060987747667316,0.0125436865441067,0.0753874987502353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42103,0.0269113162563942,0.0151429867152073,-0.0027689377054121,0.0565915702182005,0.075567566647557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40054,0.00643291849353491,0.00362012085402429,-0.000662518380352698,0.0135283553674225,0.0755978717447282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,42296,0.00557533343217865,0.00314546784718288,-0.000589783548299797,0.0117404504126571,0.0763352666283389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42094,0.00416771853870118,0.00235548372572946,-0.000449029563728562,0.00878446664113093,0.0768560326232848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42120,0.00782106179141792,0.00442181370018729,-0.000845693060949164,0.016487816643785,0.0769599837646932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41887,0.0105554866519719,0.00597172270718071,-0.00114908985410233,0.0222600631580461,0.0771554733581517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42103,0.00953041516023275,0.00539819382573825,-0.00105004473821421,0.0201108750586797,0.0775063947339555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40021,0.00770559722599117,0.00436829938849749,-0.000856269575463899,0.0162674640274462,0.0777633709729492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40020,0.00607176787194251,0.00344405185043369,-0.00067857375490752,0.0128221094987925,0.0779333775176135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39804,-0.00749939815097016,0.00426165746554245,-0.0158522467834333,0.000853450481493039,0.0784811510130678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41829,0.0112654639604276,0.0064030374423972,-0.00128448942667093,0.0238154173475261,0.078534854498841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41861,0.00684720070994357,0.00389296271820697,-0.000783006217742093,0.0144774076376292,0.0786243723085841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39784,0.00774631468316388,0.00441038200965575,-0.000898034055761386,0.0163906634220891,0.0790521395925638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39719,-0.00922389180551501,0.00526078392359857,-0.0195350282957682,0.00108724468473819,0.0795744371626119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40054,0.0107975034428514,0.00619509229642847,-0.00134487745814843,0.0229398843438512,0.0813772130370771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41985,0.0109976246735257,0.00631323585919953,-0.00137631761050537,0.0233715669575568,0.0815333732186694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41813,0.00984512019326679,0.00566211834227471,-0.00125263175759165,0.0209428721441252,0.0820996564560297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,40113,-0.00622090603499398,0.00358631005787814,-0.0132500737484351,0.000808261678447172,0.0828353221953367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40020,0.00690749458976942,0.0039824609774526,-0.000898128926037681,0.0147131181055765,0.0828616072276929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42103,0.0183524833548235,0.0105822634854625,-0.00238875307668303,0.0390937197863301,0.0828943737687783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39768,0.0187076801473836,0.0108245197825465,-0.00250837862640749,0.0399237389211746,0.0839692321616205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41861,0.00824477232600678,0.00477331608130776,-0.00111092719335643,0.01760047184537,0.0841448151006027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39784,0.00571716420190875,0.00331113910133678,-0.000772668436711336,0.0122069968405288,0.08426047002385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39665,-0.00674919196054487,0.00390978036282281,-0.0144123614716776,0.000913977550587843,0.084334997663146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39804,0.00721818731411695,0.00418513823476102,-0.000984683626014652,0.0154210582542486,0.084607253812288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39768,-0.00629867818746973,0.00365922107795183,-0.0134707515002553,0.000873395125315869,0.085222628732978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38671,0.0190252548757241,0.0110594611842874,-0.00265128904547924,0.0407017987969274,0.0854160915533156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,40113,0.00256268973128172,0.00149293528148735,-0.000363463420433489,0.00548884288299693,0.0860908066168748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39863,0.012133058701834,0.00707208164438775,-0.00172822132116594,0.025994338724834,0.0862592508888188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39768,-0.00618983847873026,0.00363438681815297,-0.0133132366423101,0.000933559684849551,0.0885728592274244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39665,-0.00962155201742358,0.00565282613139388,-0.0207010912349556,0.00145798720010842,0.0887703972001683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39768,-0.0072125497610771,0.00424218909722131,-0.0155272403916309,0.00110214086947667,0.0891236128430744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,42120,0.00421057245333254,0.0024765985160763,-0.000643560638177,0.00906470554484209,0.089128025379576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41861,0.0100852702449629,0.00594612186876466,-0.00156912861781587,0.0217396691077416,0.0898898299670138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40020,-0.00757425207038276,0.00447530714234522,-0.0163458540693794,0.00119734992861387,0.0905881931855579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39847,0.00513473369219638,0.00303818372695594,-0.000820106412637266,0.01108957379703,0.0910444180388064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39881,0.00746714408493934,0.00442794305576566,-0.00121162430436135,0.01614591247424,0.0917540157634705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39651,-0.0136089737569585,0.00808317370561464,-0.0294519942199632,0.00223404670604615,0.0922854370969135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39784,0.0105787211607549,0.00629043312939483,-0.00175052777285891,0.0229079700943688,0.0926534357574868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41861,0.00980148322364999,0.00582990870967683,-0.00162513784731659,0.0212281042946166,0.0927407095039666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39665,-0.00585757380309277,0.0034872034958211,-0.0126924926549021,0.000977345048716588,0.0930389398953788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39881,-0.00752370109017056,0.00448069265581942,-0.0163058586955766,0.00125845651523551,0.0931543937778909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42197,0.00532984684186786,0.00317422217694637,-0.00089162862494702,0.0115513223086827,0.0931559448581932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41887,0.00484270629669386,0.00288470299046346,-0.000811311564614519,0.0104967241580022,0.0932246378162311
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42144,0.00770066922683776,0.00459608881910774,-0.00130766485861341,0.0167090033122889,0.0938636226117722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,40102,-0.00846165627197153,0.00505318398806019,-0.0183658968885695,0.00144258434462643,0.0940571676219693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,40097,-0.0123833484414274,0.00741295014309157,-0.0269127307218869,0.00214603383903207,0.0948487757070054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41887,0.00555037210659379,0.00332301551158544,-0.000962738296113677,0.0120634825093013,0.0948882913605319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41876,0.010391385373517,0.00623428314451192,-0.00182780958972634,0.0226105803367604,0.0955762498719537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39784,0.00560198310209166,0.00336349936443301,-0.000990475652197032,0.0121944418563804,0.0958381821751782
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39665,-0.0052471810588969,0.00315406473703629,-0.011429147943488,0.000934785825694226,0.0962173102039501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41861,-0.00885192889615131,0.00533232476304872,-0.0193032854317268,0.00159942763942418,0.0969290269456074
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39719,-0.0156717599401938,0.00944571609140067,-0.0341853634793391,0.00284184359895151,0.0971174954539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39719,0.00667755967667063,0.00402625650930632,-0.00121390308156975,0.014569022434911,0.0972457212685919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41952,0.00599000067960165,0.00361584531407139,-0.00109705613597826,0.0130770574951816,0.097625447616251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39719,0.0117138121299578,0.00708085377706866,-0.00216466127309677,0.0255922855330124,0.0980976615519446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41861,0.00821075700667191,0.00497987458536345,-0.00154979718064045,0.0179713111939843,0.0992158910216319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41887,0.00540836078794611,0.00328532791362808,-0.00103088192276492,0.0118476034986571,0.0997439650791203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40054,0.0119588488891331,0.00726491475595026,-0.00228038403252946,0.0261980818107956,0.0997700485425913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0115889891873044,0.00707436260911471,-0.00227676152656043,0.0254547399011692,0.101411846583152
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39863,0.00602561529408656,0.00367840208998373,-0.00118405280228155,0.0132352833904547,0.101428915477718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42091,0.00444775525845553,0.00271625833526874,-0.000876111078671203,0.00977162159558225,0.101559487296407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,42296,0.00670850710298493,0.00409950195866293,-0.00132651673599441,0.0147435309419643,0.101775728796192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,40054,0.00501680093271354,0.00306645991635575,-0.000993460503343731,0.0110270623687708,0.10186361664481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39719,0.00813629091863613,0.00497533913076132,-0.00161537377765606,0.0178879556149283,0.102011072137853
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42094,0.00557145285511265,0.003408526047784,-0.00110925819854399,0.0122521639087693,0.102164948449972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40054,-0.00553944543972655,0.00339409602314871,-0.012191873645098,0.00111298276564492,0.10269105632774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41829,0.00843739848060964,0.00517268410766445,-0.00170106237041268,0.018575859331632,0.102884623385534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41887,-0.00932787823137023,0.00571871952995662,-0.0205365685100852,0.00188081204734474,0.102891270274151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40053,0.00648104900410927,0.00397988177301124,-0.00131951927099277,0.0142816172792113,0.103457951254496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39719,0.00973837267601164,0.00598725406183181,-0.00199664528517871,0.021473390637202,0.10386957966891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39706,0.00616909912635202,0.00379964247697409,-0.00127820012851719,0.0136163983812212,0.104491211612945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,42223,0.00753184818663512,0.00464259696711085,-0.00156764186890213,0.0166313382421724,0.104755804001885
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39784,0.00759112940621903,0.00468156139495406,-0.00158473092789093,0.016766989740329,0.104941245046308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39706,-0.00786618813564616,0.00485416901420995,-0.0173803594034977,0.00164798313220534,0.10515458795009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39784,0.00953513922365207,0.00589194981889841,-0.00201308242138881,0.0210833608686929,0.105620545066264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41829,0.00488669987457858,0.00302954459057217,-0.00105120752294288,0.0108246072721,0.106766293922182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41887,0.00810544088599918,0.00503086390226192,-0.00175505236243419,0.0179659341344325,0.107173433945439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39784,0.0111008841108153,0.00689001547938376,-0.00240354622877688,0.0246053144504075,0.107175706085995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42144,0.00470325222608568,0.00291982859735754,-0.00101961182473509,0.0104261162769065,0.107248265904243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40021,0.00767068555549484,0.0047717667797315,-0.0016819773327789,0.0170233484437686,0.107970651937049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,42111,0.00647900260282876,0.00404144794806956,-0.00144223537538758,0.0144002405810451,0.108928431340281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39804,0.0104013209965917,0.00649026097606675,-0.00231959051649911,0.0231222325096826,0.109051782542701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41963,0.0035144456700876,0.00219346008446316,-0.000784736095460196,0.0078136274356354,0.109127667658433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41887,-0.00833482252783721,0.00521205639436406,-0.0185504530607908,0.00188080800511635,0.109813762749471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,42004,0.00900672393830933,0.005638883860932,-0.0020454884291174,0.0200589363057361,0.110233997139564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,42120,0.00710887203205583,0.00446847413956604,-0.00164933728149361,0.0158670813456053,0.111657719475517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39881,0.00550158422304837,0.00345881277646125,-0.00127768881881568,0.0122808572649124,0.111729422647466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41876,0.00909097635147483,0.00571813643122735,-0.00211657105373078,0.0202985237566804,0.111893659247771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,40020,-0.0072682448399442,0.00457425476065119,-0.0162337841708205,0.00169729449093214,0.112101734806408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39784,0.00565449290686631,0.00356833875301204,-0.00133945104903729,0.0126484368627699,0.113080521389233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39784,-0.0139571941786588,0.00881013570232844,-0.0312250601552226,0.00331067179790492,0.113173497412781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39768,-0.0107498945677344,0.0067936335118917,-0.0240654162510422,0.00256562711557329,0.11359998334117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40021,-0.023509879947249,0.0149127401932491,-0.0527388507260171,0.00571909083151918,0.114940683454565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39784,-0.00751269768532831,0.00476640420444363,-0.0168548499260378,0.00182945455538119,0.115014839012535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39768,0.00680742717927362,0.00431920596748438,-0.00165821651699578,0.015273070875543,0.115036587402015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,42213,0.00580455456749274,0.00370073607989322,-0.00144888814909797,0.0130579972840835,0.116791941882881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39881,0.00829289035059464,0.00529048322890946,-0.0020764567780679,0.0186622374792572,0.117024917215455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41948,-0.00599902561713329,0.00382779163932126,-0.013501497230203,0.00150344599593639,0.117086010026287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40080,0.00461860271888597,0.00294911849883385,-0.00116166953882838,0.0103988749766003,0.117355207963334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39784,-0.00927173364017304,0.00592129400475523,-0.0208774698894933,0.00233400260914721,0.11741854307977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40080,-0.0166366661552901,0.0106402653180918,-0.03749158617875,0.0042182538681699,0.117950600618059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39706,-0.00633219608730495,0.00405362645457382,-0.0142773039382696,0.00161291176365973,0.118293012821345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,40020,0.00633665756902818,0.00405717893163468,-0.00161541313697578,0.0142887282750321,0.11835530891374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39733,-0.00600069826444138,0.00384594491517757,-0.0135387502981894,0.00153735376930665,0.118726988359697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42248,-0.00822926322250662,0.00528296394303291,-0.0185838725508511,0.00212534610583788,0.119329058249387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41829,0.00771267004384948,0.00495650996214494,-0.0020020894819546,0.0174274295696536,0.119716801334095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41876,0.00761543572791938,0.00489555992806788,-0.00197986173109367,0.0172107331869324,0.119832920793893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,42197,0.00471237460780853,0.00303042009044,-0.00122724876945387,0.0106519979850709,0.119964797767947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,42146,0.00459920131837727,0.00296620055663542,-0.00121455177262815,0.0104129544093827,0.121037306292785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39881,-0.0047252076168691,0.00304881090358337,-0.0107008769878925,0.0012504617541543,0.12120650078385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,40097,-0.00669822399676044,0.0043244526476173,-0.0151741511860903,0.00177770319256946,0.121430376686794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40021,0.00722227976439791,0.00466985605950566,-0.00193063811223319,0.016375197641029,0.121995137367661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,40054,0.00595983790659938,0.00385913170622021,-0.00160406023759224,0.013523736050791,0.122533465122293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,40020,0.00947843990081697,0.00614387274329595,-0.0025635506760431,0.021520430477677,0.12292145449008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39784,0.00970685440801501,0.00630111684177235,-0.00264333460185881,0.0220570434178888,0.12346902267307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42094,0.00304901913098513,0.00198200080124079,-0.000835702439446816,0.00693374070141707,0.123986576307099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,42223,-0.00503091410233868,0.00327126532849225,-0.0114425941461835,0.00138076594150613,0.124094722909191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,40054,0.012536061508735,0.00816563845438954,-0.00346858986186854,0.0285407128793384,0.12475862642442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41931,0.00821371942797669,0.0053685049269398,-0.00230855022882532,0.0187359890847787,0.126045855713061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39784,0.011325860599544,0.00741372330873733,-0.0032050370855812,0.0258567582846691,0.126619736819407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41861,-0.00606343823286786,0.00397573300327951,-0.0138558749192957,0.00172899845355998,0.127256122679402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39804,-0.00959185180012128,0.00629462588524838,-0.0219293185352081,0.00274561493496555,0.12758447893129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40113,0.00239227043886909,0.00157530328992353,-0.000695324009381022,0.0054798648871192,0.128889787096153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,40113,0.00324552471258762,0.00213750819872735,-0.000943991356917989,0.00743504078209323,0.128950527563185
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39768,-0.0107348524650498,0.00708563244959784,-0.0246226920662615,0.00315298713616197,0.129798030434208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42222,-0.00383906384215997,0.00253866871983868,-0.00881485453304377,0.00113672684872384,0.130498330596359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39706,0.00742162685214236,0.00491359285268031,-0.00220901513911106,0.0170522688433958,0.130964376803281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42120,-0.00447914916399643,0.00297097530157833,-0.0103022607550899,0.00134396242709709,0.131672165891874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41830,-0.007498172276584,0.00497449680479246,-0.0172481860139772,0.00225184146080921,0.131752944244799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39804,0.00457277704518596,0.00303744117120677,-0.0013806076503793,0.0105261617407512,0.132233011264958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40097,0.00597281087608273,0.00396845016756266,-0.00180535145234008,0.0137509732045055,0.132334038828908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42144,-0.00952029539116145,0.006325596565174,-0.0219184646589025,0.00287787387657959,0.13233738764775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40054,0.00393561673924137,0.00261525736085481,-0.00119028768803405,0.00906152116651679,0.13238713520379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40021,0.0163416870689658,0.0108660139802232,-0.00495570033227162,0.0376390744702032,0.132629444236204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39706,0.0115828559012113,0.00770280875043011,-0.00351464924963168,0.0266803610520543,0.13268390905436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41486,0.00442183505274271,0.00294778212775018,-0.00135581791764764,0.0101994880231331,0.13362586265382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41861,0.00647017971531027,0.00431802678458567,-0.00199315278247763,0.0149335122130982,0.134051366070484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39768,0.00923673207819361,0.00616630104111766,-0.00284921796239701,0.0213226821187842,0.134179402182895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41774,-0.0154738613098521,0.0103324978876049,-0.0357255571695576,0.00477783454985338,0.134264498359649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42103,0.0117646839219293,0.00788764685829677,-0.00369510392033233,0.027224471764191,0.135846104389093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,42256,0.00548322027628752,0.00367962616450243,-0.00172884700613724,0.0126952875587123,0.136207134568794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42103,-0.00787332629853399,0.00528647640514164,-0.0182348200526116,0.00248816745554362,0.136424005405658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39719,-0.0117213289738259,0.00787153362071335,-0.0271495348704241,0.00370687692277225,0.1364967445415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39804,0.013533077017835,0.00909174127168778,-0.00428673587467302,0.0313528899103431,0.136648218839753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41813,0.00545841897795823,0.00367310702301821,-0.00174087078715745,0.0126577087430739,0.13729100151325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,42094,-0.00226935159089674,0.00153155614140901,-0.00527120162805841,0.000732498446264931,0.138436766271256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42103,0.00630457436967815,0.00426332216611005,-0.00205153707589754,0.0146606858152538,0.139219834076347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,42004,0.00789602929882694,0.0053441705073833,-0.00257854489564433,0.0183706034932982,0.13956537161812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39768,0.00741538954118051,0.00502293191637156,-0.00242955701490776,0.0172603360972688,0.139891274300082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41861,0.00833967982430701,0.00565824253425227,-0.00275047554282745,0.0194298351914415,0.140533550811113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40021,0.010420934192911,0.00707075769069159,-0.00343775088084448,0.0242796192666665,0.140562559048101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41829,0.00844456697559996,0.00573106736740228,-0.00278832506450851,0.0196774590157084,0.140648734984152
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,42162,0.0122430678029554,0.00832479584752275,-0.00407353205818917,0.0285596676641,0.141403336011046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41985,0.0107028667621703,0.00727886350053153,-0.0035637056988715,0.0249694392232121,0.141477086629355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41887,-0.00926195791687158,0.00631336577643267,-0.0216361548386796,0.00311223900493646,0.142390045009449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41861,0.00699022544613551,0.00477377081862984,-0.00236636535837898,0.01634681625065,0.143137223137773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.00859290959482857,0.00586978256114229,-0.0200976834146675,0.00291186422501032,0.143239293599399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39922,0.00628787694829798,0.0042971374363608,-0.00213451242696919,0.0147102663235651,0.14342251395197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,40021,0.0149803890008376,0.0102425356377677,-0.00509498084918719,0.0350557588508624,0.143615074598408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42296,0.00424041143452222,0.00290179105738932,-0.00144709903796085,0.00992792190700529,0.14395482704518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40020,0.0133010114126203,0.0091073086468085,-0.00454931353512435,0.031151336360365,0.144188145760772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41984,0.00503102906718646,0.00344767410252431,-0.00172641217376119,0.0117884703081341,0.14452002140392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42094,-0.00610487037978275,0.00418511950909283,-0.0143077046176047,0.00209796385803918,0.144669638055783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39706,-0.00560598400178938,0.00384748479426534,-0.0131470541985495,0.00193508619497069,0.145131997691701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41772,0.00807814773010509,0.00554518079690306,-0.00279040663182492,0.0189467020920351,0.145200126308339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39665,0.0076793828041004,0.00527466360520841,-0.00265895786210809,0.0180177234703089,0.145450243354901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39665,0.00956406112243783,0.0065811506886781,-0.00333499422737125,0.0224631164722469,0.146184158089731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40080,0.0104296021993615,0.00718285946377445,-0.00364880234963641,0.0245080067483594,0.146526930503793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42213,0.00669914706236157,0.00462910518322476,-0.00237389909675896,0.0157721932214821,0.14787067701603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41861,-0.0127994994306103,0.00885769780279586,-0.0301605871240902,0.00456158826286957,0.148478623313157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41829,0.00963093579866871,0.00667655973333677,-0.00345512127867136,0.0227169928760088,0.14918622753301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39719,0.00897057840582462,0.00622075503087705,-0.0032221014546944,0.0211632582663436,0.14932080679609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41732,0.00395499539124717,0.00274523087835968,-0.0014256571303378,0.00933564791283214,0.149700472943548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40020,0.00896445488501987,0.00622729325940624,-0.00324103990341636,0.0211699496734561,0.150025719166029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39665,0.00837096409255532,0.00582513527943397,-0.00304630105513525,0.0197882292402459,0.150735936948422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,42120,-0.00453408564196245,0.00317059395733146,-0.0107484497983321,0.00168027851440721,0.152728852824621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40113,0.00269122631169086,0.001882405255058,-0.000998287988222813,0.00638074061160454,0.15283914586873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39784,-0.00668622228226411,0.00467908237486374,-0.015857223736997,0.00248477917246881,0.153045180342638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39706,0.00654708484181604,0.00459310312262495,-0.00245539727852887,0.0155495669621609,0.154066540923132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40054,0.0065121470409179,0.00457092328576999,-0.00244686259919128,0.0154711566810271,0.154275670939961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39719,0.00722575416687179,0.00507354398914998,-0.00271839205186218,0.0171699003856058,0.154417500431687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,42170,0.0115911387959849,0.00814259001694146,-0.00436833763722036,0.0275506152291902,0.154609545416455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39784,0.00498480177116899,0.00350275100615273,-0.00188059020089037,0.0118501937432283,0.154733579666959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39768,0.0102694386163671,0.00721764887717249,-0.00387715318289101,0.0244160304156252,0.154816900612151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39665,-0.00647408154043013,0.00455512189201078,-0.0154021204487713,0.002453957367911,0.155266565720336
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42103,0.0137016775902429,0.00965202415449395,-0.00521628975256528,0.032619644933051,0.155758449712366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39706,-0.0086929724735215,0.00612388745695446,-0.0206957918891522,0.00330984694210924,0.155777515053705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40021,0.00698191841371674,0.00491994203640503,-0.00266116797763712,0.0166250048050706,0.155896952287483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39881,0.0148950419487968,0.0105068270159152,-0.00569833900239693,0.0354884228999906,0.156321055074798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39784,0.00618823803525058,0.00436554105561035,-0.00236822243374569,0.0147446985042469,0.156360620796773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39804,-0.00296864122609285,0.00209479393485854,-0.00707443733841559,0.00113715488622988,0.156467880913989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39768,0.00699059212898708,0.00493452184568106,-0.0026810706885478,0.0166622549465219,0.156608709608571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41876,0.00825294645001833,0.00583109672527621,-0.00317600313152304,0.0196818960315597,0.1569952966375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41829,0.00575942315509849,0.00406938891887199,-0.00221657912589062,0.0137354254360876,0.157003975561482
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42125,-0.0062602724340869,0.00442688968004579,-0.0149369762069766,0.00241643133880284,0.157342842829428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,42103,0.00616163347575218,0.00435995419130225,-0.00238387673920023,0.0147071436907046,0.157611180491626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39768,-0.00724696034457939,0.00513261510450277,-0.0173068859494048,0.00281296526024604,0.15799615013096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42103,0.0103094548404883,0.00730297449857788,-0.00400437517672433,0.024623284857701,0.158068637940794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39706,0.00703852546261137,0.00499696606433128,-0.00275552802347794,0.0168325789487007,0.158994951952215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39706,0.00944763319679347,0.00671264743884391,-0.00370915578334058,0.0226044221769275,0.159327200805569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40021,-0.00427810562124227,0.00304050667753126,-0.0102374987092035,0.001681287466719,0.159445099908996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,40102,0.0114456287723776,0.00813949990291718,-0.00450779103734007,0.0273990485820953,0.159698189380099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42144,-0.00889831407662143,0.00633194345541289,-0.0213089232492307,0.00351229509598784,0.159954483670825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39724,0.00605073516226387,0.00430771574046674,-0.00239238768905094,0.0144938580135787,0.160161628315093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39881,-0.00831550591703327,0.00593300863816825,-0.019944202847843,0.0033131910137765,0.161073788672078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39665,0.00813575114290346,0.00582254401752826,-0.00327643513145192,0.0195479374172588,0.162357608387557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39768,-0.00645550732403737,0.00462127558213845,-0.0155132074650287,0.00260219281695398,0.162469870640451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41829,0.0101544616610851,0.00729375852221003,-0.00414130504244654,0.0244502283646168,0.163882566037957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39772,-0.00374637106276349,0.0026957371079977,-0.00903001579443898,0.00153727366891199,0.164637386322432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42186,0.00385074983782358,0.00277365568610254,-0.0015856153069374,0.00928711498258457,0.165060336130866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39706,-0.00674219442726244,0.00487047189669365,-0.016288319344782,0.00280393049025712,0.166295987889794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,42223,0.0041545645599222,0.00300601654521045,-0.00173722786869028,0.0100463569885347,0.166969891054286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39855,-0.005166606733071,0.00374808609166009,-0.0125128554727248,0.00217964200658276,0.168088589943773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,40054,0.0199869340652271,0.0145826873541933,-0.00859513314899181,0.0485690012794459,0.170530089549061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41861,0.0145161137408213,0.0106124705895647,-0.00628432861472544,0.0353165560963681,0.17138784621116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39706,0.00460307583932284,0.00336580244156573,-0.00199389694614599,0.0112000486247917,0.171466142552021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39706,0.0114418595075899,0.00840452783156838,-0.00503101504228411,0.0279147340574639,0.173418925928659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39768,0.00660055308044948,0.00485005785323359,-0.00290556031188836,0.0161066664727873,0.173567171240402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,42094,0.0262870077495716,0.0193256305684468,-0.0115912281645841,0.0641652436637273,0.173785744711609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40054,0.00646943749046031,0.00475660103749307,-0.00285350054302611,0.0157923755239467,0.173827549483506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40020,0.00651668617545184,0.00480045618782503,-0.00289220795268523,0.0159255803035889,0.17464626473535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41888,0.00651181956355489,0.00479841246977296,-0.00289306887720012,0.0159167080043099,0.174780585651258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39804,0.00420840966663267,0.00310220938586078,-0.00187192072965446,0.0102887400629198,0.174942081894166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42120,0.00856789367764721,0.00633050713722505,-0.00383990031131388,0.0209756876666083,0.17594219730253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39784,-0.00680152453004125,0.00502749408347498,-0.0166554129336522,0.00305236387356972,0.176127405967285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39863,0.00549917682937342,0.00406886718695877,-0.00247580285706577,0.0134741565158126,0.176555884665505
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41887,0.00530265432351183,0.00393256813565666,-0.00240517922237522,0.0130104878693989,0.177555503041657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42227,-0.0113669865968956,0.0084333430465288,-0.027896338968092,0.00516236577430087,0.177726047800968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39881,0.00735100332835088,0.00545594215957765,-0.00334264330442132,0.0180446499611231,0.177899660592551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39833,0.00446425545575995,0.00331511729738181,-0.00203337444710841,0.0109618853586283,0.178126261807292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,42120,0.00274274137840112,0.00203687204999629,-0.0012495278395916,0.00673501059639384,0.178150190264663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41742,-0.010290305789844,0.00764650507399343,-0.0252774557348711,0.00469684415518313,0.178406559169948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,42120,-0.00366233455272682,0.00272215388142472,-0.00899775616031927,0.00167308705486563,0.178525775852192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39706,-0.00817404623701678,0.00609796276148046,-0.0201260532495185,0.00377796077548491,0.180126350139045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39784,-0.0108490477550676,0.00809760931300606,-0.0267203620085594,0.00502226649842429,0.18034431257886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41861,0.00857649843276009,0.00641063828349916,-0.00398835260289826,0.0211413494684185,0.180968033750325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41834,-0.0038938076902021,0.0029153471427821,-0.00960788809005502,0.00182027270965081,0.18169624162914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41810,0.0046753335615546,0.00351095111561129,-0.00220613062504352,0.0115567977481527,0.183001578402288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39830,0.00870307950006927,0.00655563102644812,-0.00414595731176904,0.0215521163119076,0.184347663841974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,42103,0.00794112514352299,0.0059849390032426,-0.00378935530283249,0.0196716055898785,0.184581288142859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39665,-0.00454013549583202,0.0034312868553034,-0.0112654577322267,0.00218518674056265,0.185811649998415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42103,-0.00475844560249072,0.00360583277417495,-0.0118258778398736,0.00230898663489218,0.186974527118712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40080,-0.00519046207748969,0.00393875187131724,-0.0129104157452715,0.0025294915902921,0.187600475903956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41984,-0.00535527591309248,0.00406476449192205,-0.0133222143172597,0.00261166249107473,0.187698908975915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39646,-0.00661412620392271,0.00502524810303839,-0.016463612485878,0.00323536007803254,0.188142821696365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39784,-0.00430254040314425,0.00328416066759807,-0.0107394953116365,0.00213441450534797,0.190194388280939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39719,-0.00950775852943689,0.0072954283622473,-0.0238067981194416,0.00479128106056782,0.192518330472503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39768,-0.00381616885466897,0.00293031162161168,-0.00955957963302786,0.00192724192368992,0.192839414406725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,40080,0.00471541137196242,0.0036216700620388,-0.00238306194963362,0.0118138846935585,0.192944221683056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39665,-0.00409710247293387,0.00314712601624078,-0.0102654694647658,0.00207126451889806,0.192994516714054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41718,0.0111888858077428,0.00859678783066037,-0.00566081834035154,0.0280385899558371,0.193104682047375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42200,0.00540206228502207,0.00415399931597662,-0.0027397763742921,0.0135439009443362,0.193470330125157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41876,0.00361819461468245,0.00278328858962572,-0.00183705102098396,0.00907344025034887,0.193634514839519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41876,0.0075387182332922,0.00580593207311447,-0.00384090863001217,0.0189183450965966,0.194156018614638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41861,0.00679731441299675,0.00525774003920364,-0.00350785606384238,0.0171024848898359,0.196096707872225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40102,0.018819740735102,0.0145782629432915,-0.00975365463374927,0.0473931361039534,0.196749987698831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41968,0.00384620516898638,0.00298698105159614,-0.00200827769214206,0.00970068803011482,0.197888935955224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39881,0.00707941235321083,0.0055130788073712,-0.00372622210923671,0.0178850468156584,0.199130499233026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39706,-0.0044747014662817,0.00348985590056818,-0.0113148190313953,0.00236541609883194,0.199799944561241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39719,-0.00940207084176632,0.00735853470309527,-0.023824798859833,0.0050206571763004,0.201380000155199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41829,-0.0075116036050804,0.00588522671586836,-0.0190466479681824,0.00402344075802159,0.201855613226948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,40031,0.0117229251595232,0.00919970027921222,-0.0063084873877328,0.0297543377067791,0.20259418010814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42004,-0.00915782497698658,0.00719376225686261,-0.0232575990004373,0.00494194904646413,0.203032974193425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42208,0.0037544428576337,0.002955517117528,-0.00203837069272118,0.00954725640798858,0.203994539095355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41887,0.00841578062432167,0.00663351289715092,-0.00458590465409413,0.0214174659027375,0.204579802873673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,40097,0.00762572291509471,0.00602923191329791,-0.00419157163496919,0.0194430174651586,0.205973014761543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40080,-0.00755755594324224,0.0060208097536683,-0.0193583430604321,0.00424323117394763,0.209418912168414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42285,0.00747436362595357,0.00596035242211194,-0.00420792712138583,0.019156654373293,0.209859415781889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39706,-0.00570580571869951,0.00455315150636908,-0.0146299826711829,0.00321837123378388,0.210177084670252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39863,0.00680710141698509,0.0054383894938735,-0.00385214199100696,0.0174663448249771,0.210715403097592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,42013,0.006057832201192,0.00484317087920497,-0.00343478272204975,0.0155504471244337,0.211030730716956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,40020,0.00450598752686455,0.00360729760222278,-0.0025643157734921,0.0115762908272212,0.211644144417656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,40054,0.0065470357931609,0.00524921379595198,-0.00374142324690498,0.0168354948332268,0.212335960809991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,42105,0.0164965545213189,0.0132584124471114,-0.00948993387501938,0.0424830429176573,0.213436402598536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42213,0.00809807077814777,0.00651074697846526,-0.00466299329964414,0.0208591348559397,0.213595366632962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42296,0.00336487567946309,0.00270672998531882,-0.0019403150917618,0.00867006645068799,0.213834223671658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42146,-0.00299983427226376,0.00241724362953651,-0.00773763178615532,0.00173796324162779,0.214622887745569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41876,0.00757960262910999,0.00611725420691828,-0.00441021561644985,0.0195694208746698,0.2153487744262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39665,-0.00380251057569683,0.0030828962318423,-0.00984498719010775,0.00223996603871408,0.217446224419661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41861,0.00818418627281163,0.00665394107655322,-0.00485753823723269,0.0212259107828559,0.21872902270334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39706,0.00483057944477885,0.00392952708507983,-0.00287129364197762,0.0125324525315353,0.218985737045083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,41315,0.00617940192711331,0.00503125140432877,-0.00368185082537109,0.0160406546795977,0.219394332916265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39706,-0.00706395253635136,0.00575348273656861,-0.0183407787000258,0.00421287362732312,0.219560874607234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42004,-0.00356819101571101,0.00290641283672933,-0.0092647601757005,0.00212837814427847,0.219583718819481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39784,-0.00755816486842954,0.00615633684057035,-0.0196245850759474,0.00450825533908835,0.219585056435642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39674,0.0107187812233991,0.0087532882751685,-0.00643766379593117,0.0278752262427294,0.22077483631848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39665,-0.00710123954396729,0.00579973040398931,-0.0184687111357863,0.00426623204785176,0.220825688528777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39881,-0.00665836179249098,0.00543814806356087,-0.0173171319970703,0.00400040841208832,0.220835756249198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39706,-0.00561755994748771,0.0045905769309842,-0.0146150907322167,0.00337997083724133,0.22108701446993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42103,0.00707588895545277,0.00579069574009116,-0.00427387469512589,0.0184256526060314,0.221752224706231
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,42094,-0.00237245597607392,0.00194270777444531,-0.00618016321398672,0.00143525126183888,0.222028483792959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39665,-0.011780606934214,0.00966936172715532,-0.0307325559194385,0.00717134205101039,0.223120801025423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40054,0.00466328599850837,0.00382778059100806,-0.00283916395986743,0.0121657359568842,0.223146290153585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39784,0.00401708477001619,0.00329830724400433,-0.00244759742823229,0.0104817669682647,0.223280310270891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39804,0.00761519789026486,0.0062569807984823,-0.00464848447476045,0.0198788802552902,0.223603786270352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41829,0.0182856372230458,0.0150271036887641,-0.0111674860069319,0.0477387604530235,0.22368639887997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39784,0.00779855179609332,0.00641493726392721,-0.00477472524120401,0.0203718288333906,0.224131517516871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39881,0.00749169235525256,0.00619465082897759,-0.00464982326954352,0.0196332079800486,0.226543298453443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39768,-0.0125114792389991,0.0103574114495192,-0.0328120056800568,0.00778904720205851,0.227084446402532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41887,0.0067056112196636,0.00557738520055407,-0.00422606377342238,0.0176372862127496,0.229275231607072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39665,0.00705789767637526,0.00587723893816767,-0.00446149064243337,0.0185772859951839,0.229822344511476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,42144,0.00373727785786173,0.00311448272345494,-0.00236710828010995,0.0098416639958334,0.230173938300252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39706,0.00713864108423122,0.00594986433916208,-0.00452309302052646,0.0188003751889889,0.230244465841586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,42094,0.00847506812561385,0.0070739259245495,-0.00538982668650316,0.0223399629377309,0.230911244519736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42144,0.00521681692335465,0.004355707716681,-0.00332037020134011,0.0137540040480494,0.23105702079488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,40113,0.0028530552097814,0.00238336183470432,-0.00181833398623907,0.00752444440580187,0.231304563863815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39706,0.00658317170143942,0.00550117428192231,-0.0041991298911283,0.0173654732940071,0.231456417729628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42126,0.0356657859577259,0.0298629109368577,-0.0228655194785152,0.0941970913939671,0.232375846268665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39719,0.00737577726503221,0.00620424898204612,-0.00478455073977819,0.0195361052698426,0.234534663725481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40054,-0.00320159901588682,0.00269487324350527,-0.00848355057315714,0.00208035254138351,0.234846291451495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42144,0.00345043058100896,0.00290592494675476,-0.00224518231463036,0.00914604347664828,0.235100437147871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40054,0.00646306445844096,0.00546202844306923,-0.00424251128997473,0.0171686402068566,0.236727329943448
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40020,0.00497089949238746,0.00423479881325431,-0.003329306181591,0.0132711051663659,0.240492201369727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39665,-0.00883121782917475,0.00753442283237309,-0.023598686580626,0.0059362509222765,0.241177139396243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39804,-0.00612047781788262,0.00523203552061616,-0.0163752674382903,0.00413431180252506,0.242104458334191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42094,0.00511430384647905,0.00437844836337469,-0.00346745494573535,0.0136960626386934,0.242802911558184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42103,-0.00568547787180161,0.00486879831306198,-0.0152283225654031,0.00385736682179987,0.24293427407124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39804,0.00651247310542914,0.00558363514952737,-0.0044314517876445,0.0174563979985028,0.243499163009829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,40054,0.0113244568461617,0.00972888735855477,-0.00774416237660563,0.0303930760689291,0.244448251781609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,40020,0.00307337072695618,0.00264678737358295,-0.0021143325252664,0.00826107397917876,0.245598276936075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,40020,0.00536685422423551,0.00462708778353314,-0.00370223783148943,0.0144359462799605,0.246124332814962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41876,-0.00696211522772684,0.00600613422281236,-0.0187341383044391,0.00480990784898539,0.246409765701369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,42144,0.00437527530889727,0.00377537061044348,-0.00302445108757196,0.0117750017053665,0.246518500815181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,42004,0.00298375383864719,0.00258243001297398,-0.00207780898678181,0.00804531666407618,0.247945961234458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39706,-0.00549158848036914,0.00475502411179481,-0.014811435739487,0.00382825877874869,0.248156672429349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39665,0.00925643412026158,0.00802023901833479,-0.00646323435567461,0.0249761025961978,0.248471393508035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40054,0.00698849987503653,0.00607195511047578,-0.00491253214149599,0.0188895318915691,0.249779288491108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39665,0.00702773497806063,0.00614264627997813,-0.00501185173069652,0.0190673216868178,0.25261281868952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,40054,0.00555204609059702,0.0048533831128123,-0.0039605848105151,0.0150646769917091,0.252668008083113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39768,0.00794038318157196,0.00700199939788758,-0.0057835356382877,0.0216643020014316,0.256813315361183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,40054,0.0043862267483578,0.00390600919541401,-0.00326955127465367,0.0120420047713693,0.261486411979263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39768,-0.009479575240834,0.00846291185117979,-0.0260668824691464,0.00710773198747839,0.262683114857999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39768,-0.00887843276851992,0.00794294532078389,-0.0244466055972563,0.0066897400602165,0.263688116467851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39706,-0.00604551955018581,0.00543448105272478,-0.0166971024135264,0.00460606331315476,0.265975604155781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39706,-0.00377798405527858,0.00341818388083191,-0.0104776244617091,0.00292165635115197,0.269071969575523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42122,0.00900386981930514,0.00815078951504598,-0.00697167763018499,0.0249794172687953,0.269326507572124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39881,-0.0074229523932551,0.00672168794057322,-0.0205974607567786,0.00575155597026841,0.269475473560996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41861,-0.0070483015920849,0.00638289677341094,-0.0195587792679703,0.00546217608380054,0.269506507942964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39784,-0.00622820859417836,0.0056428409910532,-0.0172881769366426,0.00483175974828591,0.269732611122973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,42094,0.00513048613540607,0.0046606429792705,-0.00400437410396411,0.0142653463747762,0.270999549543053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40054,0.00399933076391694,0.00363371436708913,-0.00312274939557775,0.0111214109234116,0.271087423562745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39784,-0.00322065139095104,0.00292790421064111,-0.00895934364380762,0.00251804086190554,0.271363560382617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39863,0.00320959921908138,0.00291942299661563,-0.00251246985428526,0.00893166829244801,0.271620591608686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39706,0.00365488589575558,0.00332510342478477,-0.00286231681682257,0.0101720886083337,0.271714902283581
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39881,-0.00919688640436178,0.0083680972068124,-0.0255983569297141,0.00720458412099051,0.271774707126814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41861,0.003919616643494,0.00357451832521956,-0.00308643927393634,0.0109256725609243,0.272861622340387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40054,-0.0127119601647511,0.0116048342784149,-0.0354574353504444,0.0100335150209422,0.273364794085991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41887,0.00383814682603778,0.00350596926938655,-0.00303355294195985,0.0107098465940354,0.273648578665926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39700,-0.00377342137011553,0.00345243076854953,-0.0105401856764726,0.00299334293624155,0.274429728942235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39665,-0.00316872554282356,0.00290402042796074,-0.00886060558162662,0.00252315449597949,0.27523143829607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39719,0.00377553756975332,0.00346039395795257,-0.00300683458783372,0.0105579097273404,0.275266355082832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,42296,0.00600925124486527,0.00551623041368996,-0.00480256036596704,0.0168210628556976,0.276007968990019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39986,-0.00473004528301909,0.00434329285974781,-0.0132428992881248,0.00378280872208663,0.276157962912193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41887,0.00494071604778764,0.00454045252182173,-0.00395857089498295,0.0138400029905582,0.276547353884575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39881,0.0082228534631517,0.00758015565657092,-0.00663425162372731,0.0230799585500307,0.278040524554748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39719,0.00391547692292696,0.00361034758312782,-0.00316080434000357,0.0109917581858575,0.278161261246286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39863,0.0074728414887075,0.00689198546244749,-0.00603545001768958,0.0209811329951046,0.278265204066812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39804,0.0292173728705963,0.0271789028780624,-0.0240532767704061,0.0824880225115986,0.282398312501735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42094,0.00425698090785014,0.00396817626154832,-0.00352064456478457,0.0120346063804849,0.283389816096402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40102,0.0070058484601714,0.00655639414933113,-0.00584468407251763,0.0198563809928604,0.285295207313917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39665,0.00699791548453542,0.00655160749822342,-0.00584323521198249,0.0198390661810533,0.285490149694642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39719,0.00476528608755243,0.00447393069397427,-0.00400361807263714,0.013534190247742,0.286844746034583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,40021,0.00368345589749292,0.0034607946032376,-0.00309970152485277,0.0104666133198386,0.28719925495885
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41876,-0.012229686787979,0.0115380848068347,-0.0348443330093751,0.010384959433417,0.289191720767268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39768,0.00447421336328604,0.00423558815151478,-0.00382753941368293,0.012775966140255,0.290837884272065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42076,0.00807093882170521,0.00765864335686519,-0.00694000215775057,0.023081879801161,0.291978685955637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42296,0.00341850502433407,0.00324791194490023,-0.00294740238767037,0.00978441243633851,0.292578650859177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41829,-0.00452794234859866,0.00430558435700664,-0.0129668876883317,0.00391100299113436,0.292982982876422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,42103,-0.00466988277096171,0.00444612139220063,-0.013384280699675,0.00404451515775153,0.2935873100658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42144,0.00419988894804943,0.00400053435547092,-0.00364115838867358,0.0120409362847724,0.293814955024642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41876,-0.00252380205383463,0.00241009480062046,-0.00724758786305074,0.00219998375538148,0.295036719845643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41633,0.00514043365465962,0.00492096186469949,-0.00450465160015138,0.0147855189094706,0.296228470997498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,40054,-0.00646310449935055,0.00620440711261449,-0.018623742440075,0.00569753344137386,0.297575950571061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40054,-0.00447998763986035,0.00431150247613364,-0.0129305324930823,0.00397055721336159,0.298791565765275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39706,0.0103908086984964,0.0100126063760717,-0.0092338997986041,0.0300155171955969,0.299399799365589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,40054,0.00498931350171355,0.00481374702353405,-0.00444563066441319,0.0144242576678403,0.300005121815346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41829,0.00640670181322235,0.00619434080109696,-0.00573420615692769,0.0185476097833724,0.30102364490337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,40020,-0.008029952871016,0.00778945294153395,-0.0232972806364225,0.00723737489439054,0.30262243660815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40054,0.00334559539575527,0.00325682510210755,-0.00303778180437553,0.00972897259588607,0.304322486297727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39719,-0.00327335325093036,0.00318909085682379,-0.00952397133030498,0.00297726482844427,0.304716266324067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41876,-0.00735869596208443,0.00719024471195257,-0.0214515755975115,0.00673418367334261,0.306125165832357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,40097,0.00424137169537753,0.00414534726011077,-0.00388350893443958,0.0123662523251946,0.306252827736904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41861,0.00667716357617211,0.00653380365773011,-0.0061290915929789,0.0194834187453231,0.306828216701528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,40054,-0.0022889953720231,0.00223990133564585,-0.00667920198988897,0.00210121124584277,0.306842501161161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39719,-0.00515806825812801,0.00504863146300169,-0.0150533859256113,0.00473724940935529,0.306957506755279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,40113,0.0020901372091759,0.00204936562514272,-0.00192661941610384,0.00610689383445563,0.30780098365035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,42101,0.00255297698180723,0.00250365164067571,-0.00235418023391717,0.00746013419753163,0.307889229193991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40054,0.00407922463266956,0.00400880932654441,-0.00377804164735749,0.0119364909126966,0.308907328123672
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40054,0.00715246079763337,0.00707153689853967,-0.00670775152350438,0.0210126731187711,0.311826692183063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40020,0.00526986935080391,0.00521712098453501,-0.00495568777888471,0.0154954264804925,0.312464866371052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39768,0.00721835985482081,0.00714828927597597,-0.00679228712609208,0.0212290068357337,0.312613063684441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39768,0.00435141847694438,0.00431756209375247,-0.00411100322681045,0.0128138401806992,0.313553596675934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39784,-0.00339414806485694,0.00336916017248174,-0.00999770200292115,0.00320940587320728,0.313757609159519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39719,-0.00915720139633353,0.00910219456639198,-0.0269975027464618,0.00868309995379475,0.314417894071057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42262,0.0046107590760899,0.00460402674776854,-0.00441313334953644,0.0136346515017162,0.316621915365492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39865,-0.0100111651848623,0.010006459861251,-0.0296238265129142,0.00960149614318971,0.317105683928201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42103,-0.00784047014095076,0.00784896273520878,-0.02322443710196,0.00754349682005844,0.317853140503259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41887,0.00321373893400665,0.00322008406122654,-0.00309762582599736,0.00952510369401066,0.318284072082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41861,0.00413214820820125,0.00414476773998031,-0.00399159656216016,0.0122558929785627,0.318805246346523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39706,-0.00522054836865451,0.00523689566287633,-0.0154848638678921,0.00504376713058309,0.318846464883785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39881,0.00562733286679813,0.0056589684159417,-0.00546424522844759,0.0167189109620439,0.320045980535603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39665,0.0041005369442654,0.00414084483147331,-0.00401551892542229,0.0122165928139531,0.322067109194969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39706,-0.00950102427144564,0.00961792830319705,-0.0283521637457118,0.00935011520282057,0.323251205461703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39719,0.00734400712990128,0.0074348941093652,-0.00722838532445452,0.0219163995842571,0.323285257534688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39768,0.00601964299926884,0.00610816295299816,-0.00595235638860756,0.0179916423871452,0.324397189492344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,42004,-0.0040855726460966,0.00414659343672577,-0.0122128957820791,0.00404175048988592,0.324503141885492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41813,-0.00708601087661078,0.00722382228353468,-0.0212447025523387,0.00707268079911718,0.32664969396575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39706,-0.00476937862455519,0.0048652107773219,-0.0143051917481061,0.00476643449899574,0.326959347154821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,42094,0.00921007283764839,0.00940092208876278,-0.00921573445632666,0.0276358801316234,0.327253151839926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39768,0.00226051312134203,0.00233844589464302,-0.00232284083215829,0.00684386707484235,0.33372950584065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39719,-0.00313521736481581,0.00325183014566767,-0.00950880445032445,0.00323836972069282,0.334998223587204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40020,0.00739973975438765,0.00768255602361066,-0.00765807005188924,0.0224575495606645,0.335475092240919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40021,0.00481476513662896,0.00500086438481905,-0.00498692905761639,0.0146164593308743,0.335676136863555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39706,0.00744550126918445,0.00776331376597134,-0.00777059371211937,0.0226615962504883,0.337549437210057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39706,-0.00416935070680974,0.0043588128838654,-0.0127126239591859,0.00437392254556643,0.338824745931253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39881,0.00680693835382083,0.00713004859388292,-0.00716795689018969,0.0207818335978313,0.33975946850381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41861,-0.00442476608126036,0.0046357355989643,-0.0135108078552304,0.00466127569270967,0.339853576346237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39706,0.00649695913681402,0.00681259876406376,-0.00685573444075096,0.019849652714379,0.340273525141192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39804,-0.00225677561967799,0.00237137727704349,-0.00690467508268324,0.00239112384332725,0.341284548000081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39665,0.00560684629490053,0.00590242126658193,-0.00596189938760006,0.0171755919774011,0.342173253283826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,42296,0.00480739641096978,0.0050678064500531,-0.00512550423113429,0.0147402970530739,0.342834036150753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39706,-0.00356154474098816,0.00376032070873769,-0.010931773330114,0.00380868384813771,0.343589949480747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39651,-0.00340922723822383,0.00360255356931421,-0.0104702322340797,0.00365177775763202,0.343998947357083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39706,-0.00344886871543806,0.00364691564587898,-0.0105968233813609,0.00369908595048473,0.344326074567639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,42122,0.00349403204823011,0.00370022064532274,-0.00375840041660246,0.0107464645130627,0.345045928640248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39719,-0.004892340574203,0.00518126194444223,-0.0150476139853098,0.00526293283690377,0.345070094082802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41984,-0.00309152391794338,0.003291721797496,-0.00954329864103555,0.00336025080514878,0.347655347738645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39784,-0.00288490272788496,0.0030787079251338,-0.00891917026114722,0.00314936480537729,0.348754296894951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39665,0.00322798680522053,0.00344946108081097,-0.00353295691316897,0.00998893052361004,0.349400570158927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39651,0.00819842824612561,0.00876666772616168,-0.00898424049715129,0.0253810969894025,0.349716202785726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41661,0.00565320314808347,0.00607102083733876,-0.0062459976931005,0.0175524039892674,0.35177934764086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39719,0.00355825200902924,0.00382245277366144,-0.00393375542734717,0.0110502594454057,0.351936021391597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39665,-0.00515667459572336,0.00554396921518282,-0.0160228542574817,0.00570950506603496,0.352319385197902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39706,0.00460027765974162,0.00494922425574816,-0.00510020188152477,0.014300757201008,0.352654119723784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39768,-0.00373958622819679,0.00402384131527019,-0.0116263152061264,0.00414714274973278,0.35272517312455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39768,-0.00347527485934734,0.00374004016514922,-0.0108057535830398,0.00385520386434513,0.352802566485284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39665,0.00489850249145715,0.00529895192301047,-0.00548744327764337,0.0152844482605577,0.355284533628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41861,0.00779719682574882,0.00845635448132927,-0.00877725795765654,0.0243716516091542,0.356519120814345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42094,-0.00931696137999782,0.0101427907199777,-0.0291968311911542,0.0105629084311585,0.358332642744677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42004,0.00540281777247322,0.00589751551160332,-0.00615631263026929,0.0169619481752157,0.359622461640887
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39784,-0.00815104777416547,0.00891560890797009,-0.0256256412337868,0.0093235456854559,0.360609120411744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39961,0.0040759264538194,0.00446824670347194,-0.0046818370849856,0.0128336899926244,0.361684831861645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39719,0.00522946942922676,0.00573463344160901,-0.0060104121163269,0.0164693509747804,0.361836996740744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40021,-0.0160479788114182,0.0176121249306421,-0.0505677436754768,0.0184717860526403,0.362215955968895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,40097,-0.00894321395542765,0.00981845785624993,-0.0281873913536775,0.0103009634428222,0.362390706376576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40054,0.00257828817785729,0.00283203198203241,-0.00297249450692624,0.00812907086264081,0.36263063767247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39665,-0.00238516282623158,0.0026275889219373,-0.00753523711322868,0.00276491146076553,0.364037448808096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,42081,0.00260030118243882,0.00286765451625045,-0.00302030166941207,0.00822090403428971,0.364545742635829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40085,-0.0100059679941888,0.0110370506995329,-0.0316385873652733,0.0116266513768957,0.364649067223567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39768,-0.0050576647357822,0.00559200060462502,-0.0160179859208472,0.00590265644928283,0.365779356830941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41876,0.00440390012804064,0.00487076212617349,-0.00514279363925941,0.0139505938953407,0.365932983035289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39804,0.00733063404328321,0.00810777017892731,-0.00856059550741432,0.0232218635939807,0.365936813083515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39784,0.00584900437899024,0.0064709468208867,-0.00683405138994769,0.0185320601479282,0.36607591073508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40102,-0.0023988463182511,0.00265870674977805,-0.00760991154781608,0.00281221891131387,0.366938378122576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41876,0.00759646099513567,0.00844085948963989,-0.00894762360455851,0.0241405455948298,0.368157044287075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41861,-0.00773647857026906,0.00861162714944445,-0.0246152677831802,0.00914231064264207,0.369002238810589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39665,-0.0106367453207645,0.0118442497821188,-0.0338514748937173,0.0125779842521884,0.369178785989907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39881,-0.00632673623547328,0.00707445449785286,-0.0201926670512649,0.00753919458031834,0.371177639792934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39764,0.00344209182078096,0.0038494443375371,-0.00410281908079176,0.0109870027223537,0.371246550563318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41854,0.00663903780025975,0.00746087289489445,-0.00798427307373338,0.0212623486742529,0.373564778890667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39227,-0.00490154176343482,0.00550978096543347,-0.0157007124556844,0.00589762892881477,0.373698076013106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41887,0.0034300835834147,0.00389048387066527,-0.00419526480308923,0.0110554319699186,0.377977452143868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39804,-0.00749835969346893,0.00850881095025525,-0.0241756291559692,0.00917890976903136,0.37820438931246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39784,0.00503857477390022,0.0057194488111948,-0.00617154489604159,0.016248694443842,0.378362382552722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39719,-0.00535600923424965,0.00608629025116056,-0.0172851381265244,0.00657311965802505,0.378872831968716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41829,-0.00370040430100567,0.00421119985684847,-0.0119543560204287,0.00455354741841732,0.379577708017908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40097,0.00288500767329404,0.00329298366505709,-0.00356924031021786,0.00933925565680593,0.380990899194454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39784,-0.00279256241120106,0.00320148126116968,-0.00906746568309362,0.00348234086069151,0.383079793403929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40021,0.00667355258029485,0.0076623070259554,-0.00834456919057774,0.0216916743511674,0.383796042086205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39719,-0.00444381505835965,0.00512387246451561,-0.0144866050888102,0.00559897497209094,0.38581020730981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39665,0.00481383295928834,0.00557070491887975,-0.00610474868171597,0.0157324146002926,0.38753433053225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39719,-0.00559692826167668,0.00648866229269462,-0.0183147063553581,0.00712084983200478,0.388393344174484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42120,0.00259043754381682,0.00301002895884024,-0.00330921921551006,0.00849009430314369,0.389473136055607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39784,-0.00368293493145337,0.00429005777968309,-0.0120914481796322,0.00472557831672549,0.390646110786013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39706,-0.00615177411733894,0.0071720740974831,-0.0202090393484058,0.00790549111372794,0.391055657888402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40021,0.00491382794301339,0.00573024015626978,-0.00631744276327538,0.0161450986493022,0.391173423582788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39804,0.00372257726191616,0.00434942702307551,-0.00480229970331184,0.0122474542271442,0.392084801314316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40020,0.00314382869048055,0.00368047013895425,-0.00406989278186977,0.0103575501628309,0.393017434154476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40102,-0.00322992664996059,0.00378768191704042,-0.0106537832073598,0.00419392990743863,0.393819477635892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39863,0.0047972865799662,0.00564265786490866,-0.00626232283525478,0.0158568959951872,0.395242943443032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42178,0.00504728553070013,0.00596167970660179,-0.00663760669423938,0.0167321777556396,0.397221793691068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,42110,0.008772781881192,0.0103853299679482,-0.0115824648559865,0.0291280286183705,0.398278214589555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39665,-0.00359527293145329,0.00426675542467913,-0.0119581135638244,0.00476756770091781,0.3994576942661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41968,-0.00351650913407385,0.00417737347995617,-0.0117041611547879,0.00467114288664025,0.399916188299389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,42144,0.00597608017218961,0.00710202163568488,-0.00794388223375276,0.019896042578132,0.40010479362588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39706,-0.00502155842682529,0.00596802064869372,-0.016718878898265,0.0066757620446144,0.400136845922056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42094,0.00180373300866104,0.00214475886769292,-0.00239999437201707,0.00600746038933916,0.400365925491197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,42004,-0.00357120122078056,0.00425575556041665,-0.0119124821191972,0.00477007967763608,0.401402917262386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,42186,-0.00331135198451096,0.00397278844337119,-0.0110980173335185,0.00447531336449656,0.404573464235891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39768,0.00251207656126501,0.00301825183232042,-0.00340369703008301,0.00842785015261303,0.405261126461648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42256,0.00289765200297678,0.00348513350789003,-0.00393320967248767,0.00972851367844124,0.405744748411561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39719,0.00234830385670703,0.00282804180375857,-0.00319465807865978,0.00789126579207384,0.406351897099649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39784,-0.00457205601914833,0.00550790460105164,-0.0153675490372095,0.00622343699891288,0.406506664898927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41861,-0.0105691004105709,0.0127573229888978,-0.0355734534688107,0.0144352526476689,0.407418166465708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39706,0.00595122281929628,0.00718387614415428,-0.00812917442324611,0.0200316200618387,0.407454947790236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39768,0.00505333293514575,0.00611821521373608,-0.00693836888377696,0.0170450347540685,0.408851732104724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,40020,-0.009101549531087,0.0110520127286984,-0.0307634944793358,0.0125603954171618,0.410230694422644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39719,0.00697560262841131,0.00850786816590883,-0.00969981897677,0.0236510242335926,0.412291581625847
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41887,-0.00392728740403532,0.00479157818458658,-0.013318780645825,0.00546420583775439,0.412446480980129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39863,0.00441329892714089,0.00539111023609574,-0.00615327713560676,0.0149798749898885,0.413018544098286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39706,0.00955172847260117,0.0116797919538461,-0.0133406637569371,0.0324441207021395,0.413490197177474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41876,0.00433112023218264,0.00531267884887699,-0.00608173031161625,0.0147439707759815,0.414948970518296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41876,0.00310509608579262,0.00382176821665712,-0.00438556961885534,0.0105957617904406,0.416533633319957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39665,-0.0062569155393904,0.00770120474663282,-0.0213512768427907,0.00883744576400993,0.416546592867275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40020,0.00304918395914177,0.0037588297445514,-0.00431812234017896,0.0104164902584625,0.417265410075038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39665,-0.00298748606418565,0.00368830192508965,-0.0102165578373614,0.00424158570899006,0.417964581146246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42103,-0.00414570221325935,0.00512123232652816,-0.0141833175732545,0.00589191314673584,0.418235265595647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39784,0.00403803544289123,0.00499671878976118,-0.00575553338504069,0.0138316042708231,0.419029629487892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,42135,0.00534821508917391,0.00663212475730809,-0.00765074943514995,0.0183471796134978,0.420021009308787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39863,-0.0074520809492487,0.00929470269467226,-0.0256696982308063,0.0107655363323089,0.422712139940346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,40055,-0.00207172566693569,0.00258608638597451,-0.00714045498344572,0.00299700364957434,0.423088625226454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39706,-0.00560080694939221,0.00699472522370295,-0.01931046838785,0.00810885448906556,0.423312638600375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39706,0.00351048681104201,0.0043886032081449,-0.00509117547692199,0.012112149099006,0.423781122140915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,40021,0.0048785154229429,0.00609983386629495,-0.00707715895499519,0.016834189800881,0.423856741112685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39706,0.00801960602793639,0.0100315846968173,-0.0116422999778255,0.0276815120336983,0.42405593246754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39719,0.00656502737059829,0.00822727629694187,-0.00956043417140777,0.0226904889126043,0.424912412809501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39784,-0.00328890282287422,0.00414511744656438,-0.0114133330181404,0.00483552737239196,0.427539172888586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39665,0.00631743441029212,0.00796347712431994,-0.00929098075337497,0.0219258495739592,0.42762044628458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,40054,0.00180192864164488,0.00227217592176033,-0.00265153616500536,0.00625539344829512,0.427771266500006
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39768,-0.00384456111175496,0.00484941773033283,-0.0133494198632073,0.00566029763969739,0.427919024517367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39867,-0.00400443326573229,0.0050661943861894,-0.0139341742626635,0.00592530773119894,0.429298716440112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41829,0.00462779445427342,0.00585615135345488,-0.00685026219849815,0.016105851107045,0.429399518550898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39863,0.00276302115126,0.00350842984483952,-0.00411350134462546,0.00963954364714546,0.430984599723444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39719,0.00507664442526416,0.00644804856935973,-0.00756153077068091,0.0177148196212092,0.431115304351554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39706,0.0066443362427487,0.00845835812254812,-0.00993404567744562,0.023222718162943,0.432157669592876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39784,-0.00426436341530603,0.00543232836925917,-0.014911727019054,0.00638300018844194,0.43247267826358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41887,0.00593288702806816,0.00759551638315888,-0.00895432508292325,0.0208200991390596,0.43475599015594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,42144,0.00498424969899309,0.00638252738624498,-0.00752550397804707,0.0174940033760333,0.434863232025656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39881,-0.00634492075172665,0.0081251217719266,-0.0222701594247028,0.00958031792124948,0.434877656296616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39804,0.00368064647087829,0.00471696212108864,-0.00556459928645544,0.012925892228212,0.43523160408501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39665,-0.0048515241911555,0.00622756508369517,-0.017057551755198,0.00735450337288702,0.435973579131795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39706,-0.00337773253186831,0.00435502804245612,-0.0119135874950823,0.00515812243134569,0.438006339282037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39706,-0.00246981266569551,0.00318921176561319,-0.00872066772629736,0.00378104239490635,0.438695560460684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39881,-0.00571123760865085,0.00739537964185283,-0.0202061817066824,0.0087837064893807,0.439970984785523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39719,-0.00270390266026305,0.0035156259200988,-0.0095945294636567,0.0041867241431306,0.441845336786574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41985,-0.00564478953504398,0.0073430231931907,-0.0200371149936977,0.00874753592360979,0.442068830312141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41841,0.00377854595467117,0.00492316303198062,-0.00587085358801084,0.0134279454973532,0.442796408928506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39646,0.0020482550758848,0.00266939401433156,-0.00318375719220506,0.00728026734397466,0.442914032131038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,40054,-0.00286592457975238,0.00374077602876406,-0.0101978455961299,0.00446599643662519,0.44361499480358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42068,0.00270156266106068,0.00352915462283026,-0.00421558039968662,0.00961870572180798,0.443988777211563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,42144,-0.00361183831070537,0.0047298333823155,-0.0128823117400438,0.00565863511863301,0.445102226725042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42213,0.00493810325494366,0.00649762354997391,-0.0077972389030052,0.0176734454128925,0.447276685289722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39706,0.00853923469230999,0.0112436467337908,-0.0134983129059199,0.0305767822905399,0.447587297391049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39466,0.00937296864905838,0.0124270143829613,-0.0149839795415457,0.0337299168396625,0.450721575816299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41876,0.00466031594756729,0.00621529248367336,-0.0075216573204325,0.0168422892155671,0.453380389916327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39881,0.00645222590756446,0.00861489832168951,-0.010432974802947,0.0233374266180759,0.453896982737392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39863,0.00556259163417129,0.00744209374917039,-0.00902391211420268,0.0201490953825453,0.454808555033029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39706,-0.0027486968631464,0.00367889823687296,-0.00995933740741739,0.0044619436811246,0.45498841291654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39706,-0.0034067409572194,0.00456027044237937,-0.012344871024283,0.00553138910984417,0.455051289946769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,42103,0.00291366264310915,0.00390194854997172,-0.00473415651483542,0.0105614818010537,0.455246252254177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42094,0.00195628756369463,0.00262796475040315,-0.00319452334709555,0.0071070984744848,0.456641035858741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39784,0.00163534083463605,0.0021988036388426,-0.00267431429749544,0.00594499596676754,0.457049565683923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42094,0.00176367965687949,0.00237640576888367,-0.0028940756501325,0.00642143496389149,0.458002293854701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42122,-0.0035326269984043,0.00477159996966802,-0.0128849629389536,0.00581970894214502,0.45910453175697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42004,-0.00270151133968355,0.00364949506042112,-0.00985452165810895,0.00445149897874185,0.45916643155565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40054,0.00499295797570843,0.00675783739684419,-0.00825240332210617,0.018238319273523,0.460020361063685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39707,-0.00732660638173486,0.00992767042557572,-0.0267848404158633,0.0121316276523935,0.460531802650117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39665,0.00311912435089939,0.00425321327501664,-0.00521717366813324,0.011455422369932,0.463357046851626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40054,-0.00361884065020959,0.00493513945946365,-0.0132917139907583,0.00605403269033917,0.463403302538359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41887,0.00240846893713079,0.00328731418365146,-0.00403466686282607,0.00885160473708765,0.463782078126659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41829,-0.00492502735406433,0.00672647496854444,-0.0181089182924114,0.00825886358428277,0.464068941779117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,40054,0.00456926904079375,0.00627731031513585,-0.00773425917687251,0.01687279725846,0.466689046829914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40054,0.00546562535963588,0.00751726930106146,-0.00926822247044459,0.0201994731897163,0.467195132263981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39784,-0.00214273310064117,0.00294818544665901,-0.00792117657609284,0.0036357103748105,0.46736622743704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39665,-0.0067423349990392,0.00932193744029205,-0.0250133323820116,0.0115286623839332,0.469526399854964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39719,-0.00295013003728946,0.00408015024508724,-0.0109472245176605,0.00504696444308154,0.469668635624991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,40054,-0.00211638515956321,0.00293414616185971,-0.00786731163680824,0.00363454131768181,0.470743517376439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39719,-0.00412728813489108,0.0057364539050264,-0.0153707377887428,0.00711616151896067,0.471858588753466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39768,0.00260273573389553,0.00362236641436235,-0.00449710243825467,0.00970257390604573,0.472453784648306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42144,-0.00238689851323183,0.00332396324510958,-0.0089018664736466,0.00412806944718294,0.472715909707511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39706,0.00293226459493285,0.00408834964155689,-0.00508090070251864,0.0109454298923843,0.473251510273886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39784,-0.00310562652970894,0.00433820144756361,-0.0116085013669336,0.00539724830751574,0.474081962255461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39768,-0.00271969553881059,0.00380946707379822,-0.0101862510034551,0.00474685992583391,0.475285783419999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39804,0.00523661335703951,0.00735538243474645,-0.00917993621506354,0.0196531629291426,0.476515699933068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42103,0.00348399190465532,0.0048946881456441,-0.0061095968608071,0.0130775806701178,0.47660745709168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39999,0.00381883960237067,0.00536698952027424,-0.00670045985736684,0.0143381390621082,0.476763662659834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40020,0.00332434734250483,0.0047068932886037,-0.00590116350315843,0.0125498581881681,0.480034147712886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39784,-0.00589558510219079,0.00837029750506679,-0.0223013682121217,0.0105101980077401,0.481232848608656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42004,0.00166755021928723,0.00237607793053696,-0.00298956252456521,0.00632466296313967,0.482811732925584
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41861,0.00324033438883032,0.0046200405696469,-0.00581494512767759,0.0122956139053382,0.483088192499206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40000,0.00194814646381066,0.00279178125544075,-0.0035237447968532,0.00742003772447452,0.485307994934437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41861,-0.00254746920138829,0.00365974082963906,-0.00972056122748086,0.00462562282470427,0.486392048809849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39902,-0.00396068597968786,0.0057008251401543,-0.0151343032543903,0.00721293129501456,0.4872229151538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41727,0.00482319430164379,0.00694762829967805,-0.00879415716572519,0.0184405457690128,0.487556056026299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42122,0.00790655616616368,0.0114127720467895,-0.0144624770455437,0.030275589377871,0.488459192356813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41887,0.00325679806867798,0.00471374854888715,-0.00598214908714083,0.0124957452244968,0.489631795062637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,40020,0.00385235240626933,0.00558746714959552,-0.0070990832069379,0.0148037880194765,0.490546665517691
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39784,0.0030933099287225,0.00449653015566205,-0.00571988917637511,0.0119065090338201,0.491510258736609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41702,-0.005922535686195,0.00862861265493804,-0.0228346164898736,0.0109895451174835,0.492484151654453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41829,0.00326338696725662,0.00475708822821913,-0.00606050596005288,0.0125872798945661,0.492722455559405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39768,0.00352656626094413,0.00514776269642271,-0.00656304862404438,0.0136161811459326,0.493316179863177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,42296,-0.00206045642921761,0.00301279062544342,-0.00796552605508671,0.00384461319665149,0.49404853935943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,40102,0.00153440589781077,0.00224549283082977,-0.00286676005061559,0.00593557184623713,0.494414745158716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39665,0.00279028000115224,0.00409049537006186,-0.00522709092416899,0.0108076509264735,0.495167142799506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39606,-0.00268023365427559,0.00393266685965726,-0.0103882606992038,0.00502779339065264,0.495550832743836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39706,-0.00447701494632904,0.00658029423717236,-0.0173743916511869,0.00842036175852878,0.496287104601642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40054,-0.00304251062903792,0.00449077123833609,-0.0118444222561767,0.00575940099810081,0.498101350185076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,40054,0.00248390871708002,0.0036719565143715,-0.00471312605108812,0.00968094348524817,0.498767013605644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,40054,-0.00240705412716434,0.00356617678002089,-0.00939676061600528,0.0045826523616766,0.499710657826905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39784,0.00190001938115054,0.00281579151269357,-0.00361893198372885,0.00741897074602994,0.499834886661865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39881,-0.00275412513921165,0.00408297864815653,-0.0107567632895985,0.00524851301117516,0.499983787968451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39653,0.00297308786024002,0.00443074383710664,-0.005711170060489,0.011657345780969,0.502226901092843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41861,0.00388851887682821,0.00581188157058106,-0.00750276900151067,0.0152798067551671,0.50346705007494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41861,0.00350787035818831,0.00525688987485993,-0.00679563379653715,0.0138113745129138,0.504599030139037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41876,0.00519802911200909,0.00783694898066227,-0.010162390890089,0.0205584491141071,0.507168398039512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,40021,0.00205400174473484,0.00310992902351955,-0.00404145914136347,0.00814946263083315,0.508969012960929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39831,0.00564635464639031,0.00856539856468271,-0.0111418265403878,0.0224345358331684,0.509778325381089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42071,0.00448638628571268,0.00680585812939819,-0.00885309564790777,0.0178258682193331,0.50978247356396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41829,-0.00428548885266088,0.00650728809439245,-0.0170397735176701,0.00846879581234831,0.510185498992731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41829,0.00352691387464739,0.00536169612111277,-0.00698201052273363,0.0140358382720284,0.510679816680714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39665,-0.00333942844044965,0.00507675493299234,-0.0132898681091146,0.00661101122821534,0.510688830445588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40054,0.00352424034595111,0.00537402670605875,-0.00700885199792403,0.0140573326898263,0.511972261073574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40054,0.00270310270485726,0.00412765860232952,-0.0053871081557086,0.0107933135654231,0.512561751808112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40083,-0.00489195112011798,0.00748559573197522,-0.0195637187547894,0.00977981651455346,0.513437947076361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,42004,-0.000786914640787806,0.00120607083244007,-0.00315081347237034,0.00157698419079473,0.514115286021724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39719,0.00638520711910333,0.00978823157168257,-0.0127997267613945,0.0255701409996012,0.5141992612262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39881,-0.00519567881830573,0.00802758692211065,-0.0209297491856426,0.0105383915490311,0.517498310655341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39768,0.00344918823831323,0.00532940155791441,-0.00699643881519901,0.0138948152918255,0.517516615363191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39706,-0.00380967003858068,0.00590909097054074,-0.0153914883408405,0.00777214826367917,0.519127009712187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39665,0.00269584665944309,0.00420952879126383,-0.00555482977143401,0.0109465230903202,0.521916649637564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39719,-0.00267511805377627,0.00419871032881999,-0.0109045902982634,0.00555435419071091,0.524054997459046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39665,0.00533719170748611,0.00838076950257511,-0.0110891165175611,0.0217634999325333,0.524244353703662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39784,-0.00470080450225679,0.00739256166418726,-0.0191902253640638,0.00978861635955025,0.524866406205282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41829,-0.00254285707709854,0.0040025549833152,-0.0103878648443963,0.00530215069019926,0.525238756451593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39784,0.00270325701062839,0.00426232558913871,-0.00565090114408347,0.0110574151653403,0.52595020981329
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39881,-0.00442548894652796,0.00698130579284199,-0.0181088483004983,0.00925787040744233,0.526155987443728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39665,0.00170854178170029,0.00269932252068337,-0.00358213035883911,0.0069992139222397,0.526778764337246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,40020,-0.0022594077691715,0.00358941387825133,-0.00929465897054411,0.0047758434322011,0.529058439331994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41787,-0.0056399948647208,0.00897642144846405,-0.0232337809037103,0.0119537911742687,0.52981085349623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,40021,0.00454311022462234,0.00725147338428352,-0.00966977760857336,0.018755998057818,0.530994625761002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39804,0.00266998877755152,0.00426761435358848,-0.00569453535548191,0.011034512910585,0.531564778439384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,40102,0.00362894999060281,0.00582554265170896,-0.00778911360674674,0.0150470135879524,0.533338502569155
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41829,0.00255897661406049,0.00412263275628016,-0.00552138358824863,0.0106393368163696,0.534798893415995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41887,0.00183863765252938,0.00299241800047871,-0.00402650162840888,0.00770377693346765,0.538940847397625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39784,0.00178873672279454,0.00291120317172869,-0.00391722149379368,0.00749469493938276,0.538943019063496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42197,-0.00186437627640442,0.0030357914923475,-0.00781452760140553,0.00408577504859668,0.539138940504266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39719,-0.00481081754379798,0.00784237657479737,-0.0201818756304008,0.0105602405428049,0.539599538620331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39768,-0.00206329810511647,0.00336994989204563,-0.0086683998935259,0.00454180368329297,0.540376445023442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39768,-0.00195415340718426,0.00319473399963122,-0.00821583204646145,0.00430752523209293,0.540762955178402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39804,0.00269104525929976,0.00441275018032067,-0.00595794509412875,0.0113400356127283,0.54198481124739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39665,-0.00254239470305259,0.00417688190418445,-0.0107290832352541,0.00564429382914893,0.542748147033137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39706,0.00230194910210138,0.00381400102034007,-0.00517349289776517,0.00977739110196792,0.546154354421096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39706,-0.00448384194455605,0.0074331822376208,-0.0190528791302928,0.0100851952411807,0.54637555967879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40020,0.00253965566124555,0.00421424551207919,-0.00572026554242967,0.0107995768649208,0.546763551250461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39719,-0.00262105968294912,0.00436016495198412,-0.011166982988838,0.00592486362293975,0.54776119773981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,40054,0.00471063607964278,0.00783869820704619,-0.0106532124061678,0.0200744845654533,0.547888346927384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40020,0.00385163808158422,0.00641166302437505,-0.00871522144619089,0.0164184976093593,0.548036591507642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39719,0.00370633536934663,0.00617464090562224,-0.00839596080567296,0.0158086315443662,0.548351785903867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,42120,-0.00234136470932399,0.00391162653312394,-0.0100081527142469,0.00532542329559893,0.549473153539778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,40054,-0.00156080797095471,0.00261055738313791,-0.00667750044190501,0.00355588449999559,0.549930447671522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39881,0.00397027340078285,0.00664155322645342,-0.00904717092306585,0.0169877177246316,0.549990791682684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39768,-0.0031210168855712,0.00522610458270791,-0.0133641818676787,0.0071221480965363,0.550388277704337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42120,0.00206983871505398,0.00346734646233388,-0.00472616035112043,0.00886583778122839,0.55055001645361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41983,-0.00168740882282776,0.00287614930712184,-0.00732466146478656,0.00394984381913104,0.557422097010217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39881,0.00216658825106624,0.00370937315237769,-0.00510378312759402,0.00943695962972651,0.559175629436945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41542,0.00164354059647959,0.00282288009839141,-0.00388930439636757,0.00717638558932676,0.560428335230703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39881,0.00309081715333027,0.00530963389917378,-0.00731606528905033,0.0134976995957109,0.560501550280651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39881,0.00261232718716096,0.00452300782994097,-0.00625276815952333,0.0114774225338453,0.563570581938033
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,40021,0.00324121518173784,0.00561845028526006,-0.00777094737737187,0.0142533777408476,0.564027275516729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39784,0.00327925404142118,0.00569814018491879,-0.00788910072101965,0.014447608803862,0.564968460037299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39706,0.00274904062628822,0.00478568210148619,-0.00663089629262471,0.0121289775452011,0.565688970931707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39665,-0.00299265878954697,0.00525439737523919,-0.0132912776450158,0.00730596006592184,0.568993002417941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39719,0.0035613710340144,0.00628170048233314,-0.00875076191135856,0.0158735039793874,0.570764466834436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39665,0.003795073414323,0.00669799908933734,-0.00933300480077818,0.0169231516294242,0.570999424718776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39768,0.00306843471027934,0.0054540120924731,-0.00762142899096793,0.0137582984115266,0.573718281539459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39706,0.00212373860862155,0.00378161183689859,-0.00528822059169968,0.00953569780894278,0.574403183666493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39784,0.00163459744144044,0.00292131777434045,-0.00409118539626684,0.00736038027914773,0.57580430452478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39665,-0.0023405160525309,0.00419342924251682,-0.0105596373678639,0.00587860526280207,0.57676146148063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41861,0.00781691552357193,0.0140201506826257,-0.0196625798143743,0.0352964108615182,0.577162509079947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42213,0.00159085242871817,0.00286701601732576,-0.00402849896524032,0.00721020382267667,0.578985659427673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39804,0.00100337166252438,0.00182249817914744,-0.0025687247686046,0.00457546809365336,0.581955555259186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39706,-0.00373697374885895,0.00679249069683354,-0.0170502555146527,0.00957630801693478,0.582219602488901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41861,0.00176020245091774,0.00321131593854463,-0.00453397678862973,0.00805438169046521,0.583615755527061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39881,0.00288638031790752,0.00526668804512216,-0.00743632825053191,0.0132090888863469,0.583672676670731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39768,0.00376601672812199,0.00687833547767187,-0.00971552080811488,0.0172475542643589,0.584034039786196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40080,0.00267449327910791,0.00488532734774348,-0.00690074832246932,0.0122497348806851,0.5840779081123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39706,-0.00240333905650026,0.00439996292857658,-0.0110272663965104,0.00622058828350984,0.584927670055479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40021,-0.00303929895661115,0.00556679896386512,-0.0139502249257868,0.00787162701256448,0.585098582696897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41861,-0.00536397518091542,0.00984319587494358,-0.0246566390958048,0.013928688733974,0.585802699791719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39768,0.00373372008431098,0.00685477342754469,-0.00970163583367661,0.0171690760022986,0.585978877970896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39881,0.00944171826236793,0.0173455084424179,-0.0245554782847712,0.0434389148095071,0.586224269274009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41887,0.00327134595994971,0.00601129687701824,-0.00851079591900604,0.0150534878389055,0.586313617008773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39665,-0.00260330343180757,0.00479327991680386,-0.0119981320687431,0.00679152520512799,0.587062012467097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,40097,-0.00270972219207816,0.00498973375229977,-0.0124896003465857,0.0070701559624294,0.587099954906261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,40102,-0.0012956673899957,0.00238626158607367,-0.00597274009870009,0.00338140531870868,0.58716185906785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39706,-0.00211396078115882,0.00390988330749773,-0.00977733206385438,0.00554941050153673,0.588745779625325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40102,-0.00154518714522326,0.00286411147748024,-0.00715884564108452,0.004068471350638,0.589553148996518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41840,-0.00465198132712221,0.00863541657943045,-0.0215773978228059,0.0122734351685615,0.59009676969418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39784,-0.00259796744506802,0.00482263762564241,-0.0120503371913271,0.0068544023011911,0.5901034001129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39706,-0.00374773352212117,0.00698782389226651,-0.0174438683509635,0.00994840130672118,0.591746404550267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42094,0.00114196814143538,0.00213464566660118,-0.00304193736510292,0.00532587364797369,0.592680876185107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41829,-0.00329808633476703,0.0061882445463247,-0.0154270456455634,0.00883087297602939,0.59407069672447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39865,0.0054525619730276,0.0102595969657858,-0.0146562480799125,0.0255613720259677,0.595111346905841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39719,-0.0031087960019954,0.0058504970208826,-0.0145757701629253,0.00835817815893451,0.595171559387443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42094,-0.00193353023344947,0.00364110630022005,-0.00907009858188077,0.00520303811498182,0.595408359176931
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41985,-0.00124197611054578,0.00234668638216912,-0.00584148141959726,0.0033575291985057,0.596643483309611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,40020,0.00221221873506856,0.00420284320555568,-0.00602535394782058,0.0104497914179577,0.598647201666881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39719,-0.00322589214128424,0.00612885634699249,-0.0152384505813895,0.00878666629882105,0.598659698509177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39768,0.00362257067729435,0.00691181972080407,-0.00992459597548162,0.0171697373300703,0.600211324182987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39881,0.00295451989549068,0.0056390719317583,-0.0080980610907556,0.014007100881737,0.600333043419806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42094,0.00239565535096524,0.00457681397214586,-0.00657490003444064,0.0113662107363711,0.600681973562674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41683,0.00196610117345745,0.00376155916587488,-0.00540655479165732,0.00933875713857221,0.601204485453975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39768,-0.00193893658962977,0.00371231629986552,-0.00921507653736619,0.00533720335810666,0.60147357588349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40020,-0.0028826137721632,0.00553531598687604,-0.0137318331064402,0.00796660556211383,0.602539257498167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,40054,-0.00833529892381886,0.0160101487752273,-0.0397151905232644,0.0230445926756267,0.602637981884743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39719,-0.00288799799971527,0.00555134602500914,-0.0137686362087332,0.00799264020930265,0.602911551753417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,40054,-0.00237627295482572,0.00457519100341419,-0.0113436473215175,0.00659110141186609,0.603504797844496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42094,-0.00457835763691497,0.00882247385767268,-0.0218704063979534,0.0127136911241235,0.603809662575513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39706,-0.00168866699351578,0.00326248391207357,-0.00808313546117997,0.00470580147414841,0.604747135414269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,40020,0.00209035447839555,0.00404948077991851,-0.00584662785024473,0.0100273368070358,0.605723117460753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39665,-0.00253426563215753,0.0049183039833103,-0.0121741414394457,0.00710561017513066,0.606373654830187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39706,0.00369046992113218,0.00717357053659316,-0.0103697283305904,0.0177506681728548,0.606945636813217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40080,0.00164013338299181,0.00319468048881171,-0.00462144037507915,0.00790170714106277,0.607685375237647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39706,0.00451929345255582,0.00882234108210043,-0.012772495068361,0.0218110819734727,0.608482910617998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,40054,0.00186306859027989,0.00364256482933575,-0.00527635847521818,0.00900249565577796,0.609031243888914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39784,-0.00326849539763673,0.00640723313841403,-0.0158266723489282,0.00928968155365478,0.609973911659758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41829,0.00396145336402404,0.00777069704564738,-0.0112691128454448,0.0191920195734929,0.610204816911852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,40054,-0.0013148462384202,0.0025844192928776,-0.00638030805246029,0.00375061557561989,0.610931587727226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40113,0.00100580610642665,0.00198323097824651,-0.00288132661093651,0.00489293882378981,0.612056096494301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40054,0.00188035988766815,0.00371696094337051,-0.00540488356133805,0.00916560333667434,0.612946687616543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41861,-0.0016503598825099,0.0032791337335481,-0.00807746200026417,0.00477674223524437,0.614768147196344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41861,-0.00245041290923083,0.00487542286324562,-0.0120062417211922,0.00710541590273058,0.615250606395549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41876,0.00155415126409958,0.00309274941290614,-0.00450763758519645,0.00761594011339561,0.615314417296925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41770,-0.00337008635965529,0.00670853548551047,-0.0165188159112558,0.00977864319194522,0.615424524613084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42103,0.00455495278207614,0.00909074117241489,-0.013262899915857,0.0223728054800093,0.616341619797404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,42141,0.0013693724572311,0.0027336107198403,-0.00398850455365589,0.0067272494681181,0.61642250908498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39784,-0.00525705105506758,0.010516552644451,-0.0258694942381916,0.0153553921280565,0.617167503156199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39768,-0.00247241712469697,0.0049502356356143,-0.012174878970501,0.00723004472110707,0.617469673005202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39622,0.00175289288944071,0.00352158838911594,-0.00514942035322654,0.00865520613210795,0.618666299934955
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42103,0.0012035953589073,0.00242269899246078,-0.00354489466631583,0.00595208538413043,0.619338992025087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41861,0.00824664584911788,0.0167310355951762,-0.0245461839174275,0.0410394756156632,0.622095237237307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41861,0.00237012580905397,0.00481092399405482,-0.00705928521929348,0.0117995368374014,0.622264910789934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39881,-0.00234372764282043,0.00476117522881386,-0.0116756310912956,0.00698817580565473,0.622546923408186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,40020,-0.00213920209626544,0.00435158484859249,-0.0106683083995067,0.00638990420697583,0.623018124279053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41861,0.00607281695483861,0.0123815687460764,-0.0181950577874711,0.0303406916971484,0.623808196045266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39784,-0.00480564055493563,0.00985041054004187,-0.0241124452134177,0.0145011641035464,0.625657723056313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,40020,-0.00186482550310682,0.00383455069940461,-0.00938054487393985,0.0056508938677262,0.626748886771654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,42088,0.00535557214710396,0.0110309410989276,-0.0162650724067941,0.026976216701002,0.627326731772694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41696,0.00324579373121324,0.00670623076168384,-0.00989841856168708,0.0163900060241136,0.628396670427877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,42237,0.00332771907090826,0.00692332309098871,-0.0102419941874296,0.0168974323292461,0.630770888214921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39881,-0.00214956171817807,0.00447218597618546,-0.0109150462315016,0.00661592279514542,0.630774233043241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39719,-0.00292507298365074,0.00609473075063831,-0.0148707452549018,0.00902059928760035,0.631283775241014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40054,0.00164580571705969,0.00343288980092882,-0.00508265829276079,0.00837426972688017,0.631647514658528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39863,-0.00104726063808833,0.00218474321138719,-0.00532935733240722,0.00323483605623057,0.631698186792635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39768,-0.00325016809986893,0.00679908677341216,-0.0165763781757568,0.0100760419760189,0.632638666879762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39706,0.00187931616626098,0.00395266821107146,-0.00586791352743908,0.00962654585996104,0.634472525116914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39784,0.00183828755079117,0.00388119330045023,-0.00576885131809128,0.00944542641967363,0.635766564980115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39719,0.00227433296134255,0.00481083082870155,-0.00715489546291249,0.0117035613855976,0.636399471161572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39881,-0.00208158116021704,0.00440751449683105,-0.0107203095740059,0.00655714725357183,0.636736552704992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39768,-0.00300364896579764,0.00637460957817784,-0.0154978837390262,0.00949058580743092,0.637515151940726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39804,0.00111268068612539,0.00236175473118577,-0.00351635858699871,0.0057417199592495,0.637561465256631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39719,0.00235124076292575,0.00500203706726506,-0.00745275188891376,0.0121552334147653,0.638324287077197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39719,-0.00142717592866565,0.00303955017447388,-0.00738469427063446,0.00453034241330315,0.638696826862583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39665,-0.00271190027120158,0.00579320626920966,-0.0140665845588525,0.00864278401644935,0.639710427672836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40020,0.00252119919405767,0.00541887435392644,-0.00809979453963816,0.0131421929277535,0.641752822435361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39768,0.00301317861700025,0.00649459749659492,-0.0097162324763258,0.0157425897103263,0.642692004299959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41876,0.00251433332522891,0.00543128158197584,-0.00813097857544374,0.0131596452259016,0.643418508185618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39784,-0.00121375773804202,0.00263282985504426,-0.00637410425392876,0.00394658877784472,0.644801757297093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39784,-0.00287953805157468,0.00624750287219169,-0.0151246436810704,0.00936556757792104,0.644872469437263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39706,-0.00247530205450419,0.00540200949716328,-0.0130632406689442,0.00811263655993584,0.646804760389957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39768,0.00144216271820922,0.00315044461762504,-0.00473270873233586,0.00761703416875431,0.647130817759861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39719,0.00285270265445267,0.00625402106071017,-0.00940517862453926,0.0151105839334446,0.648299468101857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39881,0.00174863149664719,0.0038336752849008,-0.00576537206175839,0.00926263505505276,0.648310045393531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39768,0.00228298482420585,0.00501623767286819,-0.0075488410146158,0.0121148106630275,0.649033009470985
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,42159,0.00147040552017536,0.00323659906061949,-0.00487332863863884,0.00781413967898956,0.649616393142246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41861,-0.00184310020317453,0.00406817494773058,-0.00981672310072647,0.00613052269437741,0.6505181008776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41810,-0.00301421477026235,0.00665687205535018,-0.0160616839987487,0.010033254458224,0.650702377816889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39768,-0.00228728706034687,0.00508225010184016,-0.0122484972599536,0.00767392313925985,0.65268071989814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39784,-0.00391081779555986,0.00869701225054626,-0.0209569618066305,0.0131353262155108,0.652954931316312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39768,0.00344129369851849,0.00766169186888949,-0.0115756223645049,0.0184582097615419,0.653328441418348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,40054,-0.00298048274293663,0.00664827418690857,-0.0160111001492774,0.0100501346634042,0.653938977252009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39719,-0.00336712615660589,0.00752504015091339,-0.0181162048523961,0.0113819525391844,0.65455488680563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39665,0.00424809243815243,0.0095155457303387,-0.0144023771933114,0.0228985620696163,0.655290786154284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39719,0.00231749386925199,0.00519281596881734,-0.00786042542963,0.012495413168134,0.655398068437829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39706,-0.00219824866077748,0.00492612009182812,-0.0118534440407606,0.00745694671920562,0.655430615613642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39706,0.00311141525392238,0.00701728580497586,-0.0106424649238303,0.0168652954316751,0.657490638797381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,40054,-0.00458430850759187,0.0103444331480908,-0.0248593974778498,0.015690780462666,0.65765397633598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39706,-0.00230121793289855,0.00520145150779683,-0.0124960628881803,0.00789362702238325,0.65819555795631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39804,-0.00175042780650919,0.00396296774834094,-0.00951784459325743,0.00601698898023905,0.65871805939971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,42126,-0.00162511950813911,0.00368558344947612,-0.00884886306911231,0.0055986240528341,0.659264131357996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,42213,-0.00196330000857759,0.00448808018456984,-0.0107599371703345,0.00683333715317929,0.661794009495863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39768,0.00136382448222167,0.00313612462833521,-0.00478297978931533,0.00751062875375868,0.663661507907995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39881,-0.0015329182047517,0.00354281296615721,-0.00847683161841983,0.00541099520891644,0.665253143746863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41887,-0.00492801645733267,0.0114163144391989,-0.0273039927581626,0.0174479598434973,0.665992680880932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39665,-0.00278108035180141,0.00644816803366872,-0.0154194896977921,0.00985732899418928,0.666260766527637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39768,0.00374496677507025,0.00868736222499783,-0.0132822631859255,0.020772196736066,0.666417427509588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39719,0.00190413354894005,0.00442506681594291,-0.00676899741030806,0.0105772645081882,0.666981750717489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39768,-0.0033292417794908,0.00776251350975309,-0.0185437682586069,0.0118852846996253,0.668014137604626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39816,0.00178440417431499,0.00416388684307905,-0.00637681403811996,0.00994562238674994,0.668264591366746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41887,-0.00182160227075607,0.00425346689323097,-0.0101583973814888,0.00651519283997664,0.668466958047513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,40021,-0.0114226752771023,0.0266933028339237,-0.0637415488315928,0.0408961982773883,0.668715773093598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39706,-0.00117329930547049,0.0027436579054064,-0.00655086880006704,0.00420427018912605,0.668921617128921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39706,-0.00203757746909667,0.00476903690237848,-0.0113848897977585,0.00730973485956516,0.66920501216512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39706,0.00471169007451372,0.0110714049994045,-0.0169882637243191,0.0264116438733465,0.67042779364114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40080,-0.00157375417417947,0.00370379894588835,-0.00883320010812063,0.00568569175976169,0.670916003906823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,42144,-0.00165126068549733,0.00388989086169706,-0.00927544677442358,0.00597292540342891,0.671207879632679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41829,-0.00142014240694824,0.00334694592514512,-0.00798015642023268,0.0051398716063362,0.671347018966411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41829,0.00285154440560562,0.00672590753247719,-0.0103312343580497,0.0160343231692609,0.671599096376508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42186,0.00341772617038563,0.00806475949095703,-0.0123892024318902,0.0192246547726614,0.671729447156735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39719,-0.00206139100511394,0.00487175874881258,-0.0116100381527866,0.00748725614255871,0.67220850268224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39665,0.00244493548809104,0.00579278677426293,-0.0089089265894643,0.0137987975656464,0.672985868929809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39719,-0.00144784566581384,0.00344100012482833,-0.00819220591047738,0.00529651457884969,0.673936715434149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39665,0.00155524743267458,0.00370784326945759,-0.00571212537546229,0.00882262024081146,0.674897357445095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39719,0.00507558590198131,0.0121078191753355,-0.0186557396816762,0.0288069114856389,0.675079245114021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41887,0.00243713069336078,0.00582686107129584,-0.00898351700637907,0.0138577783931006,0.675765640607191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41829,0.00223282907358869,0.00535030179213281,-0.00825376243899162,0.012719420586169,0.676445830092018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39706,-0.0018396743264001,0.00441071345162951,-0.0104846726915939,0.00680532403879373,0.676619462465886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41829,0.00207201385624159,0.00499028434493587,-0.00770894345983272,0.0118529711723159,0.677995538212399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41887,0.00271108115191747,0.0065366293571808,-0.0101007123881569,0.0155228746919918,0.678330352823098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39784,-0.00162840229753362,0.00392725325008875,-0.00932581866770757,0.00606901407264034,0.678412739877293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39665,-0.0028568823451722,0.0069160412696651,-0.0164123232337158,0.0106985585433714,0.679556034880877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39784,0.00186455427155855,0.00454295060415902,-0.00703962891259312,0.0107687374557102,0.681500290464568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42108,-0.000819135716876238,0.00199609728564906,-0.00473148639674839,0.00309321496299591,0.681542359339669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39719,0.00375390989597938,0.00923601312895454,-0.0143486758367715,0.0218564956287303,0.684425631813411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39881,0.00330458055356025,0.00813539446267261,-0.0126407925932781,0.0192499537003986,0.684605293218469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39784,-0.00149149416559981,0.0036910910516367,-0.00872603262680773,0.00574304429560812,0.686162431083725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39665,-0.00254925803172583,0.00633695383197022,-0.0149696875423875,0.00987117147893581,0.687482903602654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,42274,0.00190868496948234,0.00474531717422918,-0.00739213669200686,0.0112095066309715,0.687525053376158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40054,-0.00346495373868744,0.00863039182771435,-0.0203805217210076,0.0134506142436327,0.688072610527412
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40054,-0.00188687118131871,0.00472104546118984,-0.0111401202852508,0.00736637792261339,0.689405743812347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39881,0.00211131686593806,0.00528352640913298,-0.00824439489596258,0.0124670286278387,0.689456393676184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40054,0.00300045291774609,0.00757116463913352,-0.0118390297749556,0.0178399356104478,0.691891477137476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40054,-0.00200176402504545,0.00507666468115943,-0.0119520268001179,0.00794849875002702,0.693362195780217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41876,-0.00132295158797244,0.0033623910976867,-0.00791323813943839,0.0052673349634935,0.693989629427979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42213,0.00186860583200734,0.00475148053338205,-0.00744429601342148,0.0111815076774362,0.694127898938659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39881,0.00176923283604996,0.00450058984432293,-0.00705192325882299,0.0105903889309229,0.694245101333651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,40080,0.0010261426898673,0.00265113667808739,-0.00417008519918398,0.00622237057891858,0.69872110719945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39784,0.00213400456742543,0.00555587339448209,-0.00875550728575946,0.0130235164206103,0.700912897385098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41861,-0.00277551995654079,0.00729240929074416,-0.0170686421663993,0.0115176022533178,0.703503514202301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39816,-0.00132175777030302,0.00349017357797807,-0.00816249798314003,0.00551898244253399,0.704912043677902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39719,0.00321268868593488,0.0084888101823837,-0.0134253792715372,0.0198507566434069,0.705095347811521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42167,-0.00194447688690346,0.00513808893355431,-0.0120151311966699,0.00812617742286299,0.70510727470686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41887,0.00170336365988346,0.00450310254390242,-0.00712271732616528,0.0105294446459322,0.705240468726836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42004,-0.00452746811036169,0.011977396114353,-0.0280031644944936,0.0189482282737702,0.705436089363683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39719,0.00276283934466059,0.00734016748234512,-0.0116238889207358,0.017149567610057,0.706627102360045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40097,-0.0011311193198255,0.0030108259067106,-0.00703233809697828,0.00477009945732727,0.707159093526081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39706,-0.000784373722630076,0.00208843293731395,-0.00487770227976542,0.00330895483450527,0.707236711435879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39719,0.00290019252580533,0.00772225965997153,-0.0122354364077389,0.0180358214593495,0.707249609228265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42126,-0.000972337164419333,0.00258921846343746,-0.00604720535275676,0.00410253102391809,0.707270214277865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41887,-0.0024211503563062,0.00647863062053016,-0.0151192663725453,0.0102769656599329,0.70862387913842
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40080,-0.00103450543443749,0.00277104748324186,-0.00646575850159152,0.00439674763271655,0.708912731444997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39768,-0.00139543596441267,0.0037416376551063,-0.00872904576842102,0.00593817383959568,0.70919468448429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39665,0.00226890647999472,0.00610327666716507,-0.00969351578764881,0.0142313287476383,0.710084883996855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39847,-0.00236107817019458,0.00637638647103901,-0.014858795653431,0.0101366393130419,0.711177755270252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39784,-0.00104425645453355,0.00283067857611678,-0.00659238646372244,0.00450387355465534,0.712204601357862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39881,-0.0016748517393069,0.00454854406462154,-0.0105899981059651,0.00724029462735132,0.712718647978146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40020,0.00104235846808625,0.0028364565023816,-0.00451709627658169,0.00660181321275418,0.713263607523424
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,42120,0.00185519952297921,0.00507826643383364,-0.00809820268733471,0.0118086017332931,0.714877465613365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42103,0.000999940283883326,0.00274677838256116,-0.00438374534593654,0.00638362591370319,0.715833264470996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40020,-0.00245655753877616,0.00674911736197603,-0.0156848275682492,0.0107717124906968,0.715878525229187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39665,-0.00241164034331563,0.00664712532729384,-0.0154400059848116,0.0106167252981803,0.716754503468572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39784,-0.00330047427011136,0.00910547320006866,-0.0211472017422459,0.0145462532020232,0.717006971791036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40020,-0.00212134818914219,0.005864388488219,-0.0136155496260514,0.00937285324776705,0.717557942389893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39881,-0.00143121863823918,0.00396367147928718,-0.00920001473764205,0.00633757746116369,0.718043737178797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41861,0.00303797924429486,0.00846206659924961,-0.0135476712902344,0.0196236297788241,0.719592468112089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41829,0.0013790159631772,0.00387012792652849,-0.00620643477281865,0.00896446669917305,0.721604564663491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39665,-0.00165802027178226,0.00466014176092904,-0.0107918981232032,0.00747585757963866,0.722006864529436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41876,0.000765669200391069,0.00215224377363999,-0.00345272859594332,0.00498406699672546,0.722030763605233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39881,0.00249185706308317,0.00700467164274933,-0.0112372993567055,0.0162210134828719,0.722040685418319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,42094,0.00493328521537176,0.0139382560922393,-0.0223856967254173,0.0322522671561608,0.723390770722888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42256,-0.00125965237688619,0.00358911697039915,-0.00829432163886853,0.00577501688509616,0.725620697078355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,42103,0.00143583072568848,0.00409811512390745,-0.00659647491717012,0.00946813636854708,0.726071491257038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40020,0.00156205765950263,0.00449939609037134,-0.0072567586776252,0.0103808739966305,0.728469968596894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39881,0.00218296029650373,0.00631267207901138,-0.0101898769783586,0.014555797571366,0.729495272974037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39719,0.00144446664354552,0.00418161492825452,-0.00675149861583334,0.00964043190292438,0.729775981166284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,42120,-0.00116949206504288,0.00338723766851922,-0.00780847789534054,0.00546949376525479,0.729901340283633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39768,0.00165919905034673,0.00481580945725076,-0.00777978748586476,0.0110981855865582,0.730453307351491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39719,0.00386808126705305,0.011234557683962,-0.0181516517935125,0.0258878143276186,0.730626019696552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39651,0.00177646915812766,0.00521730399673322,-0.00844944667546944,0.0120023849917248,0.733490160627928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39518,0.00236331187800931,0.00700990602937354,-0.0113761039395628,0.0161027276955815,0.736019061634078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42103,0.000929353512659896,0.00276030834264963,-0.00448085083893338,0.00633955786425317,0.736360091408794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39881,-0.0013771841324234,0.00411587591095345,-0.00944430091789216,0.00668993265304537,0.737931202020409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39768,0.00217109632012865,0.00650336647273633,-0.0105755019664346,0.0149176946066919,0.738505472300907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39804,-0.00112398610246079,0.00336715586866596,-0.00772361160504607,0.00547563940012448,0.738530474746251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39719,-0.00108595760085417,0.00326308835949849,-0.0074816107854712,0.00530969558376287,0.739291471354957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39768,-0.00302690742144847,0.0091492523706907,-0.0209594420680022,0.0149056272251053,0.740774478970011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,40035,0.000795473959561452,0.00240817744055219,-0.00392455382392085,0.00551550174304375,0.741163063498825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39768,-0.00259883908851188,0.00787382403963471,-0.0180315342061959,0.0128338560291722,0.741360711513358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42103,-0.00201988859641867,0.00613138184321994,-0.0140373970091297,0.0099976198162924,0.741832653563916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39784,0.00160828897845287,0.004883027430139,-0.00796244478461958,0.0111790227415253,0.741887780174387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41829,0.000962986744923429,0.00294795948575068,-0.0048150138471479,0.00674098733699476,0.74392885169096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40054,0.00105816605036395,0.00324717141273713,-0.00530628991860082,0.00742262201932873,0.744526592481902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39719,0.00145481443391238,0.0044758777550399,-0.00731790596596582,0.0102275348337906,0.745161464233633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39706,-0.00124248042244371,0.00389937978623771,-0.00888526480346961,0.0064003039585822,0.75000933966464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40097,-0.000801112023218979,0.00253666064811191,-0.00577296689351833,0.00417074284708037,0.752150012138808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39651,-0.00130686916497091,0.0041406560596875,-0.00942255504195841,0.00680881671201659,0.752298115604669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39768,0.0012945202684707,0.00411428343094361,-0.00676947525617878,0.00935851579312017,0.753040819806369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39706,-0.00187347536214097,0.00599196871930856,-0.0136177340519858,0.00987078332770381,0.754541839979702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39784,-0.00124579837057992,0.00402639917515343,-0.00913754075388063,0.0066459440127208,0.757017602674688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,40084,0.00108386972215813,0.00350554844060236,-0.0057870052214225,0.00795474466573877,0.757185258852838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,42213,-0.00073589980792747,0.00239691047683525,-0.00543384434252457,0.00396204472666963,0.758832947333737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39665,-0.0014755027487716,0.00480620439542911,-0.0108956633638127,0.00794465786626946,0.758849793899314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39873,0.00075710505825992,0.00246632688302063,-0.00407689563246052,0.00559110574898036,0.758867040046266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39784,0.0011496433586859,0.00375626125192442,-0.00621262869508596,0.00851191541245777,0.759564565647876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39665,-0.00223957668885921,0.00734926375337567,-0.0166441336454755,0.0121649802677571,0.760574171319168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42213,0.0009187528013133,0.00304992302006034,-0.00505909631800496,0.00689660192063156,0.763237803215318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39784,-0.000734438210027379,0.00246010385432672,-0.00555624176450775,0.00408736534445299,0.765297279546522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42004,-0.00154507926999043,0.00521870173914366,-0.011773734678712,0.00868357613873115,0.767184606528107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39665,-0.00230212244083017,0.00785875909132048,-0.0177052902598183,0.013101045378158,0.769576001766794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39706,0.000991246845715251,0.00338582295936025,-0.00564496615463085,0.00762745984606135,0.769708376690313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39706,0.00154225383746188,0.00526908939717088,-0.00878516138099305,0.0118696690559168,0.769758498812819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39665,-0.000732746690571957,0.00250710549650682,-0.00564667346372532,0.00418118008258141,0.770087519678806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39719,0.00164687396250041,0.00564818656084633,-0.0094235716967584,0.0127173196217592,0.770616801572609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39768,-0.00101069084953425,0.0034694454929507,-0.00781080401571762,0.00578942231664913,0.770818480992285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39768,-0.00142028358118369,0.00490513077052347,-0.0110343398914097,0.00819377272904231,0.772165737429829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41876,-0.00308347241715239,0.0106527859639311,-0.0239629329064573,0.0177959880721526,0.772240079479555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39784,-0.00107167157976469,0.00373535092487514,-0.00839295939251995,0.00624961623299058,0.774194626505367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39719,-0.00164635320540867,0.00575921335210841,-0.0129344113755412,0.00964170496472382,0.774987721761634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39881,0.00163020435012749,0.00571256093990655,-0.00956641509208934,0.0128268237923443,0.775364766263539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41829,0.00130777340559312,0.00458765862239981,-0.0076840374943105,0.0102995843054967,0.775600268609432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39881,-0.00109721235343586,0.00386491245991076,-0.00867244077486095,0.00647801606798923,0.776499712798599
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41887,0.00138700262438595,0.00490367545452378,-0.00822420126648066,0.0109982065152526,0.777296745717544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42202,-0.00263474347448716,0.00932503387947717,-0.0209118098782624,0.0156423229292881,0.777529995857819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39784,-0.000834025809009549,0.0029570427228276,-0.00662982954575164,0.00496177792773254,0.777912781003214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42096,-0.00170783937835045,0.00606045729748325,-0.0135863356814176,0.0101706569247167,0.778101072733822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39881,-0.00177615633528546,0.00633421255266185,-0.0141912129385027,0.0106389002679318,0.779170840545158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41887,0.00144741683019673,0.00516594634480542,-0.0086778380056219,0.0115726716660154,0.779340711387527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39706,-0.0013552577505249,0.00483878267910226,-0.0108392718015653,0.00812875630051552,0.779419816694837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40020,0.00128678308472551,0.00460434029578851,-0.00773772389501997,0.010311290064471,0.779888146268116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,42213,0.000854340518942534,0.00306482825925751,-0.00515272286920218,0.00686140390708725,0.780436197046897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39706,0.00109671058140323,0.00394128848090567,-0.00662821484117189,0.00882163600397835,0.780816762645631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41887,0.00121474267736962,0.00438033053253483,-0.00737070516639865,0.0098001905211379,0.781540775436576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39706,-0.00202415258528068,0.00733530174628485,-0.016401344007999,0.0123530388374376,0.782594400069309
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39768,0.00164711707801952,0.00597429967603108,-0.0100625102870014,0.0133567444430405,0.78278354142667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39768,0.00142707712332865,0.0051897814784426,-0.00874489457441885,0.0115990488210762,0.78333830683776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41935,0.00471965711737908,0.0172640985876394,-0.0291179761143942,0.0385572903491524,0.784565652149999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41876,0.00121605532781768,0.00445082559714788,-0.00750756284259215,0.00993967349822752,0.784688424896572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39706,-0.00135787257377019,0.00500160543401737,-0.0111610192244442,0.00844527407690384,0.786021563667277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39706,0.0016264064662052,0.00606760939205625,-0.0102661079422251,0.0135189208746354,0.788668150467989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39768,-0.000741390848018601,0.00278642803025503,-0.00620278978731847,0.00472000809128126,0.790188844307949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,42217,-0.00161918684770833,0.00608627458371491,-0.0135482850317895,0.0103099113363729,0.790213328692154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,42051,-0.00133467503309269,0.00503054755409481,-0.0111945482391185,0.00852519817293314,0.790771782029273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39706,0.00177782150248616,0.00670990962700398,-0.0113736013664416,0.014929244371414,0.791049621775099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39665,-0.00210858543693162,0.00803637438298484,-0.0178598792275819,0.0136427083537187,0.79303350555194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42296,0.000865731356886322,0.00330086192474444,-0.00560395801561278,0.00733542072938542,0.793114072847759
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39784,0.00186974511048655,0.00713190689326707,-0.0121087924003169,0.01584828262129,0.793198390274655
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40021,-0.00134670344847447,0.00513805312195456,-0.0114172875675054,0.00872388067055646,0.793246373383919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,40080,0.000790184300161078,0.00302432257287852,-0.00513748794268082,0.00671785654300297,0.793884259996712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39706,-0.00125732203217153,0.00482208727263366,-0.0107086130865335,0.00819396902219045,0.794296365860533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39706,-0.00101406553714329,0.00389954927309548,-0.00865718211241042,0.00662905103812385,0.794832721919331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39768,0.00102198695868599,0.00395828184297869,-0.00673624545355223,0.00878021937092422,0.796265656933088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39706,0.00125148158715057,0.00488728020001541,-0.00832758760487963,0.0108305507791808,0.797902469027124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39784,0.000909775884897287,0.00356162208580673,-0.0060710034032839,0.00789055517307848,0.798389294391903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39784,0.00105871879678487,0.00414921663627798,-0.00707374581031997,0.00919118340388971,0.798603608024056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39706,0.000876487136046136,0.00344497822172093,-0.00587567017852689,0.00762864445061916,0.799172540347476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.00251254194392669,0.00990998731444014,-0.016911033192376,0.0219361170802294,0.799857811317499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,42256,-0.00125029683080585,0.00493432609962204,-0.0109215759860651,0.00842098232445335,0.799972730661697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40097,0.000935564825079406,0.00370596807059256,-0.00632813259328201,0.00819926224344083,0.800699436736314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39706,0.00100176140524318,0.00397297598395029,-0.00678527152329938,0.00878879433378574,0.800934817468267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,40102,-0.00179808823966021,0.0072986212558135,-0.0161033859010547,0.0125072094217343,0.805408212993562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39881,-0.000691803566287917,0.00282812040945785,-0.0062349195688253,0.00485131243624947,0.806758452819631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40021,-0.000628880982024854,0.00258612425975435,-0.00569768453114338,0.00443992256709367,0.807874375088921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39804,0.001370230530423,0.00570408774639941,-0.00980978145251983,0.0125502425133658,0.810165088357646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41829,-0.00076772171681248,0.00325542634944762,-0.00714835736172981,0.00561291392810485,0.813569716379839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39739,-0.00161098462765323,0.00690692021371776,-0.01514854824654,0.0119265789912336,0.815577937422996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39719,0.0012662625228024,0.005447684790305,-0.00941119966619541,0.0119437247118002,0.816200422809426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40054,0.00052663590928348,0.0022702621871614,-0.00392307797755287,0.00497634979611983,0.816564594322024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,40020,-0.0012082515663285,0.00522333839817315,-0.0114459948267479,0.00902949169409088,0.817072228410376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39706,0.00117126942212208,0.00510819543155598,-0.00884079362372764,0.0111833324679718,0.818646268177611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41887,-0.00214618756279696,0.00943650120952437,-0.0206417299334647,0.0163493548078708,0.820089424812611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39784,0.000885126460012864,0.00389986453060234,-0.00675860801996771,0.00852886093999344,0.82045659362621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41861,0.00129125896575668,0.0057032976349404,-0.00988720439872651,0.0124697223302399,0.820889565620916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39784,-0.000798909494754453,0.00353458778949306,-0.00772670156216085,0.00612888257265194,0.821185394297755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39768,-0.000807714190021252,0.00357554012644752,-0.0078157728378584,0.0062003444578159,0.821283634441391
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39881,0.00167669522716587,0.00749957318124337,-0.0130224682080711,0.0163758586624029,0.823094558618214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42103,-0.00154530283372085,0.00693253958387024,-0.0151330804181065,0.0120424747506648,0.823612399282997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39784,-0.000583210848861215,0.00266090043205124,-0.00579857569568164,0.00463215399795921,0.826515612189714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42103,0.00124646539015517,0.00569488412868539,-0.00991550750206819,0.0124084382823785,0.826751206256359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39706,0.00105751552554496,0.00486509119577746,-0.00847806321817887,0.0105930942692688,0.827925724700286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39719,0.00115737495397005,0.00537877112444211,-0.00938501644993649,0.0116997663578766,0.829635358328408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,40054,0.00119787996024794,0.00558864899989171,-0.00975587207953981,0.0121516320000357,0.830284705043355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39665,-0.00127512712544143,0.00594988914434916,-0.0129369098483658,0.0103866555974829,0.830308656915913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41887,0.00129615454653938,0.0060700785573112,-0.0106011994257906,0.0131935085188693,0.830915650379644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41887,0.001237318748349,0.00581525301008421,-0.0101605771514161,0.0126352146481141,0.831508793347239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39665,0.00184654776556497,0.0087217320697409,-0.0152480470911272,0.0189411426222571,0.832331156476215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39881,-0.0011597391994318,0.0054809412727334,-0.0119023840939893,0.00958290569512566,0.832427126273181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42094,-0.00139254663513507,0.00664496031455248,-0.0144166688516579,0.0116315755813878,0.83401103368682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39719,-0.00136654534527486,0.00662237686428954,-0.0143464039992824,0.0116133133087326,0.83651940711188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,42045,-0.00148661051810183,0.00721223605034549,-0.015622593176779,0.0126493721405753,0.836697796512952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39804,0.0014377298304448,0.00700169524405701,-0.0122855928479069,0.0151610525087965,0.837310240682617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39706,0.000583167637130938,0.00285742249734698,-0.00501738045766914,0.00618371573193102,0.838288136964906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42004,-0.00141326414821612,0.00693275105487632,-0.0150014562157737,0.0121749279193415,0.838471381734236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40054,-0.000558621956525027,0.00275643452610398,-0.00596123362768882,0.00484398971463877,0.839403753728204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39719,0.000977204999525206,0.00482868491214033,-0.00848701742826985,0.0104414274273203,0.839627500428815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39665,-0.000907929538067115,0.00450536102080276,-0.00973843713884053,0.0079225780627063,0.840294313024981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,42144,-0.00102987149729502,0.00516376574231812,-0.0111508523522385,0.0090911093576485,0.841920181282275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39706,-0.000755057802463543,0.00380162328961746,-0.00820623945011377,0.00669612384518668,0.842568090742265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39719,0.000578318407792175,0.00292199111697599,-0.00514878418148077,0.00630542099706512,0.84311203360809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39804,0.000597049006518128,0.00302004954762809,-0.00532224810683294,0.00651634611986919,0.843287408510906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39706,-0.000508811033401583,0.00259640477234134,-0.00559776438719062,0.00458014232038745,0.844639367436582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39706,-0.000792250189233464,0.00404706234140647,-0.00872449237839015,0.00713999199992322,0.844802332295212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39719,-0.00151954863414473,0.00781605531718295,-0.0168390170558233,0.0137999197875339,0.845855675591029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42087,0.00157346801217621,0.00831365307413403,-0.0147212920131265,0.0178682280374789,0.849889569285993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40020,0.000836724692303099,0.0044539105427909,-0.00789293997156707,0.00956638935617327,0.850987622342115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39706,0.00116516135883842,0.00637562094738532,-0.0113310556980368,0.0136613784157136,0.854995659468281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42223,-0.00109091793036306,0.00597073521648803,-0.0127935589546796,0.0106117230939535,0.855027767924438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39706,-0.000822457684720461,0.00450223186410514,-0.00964683213836653,0.0080019167689256,0.855054380625131
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39706,0.000788571560392472,0.0043325311265083,-0.0077031894475638,0.00928033256834875,0.85557701644362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39881,0.000645078345359579,0.00356880594745167,-0.00634978131164569,0.00763993800236485,0.85656357162859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39719,-0.000959919502682993,0.00538200066221852,-0.0115086408006313,0.00958880179526531,0.858445756160219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41876,0.000492057192452874,0.00278236289824587,-0.00496137408810903,0.00594548847301478,0.859630078362287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41861,0.00092204520075146,0.0052455835578987,-0.00935929857272999,0.0112033889742329,0.860473108658042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39804,-0.0010263509560391,0.00586392284134758,-0.0125196397250804,0.0104669378130022,0.861060936111055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40020,-0.000584600020618922,0.00335812823694882,-0.0071665313650386,0.00599733132380076,0.861801854122769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39665,-0.00126721769266422,0.00729830778861865,-0.0155719009583568,0.0130374655730283,0.86215826255752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39863,-0.00123575228196713,0.00712537231351851,-0.0152014820164634,0.0127299774525292,0.862316850468532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39803,0.000961001222329703,0.00558861432008364,-0.00999268284503422,0.0119146852896936,0.863474632583044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39881,0.00106042495449515,0.0062011864619606,-0.0110939005109476,0.0132147504199379,0.864224204573624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40020,0.000872131459997741,0.00527526685169939,-0.00946739156933307,0.0112116544893286,0.868691572502415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40021,-0.000716703307773656,0.00434714198377112,-0.00923710159596505,0.00780369498041774,0.869051192638307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41876,-0.00143316093013373,0.00879639898191989,-0.0186741029346967,0.0158077810744293,0.870579399988687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40113,-0.0005201246276125,0.00319253065493924,-0.00677748471129341,0.00573723545606842,0.870585046781565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42062,0.000974741768588251,0.00606672744025518,-0.0109160440143119,0.0128655275514884,0.872355753959332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41861,0.00152860164137859,0.00951436364289735,-0.0171195510987002,0.0201767543814574,0.872361772391463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39719,-0.00153487238785964,0.00958573915763278,-0.0203229211368199,0.0172531763611006,0.872789304402656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39665,-0.000612342015407872,0.00382947373116856,-0.00811811052849826,0.00689342649768251,0.872961047335265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,42004,-0.000544030641435737,0.00347378385100795,-0.00735264698941132,0.00626458570653984,0.875554382066851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41971,0.000956765551287417,0.00615226592760935,-0.0111016756668269,0.0130152067694018,0.876418309509456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40080,-0.00115622942097829,0.00746009504913381,-0.0157780157172806,0.013465556875324,0.87683320617584
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39784,0.000638591909891781,0.00419299886460744,-0.00757968586473879,0.00885686968452236,0.878953568069495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39665,-0.00101710875057297,0.00671908449609951,-0.014186514362928,0.0121522968617821,0.8796819643411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39768,-0.000785179219210081,0.00522043564218295,-0.0110172330778887,0.00944687463946849,0.880448026500932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39665,-0.000638939615542571,0.00430645160531971,-0.00907958476196921,0.00780170553088407,0.882055209100901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39665,-0.000939962246547073,0.00635103994174229,-0.013388000532362,0.0115080760392678,0.882344582241373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39665,0.000629265307359306,0.0042690822704028,-0.00773813594263018,0.0089966665573488,0.882818666342254
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42103,0.000518069058514608,0.00352415528704268,-0.00638927530408904,0.00742541342111825,0.883130232691685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39784,0.000416390936054875,0.00283381716629475,-0.00513789070988283,0.00597067258199258,0.883185005630055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,42186,-0.000538997328651334,0.0037535693863416,-0.00789599332588087,0.00681799866857821,0.885821772986114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,42226,-0.000311933122252619,0.00218127187410853,-0.00458722599550534,0.00396335975100011,0.886288320905164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39719,0.000474091810827564,0.00334201094606138,-0.00607624964345274,0.00702443326510787,0.887194690712724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39881,0.000580830032283715,0.00409519120191059,-0.00744574472346104,0.00860740478802847,0.887215212168071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39881,0.000614825988774696,0.00436118061466897,-0.00793308801597648,0.00916273999352588,0.887890800168762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41887,-0.00195826498505028,0.0140072215972388,-0.0294124193156384,0.0254958893455378,0.888817106105776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39784,0.000658565334649917,0.00474114098973149,-0.00863407100522381,0.00995120167452364,0.88952833684266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39665,-0.00198534331680655,0.0144394784542399,-0.0302867210871167,0.0263160344535036,0.890642887429175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42184,-0.000398421277666887,0.00291038932949646,-0.00610278436347994,0.00530594180814617,0.891114953760766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,40097,-0.00122617084352328,0.00901810316192469,-0.0189016530408957,0.0164493113538491,0.891849317029181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39719,-0.0011625523377407,0.00864184330165677,-0.018100565208988,0.0157754605335066,0.892989250296257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39804,-0.000342556250367243,0.00257489456171611,-0.00538934959133083,0.00470423709059634,0.894166640956552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39665,0.000416865700058951,0.00313763207021454,-0.00573289315756154,0.00656662455767945,0.894306679134666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40002,-0.000538676537201752,0.00413477485223521,-0.00864283524758276,0.00756548217317926,0.896347696819355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39768,-0.000589705601508988,0.00454014519816394,-0.00948839018991031,0.00830897898689233,0.896658341705509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39706,-0.000524129280707235,0.0041047367402478,-0.00856941329159292,0.00752115473017845,0.898397624562623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39862,-0.000687917969708799,0.00546890333741746,-0.011406968511047,0.0100311325716294,0.899902754416909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39768,0.00106477783532978,0.00847180443500761,-0.0155399588572851,0.0176695145279447,0.899983749973903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,42223,0.000607812411889101,0.00488031556545439,-0.00895760609640151,0.0101732309201797,0.900886747089702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41887,-0.000534131974753215,0.00431740604544425,-0.00899624782382395,0.00792798387431752,0.901542144179786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42162,0.00126379548196213,0.0103070345983128,-0.018937992330731,0.0214655832946552,0.902413996098211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39784,-0.00123645714240834,0.0102138240195604,-0.0212555522207467,0.01878263793593,0.903648010021708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41861,0.00037823891769023,0.00319820153811911,-0.00589023609702322,0.00664671393240368,0.905858668898444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39719,0.000683267229753685,0.00585386476530386,-0.0107903077102419,0.0121568421697492,0.907083608203889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,40080,0.000615992508672883,0.00538309358350225,-0.00993487091499152,0.0111668559323373,0.908898291531837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42094,-0.000227581904787403,0.00200513330689206,-0.00415764318629584,0.00370247937672103,0.909636216147463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39989,0.000586568760168585,0.0051956555703182,-0.0095969161576551,0.0107700536779923,0.910115102432036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39863,-0.000410754760147805,0.00378095002946205,-0.00782141681789342,0.00699990729759781,0.913491681162473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39706,0.000565895185976837,0.00521149011149459,-0.00964862543255257,0.0107804158045062,0.913532889151692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39863,-0.000436042116085937,0.0040374624015571,-0.00834946842313786,0.00747738419096598,0.913998474210132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39863,-0.00055219698604265,0.00514052914477169,-0.0106276341097952,0.00952324013770986,0.914457600820061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40054,0.0002933853885588,0.00273882892582233,-0.00507471930605297,0.00566149008317056,0.914695170294112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39752,0.000594249109370677,0.00562164262540127,-0.0104241704364158,0.0116126686551572,0.91581653347179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39881,-0.000432146218913613,0.00413042708831989,-0.0085277833120206,0.00766349087419337,0.916675285115777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39706,0.00049535156388025,0.00486587936533494,-0.00904177199217624,0.0100324751199367,0.918916544395452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39665,-0.000463008955644765,0.0047547221152339,-0.0097822643015032,0.00885624639021367,0.922427473391729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39784,0.000419691863055853,0.0044730717392719,-0.00834752874591708,0.00918691247202878,0.925248898100121
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39665,0.000587250297285486,0.00629582915413233,-0.0117525748448139,0.0129270754393848,0.925686014952143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39768,0.000387051294005485,0.00417427717491241,-0.00779453196882284,0.00856863455683381,0.926125420650288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41829,-0.000522900262677178,0.00566504539768145,-0.0116263892421328,0.0105805887167785,0.926458827526097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39881,-0.000583696995935261,0.00633723785670359,-0.0130046831950743,0.0118372892032038,0.926615627273182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39706,-0.000341682119930216,0.00373409635954633,-0.00766051098464102,0.00697714674478059,0.927094431893671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,42004,0.000316226027816189,0.00345677038362001,-0.00645904392407902,0.0070914959797114,0.927112472956604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39804,0.000536584280324783,0.00587892731836425,-0.0109861132636691,0.0120592818243187,0.92727780693381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41861,-0.000397871277614418,0.00440731117457539,-0.00903620117978218,0.00824045862455335,0.928069886047011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39881,0.000781462293725401,0.00868766727935349,-0.0162463655738074,0.0178092901612583,0.928328027838678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41861,-0.000525160525526426,0.00602465566807923,-0.0123334856349617,0.0112831645839089,0.930538911959793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39439,0.000451326646878169,0.00519197869969425,-0.00972495160452256,0.0106276048982789,0.930730698628509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,42161,0.000172958768912728,0.00199223248951134,-0.0037318169105295,0.00407773444835496,0.930818665852939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39665,-0.000225249637813446,0.00261959897261937,-0.00535966362414741,0.00490916434852052,0.931478947480729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39706,-0.000509301351012988,0.00603247244980138,-0.0123329473526237,0.0113143446505977,0.932718838738724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,42144,-0.000583603009556685,0.00697951633029112,-0.0142634550169273,0.0130962489978139,0.933362608041088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42197,0.000368798559901479,0.00444639540703104,-0.00834613643787935,0.00908373355768231,0.933897927452399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39706,0.000458969459191491,0.00565648242080437,-0.0106277360855851,0.0115456750039681,0.935331811806305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41887,0.000428934194245499,0.00537981145327048,-0.0101154962541646,0.0109733646426556,0.9364529856517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,42021,-0.00103605373286761,0.0130611360003746,-0.0266358802936018,0.0245637728278666,0.93677663077032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39706,-0.000311933427891947,0.00411909108543191,-0.00838535195533849,0.00776148509955459,0.939636380471063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40097,0.000152891571749058,0.00212033553116889,-0.00400296606934197,0.00430874921284008,0.942517876367685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42144,-0.000204873927237075,0.00284561190671896,-0.00578227326440624,0.00537252540993209,0.942605852702557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39881,0.000166991815939817,0.00235305586346406,-0.00444499767644975,0.00477898130832938,0.943424501606381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39864,-0.000364240411834728,0.00537557202055621,-0.0109003615721249,0.0101718807484554,0.945979191792988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39881,-0.000366649712484312,0.0054801992081333,-0.0111078401604256,0.010374540735457,0.946659022129814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40097,0.000410316975291307,0.00634530231932579,-0.0120264755705872,0.0128471095211699,0.948442166784299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39804,0.000345284273320808,0.00539718673381034,-0.0102332017249475,0.0109237702715891,0.948991448664887
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39863,0.000233744741136454,0.00385016711090931,-0.00731258279624579,0.0077800722785187,0.951591077981581
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39784,0.000296763617359484,0.00492746179636238,-0.00936106150351078,0.00995458873822975,0.951976402468318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41861,-0.000414863404637669,0.00741083262607646,-0.0149400953517475,0.0141103685424722,0.955358085915032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39706,-0.000507244435445603,0.00930813267522885,-0.0187511844788941,0.0177366956080029,0.956542020665981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39804,0.000467658136388653,0.00861154593956654,-0.0164109719051618,0.0173462881779391,0.956692435926613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41861,-0.000276137346630936,0.00509043990439,-0.0102533995592353,0.00970112486597346,0.956739817105296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41887,-0.000199895903146364,0.00368793923134848,-0.00742825679658939,0.00702846499029666,0.956774600504076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39719,-0.000364850460796138,0.0071390718126298,-0.0143574312135506,0.0136277302919583,0.95924190680478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41861,0.000219090624493289,0.00453497280953803,-0.00866945608220125,0.00910763733118783,0.961468876778692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39881,-0.000137665670828715,0.00288845839594077,-0.00579904412687263,0.0055237127852152,0.96198762269235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39719,-0.000260224807716914,0.00548175949541545,-0.0110044734187312,0.0104840238032974,0.962138714123489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41861,-0.000249406305549722,0.00543490945887244,-0.0109018288449397,0.0104030162338403,0.963398895789797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40020,0.00039043979359039,0.00970324454378006,-0.0186279195122185,0.0194087990993993,0.967904071961355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39665,-0.000143053183165364,0.00362126303286873,-0.00724072872758807,0.00695462236125734,0.968489579949159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42296,0.000274024434946532,0.00704606242175022,-0.0135362579116839,0.014084306781577,0.968978334830458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39719,-0.000290766990047165,0.00759022577527069,-0.0151676095095777,0.0145860755294834,0.969442773698539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39768,0.000205702789591166,0.00599379972821194,-0.0115421446777042,0.0119535502568866,0.972623211999932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39804,-0.000172010622326915,0.00539522953635064,-0.0107466605135742,0.0104026392689203,0.974566765624674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42144,0.000202049426864206,0.0068175033835116,-0.0131602572048185,0.0135643560585469,0.976357120961478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39665,-0.000101267970562531,0.00344744805992458,-0.00685826616801472,0.00665573022688965,0.976566259949199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39665,-0.000113550431245697,0.00555687184031422,-0.0110050192382616,0.0107779183757702,0.983697362422558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39784,0.000124623995200369,0.00612440528012529,-0.0118792103538452,0.0121284583442459,0.983765549884058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42126,-6.71083799541261e-05,0.00344642334221435,-0.00682209813069425,0.006687881370786,0.984464960855676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40021,4.70827021594173e-05,0.00276106013759945,-0.00536459516753551,0.00545876057185434,0.986395126810197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39784,-0.00014695864420378,0.0087215885187671,-0.0172412721409873,0.0169473548525797,0.986556609930457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41861,-0.000127967127989279,0.00793235282396302,-0.0156753786629568,0.0154194444069782,0.987129095990414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39665,0.000133953924939411,0.00878468428610877,-0.0170840272758338,0.0173519351257126,0.987834158720933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40020,-7.85776396619806e-05,0.00662438851954917,-0.0130623791379783,0.0129052238586544,0.99053603706919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39719,-4.35738726542566e-05,0.00374098610808197,-0.00737590664449492,0.00728875889918641,0.990706913294597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39784,3.22281248709572e-05,0.00286055093399083,-0.00557445170575107,0.00563890795549298,0.991011111917463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39719,-7.25369949120672e-05,0.00908727163838678,-0.0178835894061502,0.017738515416326,0.993631294268816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39706,2.58722139458888e-05,0.00505020088661296,-0.00987252152381551,0.00992426595170729,0.995912546988176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42213,1.12281259648818e-05,0.00234590447708458,-0.0045867446491209,0.00460920090105067,0.996181199104987
